*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 1 4 # 1 A 127 ARG E 7 ARG~? 30.80 OXT ACT B1069 A 132 GLN C 10 GLN~? 29.20 OXT ACT B1069 A 135 ASP C 6 ASP~? 26.20 OXT ACT B1069 A 138 SER C 3 SER~? 20.83 OXT ACT B1069 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 4.93 -4.34 -8.45 2.17 -4.93 -7.13 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -5.95 -2.78 -14.13 -6.65 -4.51 -15.19 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -6.00 -4.16 -6.70 -6.49 -5.63 -5.27 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -6.40 -1.33 -3.63 -8.43 -0.54 -4.77 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 2 4 # 2 A 127 ARG E 40 ARG~? 29.89 NA NA D1069 A 132 GLN E 33 GLN~? 40.15 NA NA D1069 A 135 ASP D 31 ASP~? 40.40 NA NA D1069 A 138 SER D 30 SER~? 41.47 NA NA D1069 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -1.95 6.50 -43.37 -2.54 7.57 -41.51 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 3 4 # 3 A 127 ARG F 7 ARG~? 8.59 CH3 ACT B1069 A 132 GLN B 10 GLN~? 16.49 CH3 ACT B1069 A 135 ASP B 6 ASP~? 10.84 CH3 ACT B1069 A 138 SER B 3 SER~? 8.11 CH3 ACT B1069 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -24.79 13.40 -5.76 -25.67 16.36 -5.50 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -24.12 24.47 -11.53 -24.90 25.88 -12.90 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -25.70 24.60 -4.72 -27.42 24.68 -3.40 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -22.25 25.44 -1.76 -24.43 24.37 -1.48 1l7d_c00 source 1l7d NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, SUBU: 3 hits 1l7d_c00 naa= 4 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 A 63 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 132 SER B 15 SER~? 18.52 CH3 ACT B1069 A 157 HIS A 18 HIS~? 22.68 O ACT B1069 A 165 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 11.94 40.85 12.92 10.15 41.84 12.44 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 8.67 45.38 10.10 8.76 42.96 10.05 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 11.06 43.85 17.98 11.22 41.97 17.05 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 6.60 37.92 5.74 3.89 37.17 6.93 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 A 63 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 132 SER B 15 SER~? 18.52 CH3 ACT B1069 A 157 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 165 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 11.94 40.85 12.92 10.15 41.84 12.44 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 8.67 45.38 10.10 8.76 42.96 10.05 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 11.06 43.85 17.98 11.22 41.97 17.05 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 6.60 37.92 5.74 3.89 37.17 6.93 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 3 4 # 3 A 63 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 132 SER D 15 SER~? 29.04 OXT ACT B1069 A 157 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 165 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 11.94 40.85 12.92 10.15 41.84 12.44 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 8.67 45.38 10.10 8.76 42.96 10.05 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 11.06 43.85 17.98 11.22 41.97 17.05 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 6.60 37.92 5.74 3.89 37.17 6.93 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 4 4 # 4 A 63 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 132 SER D 15 SER~? 29.04 OXT ACT B1069 A 157 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 165 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 11.94 40.85 12.92 10.15 41.84 12.44 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 8.67 45.38 10.10 8.76 42.96 10.05 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 11.06 43.85 17.98 11.22 41.97 17.05 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 6.60 37.92 5.74 3.89 37.17 6.93 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 5 4 # 5 A 63 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 132 SER E 15 SER~? 31.11 OXT ACT B1069 A 157 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 165 ARG E 13 ARG~? 38.24 OXT ACT B1069 coo 11.94 40.85 12.92 10.15 41.84 12.44 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 8.67 45.38 10.10 8.76 42.96 10.05 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 11.06 43.85 17.98 11.22 41.97 17.05 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 6.60 37.92 5.74 3.89 37.17 6.93 13.07 1.77 -16.33 14.59 4.19 -15.10 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 6 4 # 6 A 63 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 132 SER F 15 SER~? 18.74 OXT ACT B1069 A 157 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 165 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 11.94 40.85 12.92 10.15 41.84 12.44 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 8.67 45.38 10.10 8.76 42.96 10.05 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 11.06 43.85 17.98 11.22 41.97 17.05 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 6.60 37.92 5.74 3.89 37.17 6.93 -18.65 6.83 -15.20 -21.43 5.64 -15.99 1nkk_c00 source 1nkk PEPTIDOMIMETIC INHIBITOR : 6 hits 1nkk_c00 naa= 4 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 B 363 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 432 SER B 15 SER~? 18.52 CH3 ACT B1069 B 457 HIS A 18 HIS~? 22.68 O ACT B1069 B 465 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 B 363 HIS D 18 HIS~? 32.59 OXT ACT B1069 B 432 SER D 15 SER~? 29.04 OXT ACT B1069 B 457 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 465 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 3 4 # 3 B 363 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 432 SER E 15 SER~? 31.11 OXT ACT B1069 B 457 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 465 ARG E 13 ARG~? 38.24 OXT ACT B1069 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 13.07 1.77 -16.33 14.59 4.19 -15.10 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 4 4 # 4 B 363 HIS F 18 HIS~? 22.80 CH3 ACT B1069 B 432 SER F 15 SER~? 18.74 OXT ACT B1069 B 457 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 465 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 -18.65 6.83 -15.20 -21.43 5.64 -15.99 1nkk_c01 source 1nkk PEPTIDOMIMETIC INHIBITOR : 4 hits 1nkk_c01 naa= 4 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 C1063 HIS B 18 HIS~? 22.64 CH3 ACT B1069 C1132 SER B 15 SER~? 18.52 CH3 ACT B1069 C1157 HIS A 18 HIS~? 22.68 O ACT B1069 C1165 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 35.29 94.34 12.32 34.58 95.70 13.75 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 32.69 99.54 14.77 32.37 97.11 14.96 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 40.55 96.94 13.18 39.34 95.23 13.09 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 27.55 93.06 17.78 29.73 91.78 19.50 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 C1063 HIS B 18 HIS~? 22.64 CH3 ACT B1069 C1132 SER B 15 SER~? 18.52 CH3 ACT B1069 C1157 HIS F 18 HIS~? 22.80 CH3 ACT B1069 C1165 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 35.29 94.34 12.32 34.58 95.70 13.75 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 32.69 99.54 14.77 32.37 97.11 14.96 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 40.55 96.94 13.18 39.34 95.23 13.09 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 27.55 93.06 17.78 29.73 91.78 19.50 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 3 4 # 3 C1063 HIS D 18 HIS~? 32.59 OXT ACT B1069 C1132 SER D 15 SER~? 29.04 OXT ACT B1069 C1157 HIS C 18 HIS~? 33.75 OXT ACT B1069 C1165 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 35.29 94.34 12.32 34.58 95.70 13.75 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 32.69 99.54 14.77 32.37 97.11 14.96 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 40.55 96.94 13.18 39.34 95.23 13.09 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 27.55 93.06 17.78 29.73 91.78 19.50 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 4 4 # 4 C1063 HIS D 18 HIS~? 32.59 OXT ACT B1069 C1132 SER D 15 SER~? 29.04 OXT ACT B1069 C1157 HIS E 18 HIS~? 36.76 OXT ACT B1069 C1165 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 35.29 94.34 12.32 34.58 95.70 13.75 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 32.69 99.54 14.77 32.37 97.11 14.96 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 40.55 96.94 13.18 39.34 95.23 13.09 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 27.55 93.06 17.78 29.73 91.78 19.50 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 5 4 # 5 C1063 HIS E 18 HIS~? 36.76 OXT ACT B1069 C1132 SER E 15 SER~? 31.11 OXT ACT B1069 C1157 HIS C 18 HIS~? 33.75 OXT ACT B1069 C1165 ARG E 13 ARG~? 38.24 OXT ACT B1069 coo 35.29 94.34 12.32 34.58 95.70 13.75 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 32.69 99.54 14.77 32.37 97.11 14.96 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 40.55 96.94 13.18 39.34 95.23 13.09 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 27.55 93.06 17.78 29.73 91.78 19.50 13.07 1.77 -16.33 14.59 4.19 -15.10 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 6 4 # 6 C1063 HIS F 18 HIS~? 22.80 CH3 ACT B1069 C1132 SER F 15 SER~? 18.74 OXT ACT B1069 C1157 HIS B 18 HIS~? 22.64 CH3 ACT B1069 C1165 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 35.29 94.34 12.32 34.58 95.70 13.75 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 32.69 99.54 14.77 32.37 97.11 14.96 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 40.55 96.94 13.18 39.34 95.23 13.09 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 27.55 93.06 17.78 29.73 91.78 19.50 -18.65 6.83 -15.20 -21.43 5.64 -15.99 1nkk_c02 source 1nkk PEPTIDOMIMETIC INHIBITOR : 6 hits 1nkk_c02 naa= 4 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 D1363 HIS B 18 HIS~? 22.64 CH3 ACT B1069 D1432 SER B 15 SER~? 18.52 CH3 ACT B1069 D1457 HIS A 18 HIS~? 22.68 O ACT B1069 D1465 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 D1363 HIS B 18 HIS~? 22.64 CH3 ACT B1069 D1432 SER B 15 SER~? 18.52 CH3 ACT B1069 D1457 HIS F 18 HIS~? 22.80 CH3 ACT B1069 D1465 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 3 4 # 3 D1363 HIS D 18 HIS~? 32.59 OXT ACT B1069 D1432 SER D 15 SER~? 29.04 OXT ACT B1069 D1457 HIS C 18 HIS~? 33.75 OXT ACT B1069 D1465 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 4 4 # 4 D1363 HIS D 18 HIS~? 32.59 OXT ACT B1069 D1432 SER D 15 SER~? 29.04 OXT ACT B1069 D1457 HIS E 18 HIS~? 36.76 OXT ACT B1069 D1465 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 5 4 # 5 D1363 HIS E 18 HIS~? 36.76 OXT ACT B1069 D1432 SER E 15 SER~? 31.11 OXT ACT B1069 D1457 HIS C 18 HIS~? 33.75 OXT ACT B1069 D1465 ARG E 13 ARG~? 38.24 OXT ACT B1069 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 13.07 1.77 -16.33 14.59 4.19 -15.10 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 6 4 # 6 D1363 HIS F 18 HIS~? 22.80 CH3 ACT B1069 D1432 SER F 15 SER~? 18.74 OXT ACT B1069 D1457 HIS B 18 HIS~? 22.64 CH3 ACT B1069 D1465 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 -18.65 6.83 -15.20 -21.43 5.64 -15.99 1nkk_c03 source 1nkk PEPTIDOMIMETIC INHIBITOR : 6 hits 1nkk_c03 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER B 3 SER~? 8.11 CH3 ACT B1069 A 159 GLU F 5 GLU~? 4.67 OXT ACT B1069 A 184 ARG F 7 ARG~? 8.59 CH3 ACT B1069 A 189 GLU B 5 GLU~? 7.35 CH3 ACT B1069 coo 53.09 24.63 27.00 51.51 25.19 25.28 -22.25 25.44 -1.76 -24.43 24.37 -1.48 coo 52.64 14.17 18.05 51.99 14.09 16.04 -16.48 12.29 -1.23 -17.71 12.65 0.50 coo 45.78 18.05 21.49 44.51 17.88 18.72 -24.79 13.40 -5.76 -25.67 16.36 -5.50 coo 49.07 22.26 28.01 48.95 23.27 26.11 -26.27 20.06 -2.00 -26.37 18.13 -2.87 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER E 3 SER~? 32.62 OXT ACT B1069 A 159 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 184 ARG D 7 ARG~? 28.00 OXT ACT B1069 A 189 GLU E 5 GLU~? 30.85 OXT ACT B1069 coo 53.09 24.63 27.00 51.51 25.19 25.28 7.87 -2.43 -3.07 9.41 -0.57 -3.09 coo 52.64 14.17 18.05 51.99 14.09 16.04 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 45.78 18.05 21.49 44.51 17.88 18.72 4.77 8.93 -7.43 7.03 6.86 -7.43 coo 49.07 22.26 28.01 48.95 23.27 26.11 9.19 3.53 -3.57 10.09 3.91 -1.63 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 2 hits 1og1_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 35 ASP~? 45.42 NA NA D1069 A 100 ARG F 40 ARG~? 40.52 NA NA D1069 A 116 GLN A 42 GLN~? 39.09 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 26.40 25.34 6.28 26.15 22.33 7.25 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 26.74 21.94 13.78 27.57 20.97 12.08 -21.84 25.72 -57.34 -19.68 25.85 -56.88 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 35 ASP~? 46.31 NA NA D1069 A 100 ARG A 40 ARG~? 46.07 NA NA D1069 A 116 GLN B 42 GLN~? 38.96 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 26.40 25.34 6.28 26.15 22.33 7.25 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 26.74 21.94 13.78 27.57 20.97 12.08 -25.88 13.67 -56.90 -26.78 15.40 -56.02 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP B 37 ASP~? 39.88 NA NA D1069 A 100 ARG B 40 ARG~? 36.76 NA NA D1069 A 116 GLN B 42 GLN~? 38.96 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 26.40 25.34 6.28 26.15 22.33 7.25 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 26.74 21.94 13.78 27.57 20.97 12.08 -25.88 13.67 -56.90 -26.78 15.40 -56.02 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP C 35 ASP~? 34.97 NA NA D1069 A 100 ARG D 40 ARG~? 31.12 NA NA D1069 A 116 GLN C 42 GLN~? 24.55 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 26.40 25.34 6.28 26.15 22.33 7.25 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 26.74 21.94 13.78 27.57 20.97 12.08 5.41 -3.76 -59.03 4.20 -5.36 -58.36 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP C 37 ASP~? 33.08 NA NA D1069 A 100 ARG C 40 ARG~? 30.54 NA NA D1069 A 116 GLN C 42 GLN~? 24.55 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 26.40 25.34 6.28 26.15 22.33 7.25 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 26.74 21.94 13.78 27.57 20.97 12.08 5.41 -3.76 -59.03 4.20 -5.36 -58.36 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 6 3 # 6 A 46 ASP C 37 ASP~? 33.08 NA NA D1069 A 100 ARG C 40 ARG~? 30.54 NA NA D1069 A 116 GLN C 44 GLN~? 23.14 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 26.40 25.34 6.28 26.15 22.33 7.25 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 26.74 21.94 13.78 27.57 20.97 12.08 8.93 4.74 -61.32 7.92 5.91 -59.83 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 7 3 # 7 A 46 ASP E 35 ASP~? 33.25 NA NA D1069 A 100 ARG C 40 ARG~? 30.54 NA NA D1069 A 116 GLN E 42 GLN~? 22.20 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 26.40 25.34 6.28 26.15 22.33 7.25 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 26.74 21.94 13.78 27.57 20.97 12.08 2.18 7.59 -60.56 4.31 7.40 -60.07 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 8 3 # 8 A 46 ASP F 35 ASP~? 38.96 NA NA D1069 A 100 ARG B 40 ARG~? 36.76 NA NA D1069 A 116 GLN F 42 GLN~? 30.81 NA NA D1069 coo 32.24 20.09 5.34 30.38 19.04 5.27 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 26.40 25.34 6.28 26.15 22.33 7.25 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 26.74 21.94 13.78 27.57 20.97 12.08 -13.65 15.93 -57.57 -14.32 14.09 -56.56 12as_c00 source 12as ASPARAGINE SYNTHETASE : 8 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 35 ASP~? 45.42 NA NA D1069 B 100 ARG F 40 ARG~? 40.52 NA NA D1069 B 116 GLN A 42 GLN~? 39.09 NA NA D1069 coo 32.18 48.37 12.48 33.96 49.46 12.97 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 39.04 43.25 11.37 38.30 45.35 13.56 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 37.43 42.63 19.41 36.76 44.08 17.97 -21.84 25.72 -57.34 -19.68 25.85 -56.88 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP B 35 ASP~? 46.31 NA NA D1069 B 100 ARG A 40 ARG~? 46.07 NA NA D1069 B 116 GLN B 42 GLN~? 38.96 NA NA D1069 coo 32.18 48.37 12.48 33.96 49.46 12.97 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 39.04 43.25 11.37 38.30 45.35 13.56 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 37.43 42.63 19.41 36.76 44.08 17.97 -25.88 13.67 -56.90 -26.78 15.40 -56.02 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP B 37 ASP~? 39.88 NA NA D1069 B 100 ARG B 40 ARG~? 36.76 NA NA D1069 B 116 GLN B 42 GLN~? 38.96 NA NA D1069 coo 32.18 48.37 12.48 33.96 49.46 12.97 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 39.04 43.25 11.37 38.30 45.35 13.56 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 37.43 42.63 19.41 36.76 44.08 17.97 -25.88 13.67 -56.90 -26.78 15.40 -56.02 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP C 35 ASP~? 34.97 NA NA D1069 B 100 ARG D 40 ARG~? 31.12 NA NA D1069 B 116 GLN C 42 GLN~? 24.55 NA NA D1069 coo 32.18 48.37 12.48 33.96 49.46 12.97 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 39.04 43.25 11.37 38.30 45.35 13.56 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 37.43 42.63 19.41 36.76 44.08 17.97 5.41 -3.76 -59.03 4.20 -5.36 -58.36 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 5 3 # 5 B 46 ASP E 35 ASP~? 33.25 NA NA D1069 B 100 ARG C 40 ARG~? 30.54 NA NA D1069 B 116 GLN E 42 GLN~? 22.20 NA NA D1069 coo 32.18 48.37 12.48 33.96 49.46 12.97 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 39.04 43.25 11.37 38.30 45.35 13.56 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 37.43 42.63 19.41 36.76 44.08 17.97 2.18 7.59 -60.56 4.31 7.40 -60.07 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 6 3 # 6 B 46 ASP F 35 ASP~? 38.96 NA NA D1069 B 100 ARG B 40 ARG~? 36.76 NA NA D1069 B 116 GLN F 42 GLN~? 30.81 NA NA D1069 coo 32.18 48.37 12.48 33.96 49.46 12.97 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 39.04 43.25 11.37 38.30 45.35 13.56 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 37.43 42.63 19.41 36.76 44.08 17.97 -13.65 15.93 -57.57 -14.32 14.09 -56.56 12as_c01 source 12as ASPARAGINE SYNTHETASE : 6 hits 12as_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN C 16 ASN~? 39.67 OXT ACT B1069 63 ARG C 13 ARG~? 33.47 OXT ACT B1069 255 ARG E 7 ARG~? 30.80 OXT ACT B1069 coo 42.10 13.02 11.14 41.85 11.12 10.23 2.45 -6.99 -19.73 3.49 -8.62 -20.55 coo 44.36 11.24 3.39 41.81 12.78 4.00 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 coo 38.40 3.83 10.26 40.02 6.30 9.25 4.93 -4.34 -8.45 2.17 -4.93 -7.13 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 1 hits 1aj0_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 31 ASP~? 41.79 O ACT B1069 35 SER A 30 SER~? 40.12 CH3 ACT B1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 35 ASP~? 45.42 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP A 31 ASP~? 41.79 O ACT B1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 38 SER~? 45.54 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1am5_c04 PEPSIN user 5 3 # 5 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 35 SER B 30 SER~? 40.67 CH3 ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1am5_c04 PEPSIN user 6 3 # 6 32 ASP B 35 ASP~? 46.31 NA NA D1069 35 SER B 34 SER~? 44.97 NA NA D1069 215 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1am5_c04 PEPSIN user 7 3 # 7 32 ASP B 37 ASP~? 39.88 NA NA D1069 35 SER B 38 SER~? 40.72 NA NA D1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1am5_c04 PEPSIN user 8 3 # 8 32 ASP C 31 ASP~? 40.83 NA NA D1069 35 SER C 30 SER~? 42.91 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo -12.30 10.35 145.24 -10.75 8.55 145.88 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo -8.20 12.64 138.30 -8.86 10.97 139.38 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1am5_c04 PEPSIN user 9 3 # 9 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 34 SER~? 36.89 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -12.30 10.35 145.24 -10.75 8.55 145.88 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo -8.20 12.64 138.30 -8.86 10.97 139.38 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1am5_c04 PEPSIN user 10 3 # 10 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 38 SER~? 28.14 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -12.30 10.35 145.24 -10.75 8.55 145.88 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo -8.20 12.64 138.30 -8.86 10.97 139.38 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1am5_c04 PEPSIN user 11 3 # 11 32 ASP D 31 ASP~? 40.40 NA NA D1069 35 SER D 30 SER~? 41.47 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1am5_c04 PEPSIN user 12 3 # 12 32 ASP D 35 ASP~? 33.74 NA NA D1069 35 SER D 34 SER~? 37.31 NA NA D1069 215 ASP D 31 ASP~? 40.40 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1am5_c04 PEPSIN user 13 3 # 13 32 ASP D 37 ASP~? 34.01 NA NA D1069 35 SER D 34 SER~? 37.31 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo -8.20 12.64 138.30 -8.86 10.97 139.38 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1am5_c04 PEPSIN user 14 3 # 14 32 ASP E 31 ASP~? 40.09 NA NA D1069 35 SER E 30 SER~? 42.45 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 5.80 7.64 -43.44 6.92 9.05 -42.34 coo -12.30 10.35 145.24 -10.75 8.55 145.88 1.41 8.63 -41.51 1.21 9.99 -39.50 coo -8.20 12.64 138.30 -8.86 10.97 139.38 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1am5_c04 PEPSIN user 15 3 # 15 32 ASP E 35 ASP~? 33.25 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP E 31 ASP~? 40.09 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 3.94 6.10 -49.30 5.84 6.97 -48.85 coo -12.30 10.35 145.24 -10.75 8.55 145.88 1.08 9.58 -47.46 1.38 11.36 -45.92 coo -8.20 12.64 138.30 -8.86 10.97 139.38 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1am5_c04 PEPSIN user 16 3 # 16 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo -12.30 10.35 145.24 -10.75 8.55 145.88 1.08 9.58 -47.46 1.38 11.36 -45.92 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1am5_c04 PEPSIN user 17 3 # 17 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 38 SER~? 28.19 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo -12.30 10.35 145.24 -10.75 8.55 145.88 0.51 9.62 -53.61 2.82 10.07 -54.28 coo -8.20 12.64 138.30 -8.86 10.97 139.38 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1am5_c04 PEPSIN user 18 3 # 18 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 35 SER F 30 SER~? 41.37 O ACT B1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1am5_c04 PEPSIN user 19 3 # 19 32 ASP F 35 ASP~? 38.96 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1am5_c04 PEPSIN user 20 3 # 20 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1am5_c04 PEPSIN user 21 3 # 21 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 38 SER~? 34.44 NA NA D1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -15.17 14.97 -47.64 -14.21 13.34 -46.63 1am5_c04 source 1am5 PEPSIN : 21 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 31 ASP~? 41.79 O ACT B1069 214 ASP E 31 ASP~? 40.09 NA NA D1069 289 ASP F 37 ASP~? 40.42 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 26.86 59.76 46.36 25.42 58.23 45.92 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 35 ASP~? 45.42 NA NA D1069 214 ASP E 31 ASP~? 40.09 NA NA D1069 289 ASP F 37 ASP~? 40.42 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 26.86 59.76 46.36 25.42 58.23 45.92 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 37 ASP~? 48.68 NA NA D1069 214 ASP D 35 ASP~? 33.74 NA NA D1069 289 ASP B 35 ASP~? 46.31 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 31 ASP~? 42.18 CH3 ACT B1069 214 ASP E 35 ASP~? 33.25 NA NA D1069 289 ASP B 37 ASP~? 39.88 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 26.86 59.76 46.36 25.42 58.23 45.92 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 37 ASP~? 33.08 NA NA D1069 214 ASP B 37 ASP~? 39.88 NA NA D1069 289 ASP E 35 ASP~? 33.25 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 26.86 59.76 46.36 25.42 58.23 45.92 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP D 37 ASP~? 34.01 NA NA D1069 214 ASP A 35 ASP~? 45.42 NA NA D1069 289 ASP D 31 ASP~? 40.40 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 26.86 59.76 46.36 25.42 58.23 45.92 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP D 37 ASP~? 34.01 NA NA D1069 214 ASP B 31 ASP~? 42.18 CH3 ACT B1069 289 ASP D 31 ASP~? 40.40 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP E 31 ASP~? 40.09 NA NA D1069 214 ASP A 31 ASP~? 41.79 O ACT B1069 289 ASP E 37 ASP~? 33.39 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP E 31 ASP~? 40.09 NA NA D1069 214 ASP B 35 ASP~? 46.31 NA NA D1069 289 ASP E 37 ASP~? 33.39 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP E 35 ASP~? 33.25 NA NA D1069 214 ASP B 35 ASP~? 46.31 NA NA D1069 289 ASP D 35 ASP~? 33.74 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP F 37 ASP~? 40.42 NA NA D1069 214 ASP C 31 ASP~? 40.83 NA NA D1069 289 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 26.86 59.76 46.36 25.42 58.23 45.92 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.67 13.66 -41.84 -10.91 12.80 -40.94 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 11 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 35 ASP~? 45.42 NA NA D1069 227 GLU A 45 GLU~? 42.99 NA NA D1069 289 ASP B 35 ASP~? 46.31 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 3.96 55.76 41.24 4.83 57.69 41.17 -28.22 26.22 -60.76 -30.15 26.07 -61.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 35 ASP~? 46.31 NA NA D1069 227 GLU A 45 GLU~? 42.99 NA NA D1069 289 ASP A 35 ASP~? 45.42 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 3.96 55.76 41.24 4.83 57.69 41.17 -28.22 26.22 -60.76 -30.15 26.07 -61.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 35 ASP~? 46.31 NA NA D1069 227 GLU B 45 GLU~? 30.22 NA NA D1069 289 ASP F 35 ASP~? 38.96 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 37 ASP~? 39.88 NA NA D1069 227 GLU B 45 GLU~? 30.22 NA NA D1069 289 ASP F 35 ASP~? 38.96 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 35 ASP~? 34.97 NA NA D1069 227 GLU C 45 GLU~? 22.33 NA NA D1069 289 ASP E 35 ASP~? 33.25 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 3.96 55.76 41.24 4.83 57.69 41.17 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP D 35 ASP~? 33.74 NA NA D1069 227 GLU E 45 GLU~? 20.97 NA NA D1069 289 ASP E 35 ASP~? 33.25 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP E 35 ASP~? 33.25 NA NA D1069 227 GLU C 45 GLU~? 22.33 NA NA D1069 289 ASP C 35 ASP~? 34.97 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP E 35 ASP~? 33.25 NA NA D1069 227 GLU E 45 GLU~? 20.97 NA NA D1069 289 ASP D 35 ASP~? 33.74 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP F 35 ASP~? 38.96 NA NA D1069 227 GLU F 45 GLU~? 25.79 NA NA D1069 289 ASP A 35 ASP~? 45.42 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP F 37 ASP~? 40.42 NA NA D1069 227 GLU F 45 GLU~? 25.79 NA NA D1069 289 ASP A 35 ASP~? 45.42 NA NA D1069 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 3.96 55.76 41.24 4.83 57.69 41.17 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 10 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 31 ASP~? 41.79 O ACT B1069 E 36 SER A 30 SER~? 40.12 CH3 ACT B1069 E 213 ASP A 35 ASP~? 45.42 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 28.33 15.15 21.27 28.70 13.12 19.97 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 20.15 16.04 19.79 21.65 14.49 19.86 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 35 ASP~? 45.42 NA NA D1069 E 36 SER A 34 SER~? 48.00 O ACT B1069 E 213 ASP A 31 ASP~? 41.79 O ACT B1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 28.33 15.15 21.27 28.70 13.12 19.97 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 20.15 16.04 19.79 21.65 14.49 19.86 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP A 37 ASP~? 48.68 NA NA D1069 E 36 SER A 34 SER~? 48.00 O ACT B1069 E 213 ASP B 35 ASP~? 46.31 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 28.33 15.15 21.27 28.70 13.12 19.97 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 20.15 16.04 19.79 21.65 14.49 19.86 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP A 37 ASP~? 48.68 NA NA D1069 E 36 SER A 38 SER~? 45.54 NA NA D1069 E 213 ASP A 35 ASP~? 45.42 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 28.33 15.15 21.27 28.70 13.12 19.97 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo 20.15 16.04 19.79 21.65 14.49 19.86 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 5 3 # 5 E 33 ASP B 31 ASP~? 42.18 CH3 ACT B1069 E 36 SER B 30 SER~? 40.67 CH3 ACT B1069 E 213 ASP B 35 ASP~? 46.31 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 28.33 15.15 21.27 28.70 13.12 19.97 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 20.15 16.04 19.79 21.65 14.49 19.86 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 6 3 # 6 E 33 ASP B 35 ASP~? 46.31 NA NA D1069 E 36 SER B 34 SER~? 44.97 NA NA D1069 E 213 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 28.33 15.15 21.27 28.70 13.12 19.97 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 20.15 16.04 19.79 21.65 14.49 19.86 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 7 3 # 7 E 33 ASP B 37 ASP~? 39.88 NA NA D1069 E 36 SER B 38 SER~? 40.72 NA NA D1069 E 213 ASP B 35 ASP~? 46.31 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 28.33 15.15 21.27 28.70 13.12 19.97 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo 20.15 16.04 19.79 21.65 14.49 19.86 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 8 3 # 8 E 33 ASP C 31 ASP~? 40.83 NA NA D1069 E 36 SER C 30 SER~? 42.91 NA NA D1069 E 213 ASP C 35 ASP~? 34.97 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 28.33 15.15 21.27 28.70 13.12 19.97 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 20.15 16.04 19.79 21.65 14.49 19.86 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 9 3 # 9 E 33 ASP C 37 ASP~? 33.08 NA NA D1069 E 36 SER C 34 SER~? 36.89 NA NA D1069 E 213 ASP E 35 ASP~? 33.25 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 28.33 15.15 21.27 28.70 13.12 19.97 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 20.15 16.04 19.79 21.65 14.49 19.86 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 10 3 # 10 E 33 ASP C 37 ASP~? 33.08 NA NA D1069 E 36 SER C 38 SER~? 28.14 NA NA D1069 E 213 ASP C 35 ASP~? 34.97 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 28.33 15.15 21.27 28.70 13.12 19.97 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 20.15 16.04 19.79 21.65 14.49 19.86 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 11 3 # 11 E 33 ASP D 31 ASP~? 40.40 NA NA D1069 E 36 SER D 30 SER~? 41.47 NA NA D1069 E 213 ASP D 35 ASP~? 33.74 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 28.33 15.15 21.27 28.70 13.12 19.97 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 20.15 16.04 19.79 21.65 14.49 19.86 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 12 3 # 12 E 33 ASP D 35 ASP~? 33.74 NA NA D1069 E 36 SER D 34 SER~? 37.31 NA NA D1069 E 213 ASP D 31 ASP~? 40.40 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 28.33 15.15 21.27 28.70 13.12 19.97 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 20.15 16.04 19.79 21.65 14.49 19.86 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 13 3 # 13 E 33 ASP D 37 ASP~? 34.01 NA NA D1069 E 36 SER D 34 SER~? 37.31 NA NA D1069 E 213 ASP C 35 ASP~? 34.97 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 28.33 15.15 21.27 28.70 13.12 19.97 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 20.15 16.04 19.79 21.65 14.49 19.86 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 14 3 # 14 E 33 ASP E 31 ASP~? 40.09 NA NA D1069 E 36 SER E 30 SER~? 42.45 NA NA D1069 E 213 ASP E 35 ASP~? 33.25 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 28.33 15.15 21.27 28.70 13.12 19.97 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 20.15 16.04 19.79 21.65 14.49 19.86 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 15 3 # 15 E 33 ASP E 35 ASP~? 33.25 NA NA D1069 E 36 SER E 34 SER~? 36.48 NA NA D1069 E 213 ASP E 31 ASP~? 40.09 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 28.33 15.15 21.27 28.70 13.12 19.97 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 20.15 16.04 19.79 21.65 14.49 19.86 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 16 3 # 16 E 33 ASP E 37 ASP~? 33.39 NA NA D1069 E 36 SER E 34 SER~? 36.48 NA NA D1069 E 213 ASP D 35 ASP~? 33.74 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 28.33 15.15 21.27 28.70 13.12 19.97 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 20.15 16.04 19.79 21.65 14.49 19.86 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 17 3 # 17 E 33 ASP E 37 ASP~? 33.39 NA NA D1069 E 36 SER E 38 SER~? 28.19 NA NA D1069 E 213 ASP E 35 ASP~? 33.25 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 28.33 15.15 21.27 28.70 13.12 19.97 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 20.15 16.04 19.79 21.65 14.49 19.86 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 18 3 # 18 E 33 ASP F 31 ASP~? 42.55 OXT ACT B1069 E 36 SER F 30 SER~? 41.37 O ACT B1069 E 213 ASP F 35 ASP~? 38.96 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 28.33 15.15 21.27 28.70 13.12 19.97 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 20.15 16.04 19.79 21.65 14.49 19.86 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 19 3 # 19 E 33 ASP F 35 ASP~? 38.96 NA NA D1069 E 36 SER F 34 SER~? 40.55 NA NA D1069 E 213 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 28.33 15.15 21.27 28.70 13.12 19.97 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 20.15 16.04 19.79 21.65 14.49 19.86 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 20 3 # 20 E 33 ASP F 37 ASP~? 40.42 NA NA D1069 E 36 SER F 34 SER~? 40.55 NA NA D1069 E 213 ASP A 35 ASP~? 45.42 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 28.33 15.15 21.27 28.70 13.12 19.97 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 20.15 16.04 19.79 21.65 14.49 19.86 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 21 3 # 21 E 33 ASP F 37 ASP~? 40.42 NA NA D1069 E 36 SER F 38 SER~? 34.44 NA NA D1069 E 213 ASP F 35 ASP~? 38.96 NA NA D1069 coo 26.30 12.96 16.78 25.46 12.99 18.72 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 28.33 15.15 21.27 28.70 13.12 19.97 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 20.15 16.04 19.79 21.65 14.49 19.86 -15.17 14.97 -47.64 -14.21 13.34 -46.63 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 21 hits 1apt_c04 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER F 19 SER~? 23.26 OXT ACT B1069 A 292 ASP A 31 ASP~? 41.79 O ACT B1069 A 322 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 36.34 32.23 39.60 36.43 34.62 39.93 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 19.73 19.18 41.39 21.50 18.65 40.34 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER F 19 SER~? 23.26 OXT ACT B1069 A 292 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 322 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 36.34 32.23 39.60 36.43 34.62 39.93 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 19.73 19.18 41.39 21.50 18.65 40.34 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.09 5.21 -23.56 1.84 6.25 -23.07 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER F 19 SER~? 23.26 OXT ACT B1069 B 292 ASP A 31 ASP~? 41.79 O ACT B1069 B 322 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 35.42 71.28 22.94 36.24 69.06 22.37 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 24.74 78.07 5.59 24.32 79.03 7.46 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER F 19 SER~? 23.26 OXT ACT B1069 B 292 ASP B 31 ASP~? 42.18 CH3 ACT B1069 B 322 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 35.42 71.28 22.94 36.24 69.06 22.37 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.09 5.21 -23.56 1.84 6.25 -23.07 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG B 40 ARG~? 36.76 NA NA D1069 B 342 ASP F 31 ASP~? 42.55 OXT ACT B1069 B 531 ARG E 40 ARG~? 29.89 NA NA D1069 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -5.59 5.26 -52.86 -8.61 5.84 -52.81 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 56 ARG~? 24.39 NA NA D1069 B 342 ASP A 65 ASP~? 23.30 NA NA D1069 B 531 ARG A 56 ARG~? 34.66 NA NA D1069 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -21.57 11.48 -78.51 -22.99 9.40 -76.67 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -22.39 10.35 -89.46 -21.06 10.15 -87.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -27.95 21.09 -79.81 -27.41 23.73 -81.37 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG D 56 ARG~? 10.15 NA NA D1069 B 342 ASP E 65 ASP~? 13.11 NA NA D1069 B 531 ARG E 56 ARG~? 8.81 NA NA D1069 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -8.10 1.54 -92.84 -8.15 0.05 -91.32 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG E 40 ARG~? 29.89 NA NA D1069 B 342 ASP D 31 ASP~? 40.40 NA NA D1069 B 531 ARG B 40 ARG~? 36.76 NA NA D1069 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -16.98 10.60 -53.04 -17.44 11.09 -50.03 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG E 56 ARG~? 8.81 NA NA D1069 B 342 ASP C 65 ASP~? 13.65 NA NA D1069 B 531 ARG C 56 ARG~? 9.44 NA NA D1069 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -1.98 8.80 -79.85 -2.24 9.73 -76.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.60 12.35 -91.52 1.10 12.74 -90.08 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 7.82 2.72 -82.08 8.63 1.22 -84.68 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG F 56 ARG~? 22.05 NA NA D1069 B 342 ASP B 65 ASP~? 20.03 NA NA D1069 B 531 ARG B 56 ARG~? 24.39 NA NA D1069 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -13.14 21.58 -79.47 -10.11 21.88 -78.75 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -10.21 16.99 -89.36 -10.15 18.44 -87.79 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -21.57 11.48 -78.51 -22.99 9.40 -76.67 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG B 40 ARG~? 36.76 NA NA D1069 A 342 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 531 ARG E 40 ARG~? 29.89 NA NA D1069 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -5.59 5.26 -52.86 -8.61 5.84 -52.81 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG C 56 ARG~? 9.44 NA NA D1069 A 342 ASP C 65 ASP~? 13.65 NA NA D1069 A 531 ARG E 56 ARG~? 8.81 NA NA D1069 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 7.82 2.72 -82.08 8.63 1.22 -84.68 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 2.60 12.35 -91.52 1.10 12.74 -90.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG D 40 ARG~? 31.12 NA NA D1069 A 342 ASP C 37 ASP~? 33.08 NA NA D1069 A 531 ARG E 40 ARG~? 29.89 NA NA D1069 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -5.59 5.26 -52.86 -8.61 5.84 -52.81 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG D 56 ARG~? 10.15 NA NA D1069 A 342 ASP E 65 ASP~? 13.11 NA NA D1069 A 531 ARG E 56 ARG~? 8.81 NA NA D1069 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -8.10 1.54 -92.84 -8.15 0.05 -91.32 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG E 56 ARG~? 8.81 NA NA D1069 A 342 ASP C 65 ASP~? 13.65 NA NA D1069 A 531 ARG C 56 ARG~? 9.44 NA NA D1069 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -1.98 8.80 -79.85 -2.24 9.73 -76.86 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 2.60 12.35 -91.52 1.10 12.74 -90.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 7.82 2.72 -82.08 8.63 1.22 -84.68 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG F 56 ARG~? 22.05 NA NA D1069 A 342 ASP B 65 ASP~? 20.03 NA NA D1069 A 531 ARG B 56 ARG~? 24.39 NA NA D1069 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -13.14 21.58 -79.47 -10.11 21.88 -78.75 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -10.21 16.99 -89.36 -10.15 18.44 -87.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -21.57 11.48 -78.51 -22.99 9.40 -76.67 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 31 ASP~? 41.79 O ACT B1069 A 35 SER A 30 SER~? 40.12 CH3 ACT B1069 A 217 ASP A 35 ASP~? 45.42 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 37 ASP~? 48.68 NA NA D1069 A 35 SER A 34 SER~? 48.00 O ACT B1069 A 217 ASP B 35 ASP~? 46.31 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 35 SER B 30 SER~? 40.67 CH3 ACT B1069 A 217 ASP B 35 ASP~? 46.31 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP C 31 ASP~? 40.83 NA NA D1069 A 35 SER C 30 SER~? 42.91 NA NA D1069 A 217 ASP C 35 ASP~? 34.97 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo -11.96 5.74 52.90 -10.55 6.74 51.22 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo -5.22 1.43 56.08 -5.36 2.84 54.49 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP C 35 ASP~? 34.97 NA NA D1069 A 35 SER C 34 SER~? 36.89 NA NA D1069 A 217 ASP E 35 ASP~? 33.25 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo -11.96 5.74 52.90 -10.55 6.74 51.22 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo -5.22 1.43 56.08 -5.36 2.84 54.49 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP C 37 ASP~? 33.08 NA NA D1069 A 35 SER C 34 SER~? 36.89 NA NA D1069 A 217 ASP E 35 ASP~? 33.25 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -11.96 5.74 52.90 -10.55 6.74 51.22 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo -5.22 1.43 56.08 -5.36 2.84 54.49 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1avf_c04 GASTRICSIN user 7 3 # 7 A 32 ASP C 37 ASP~? 33.08 NA NA D1069 A 35 SER C 38 SER~? 28.14 NA NA D1069 A 217 ASP C 35 ASP~? 34.97 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -11.96 5.74 52.90 -10.55 6.74 51.22 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo -5.22 1.43 56.08 -5.36 2.84 54.49 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1avf_c04 GASTRICSIN user 8 3 # 8 A 32 ASP D 31 ASP~? 40.40 NA NA D1069 A 35 SER D 30 SER~? 41.47 NA NA D1069 A 217 ASP D 35 ASP~? 33.74 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1avf_c04 GASTRICSIN user 9 3 # 9 A 32 ASP D 37 ASP~? 34.01 NA NA D1069 A 35 SER D 34 SER~? 37.31 NA NA D1069 A 217 ASP C 35 ASP~? 34.97 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo -5.22 1.43 56.08 -5.36 2.84 54.49 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1avf_c04 GASTRICSIN user 10 3 # 10 A 32 ASP E 31 ASP~? 40.09 NA NA D1069 A 35 SER E 30 SER~? 42.45 NA NA D1069 A 217 ASP E 35 ASP~? 33.25 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 5.80 7.64 -43.44 6.92 9.05 -42.34 coo -11.96 5.74 52.90 -10.55 6.74 51.22 1.41 8.63 -41.51 1.21 9.99 -39.50 coo -5.22 1.43 56.08 -5.36 2.84 54.49 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1avf_c04 GASTRICSIN user 11 3 # 11 A 32 ASP E 35 ASP~? 33.25 NA NA D1069 A 35 SER E 34 SER~? 36.48 NA NA D1069 A 217 ASP D 35 ASP~? 33.74 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 3.94 6.10 -49.30 5.84 6.97 -48.85 coo -11.96 5.74 52.90 -10.55 6.74 51.22 1.08 9.58 -47.46 1.38 11.36 -45.92 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1avf_c04 GASTRICSIN user 12 3 # 12 A 32 ASP E 37 ASP~? 33.39 NA NA D1069 A 35 SER E 34 SER~? 36.48 NA NA D1069 A 217 ASP D 35 ASP~? 33.74 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo -11.96 5.74 52.90 -10.55 6.74 51.22 1.08 9.58 -47.46 1.38 11.36 -45.92 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1avf_c04 GASTRICSIN user 13 3 # 13 A 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 35 SER F 30 SER~? 41.37 O ACT B1069 A 217 ASP F 35 ASP~? 38.96 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1avf_c04 GASTRICSIN user 14 3 # 14 A 32 ASP F 37 ASP~? 40.42 NA NA D1069 A 35 SER F 34 SER~? 40.55 NA NA D1069 A 217 ASP A 35 ASP~? 45.42 NA NA D1069 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1avf_c04 source 1avf GASTRICSIN : 14 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 31 ASP~? 41.79 O ACT B1069 J 35 SER A 30 SER~? 40.12 CH3 ACT B1069 J 217 ASP A 35 ASP~? 45.42 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 37 ASP~? 48.68 NA NA D1069 J 35 SER A 34 SER~? 48.00 O ACT B1069 J 217 ASP B 35 ASP~? 46.31 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 J 35 SER B 30 SER~? 40.67 CH3 ACT B1069 J 217 ASP B 35 ASP~? 46.31 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP C 31 ASP~? 40.83 NA NA D1069 J 35 SER C 30 SER~? 42.91 NA NA D1069 J 217 ASP C 35 ASP~? 34.97 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP C 37 ASP~? 33.08 NA NA D1069 J 35 SER C 34 SER~? 36.89 NA NA D1069 J 217 ASP E 35 ASP~? 33.25 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP C 37 ASP~? 33.08 NA NA D1069 J 35 SER C 38 SER~? 28.14 NA NA D1069 J 217 ASP C 35 ASP~? 34.97 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1avf_c05 GASTRICSIN user 7 3 # 7 J 32 ASP D 31 ASP~? 40.40 NA NA D1069 J 35 SER D 30 SER~? 41.47 NA NA D1069 J 217 ASP D 35 ASP~? 33.74 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1avf_c05 GASTRICSIN user 8 3 # 8 J 32 ASP D 37 ASP~? 34.01 NA NA D1069 J 35 SER D 34 SER~? 37.31 NA NA D1069 J 217 ASP C 35 ASP~? 34.97 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1avf_c05 GASTRICSIN user 9 3 # 9 J 32 ASP E 31 ASP~? 40.09 NA NA D1069 J 35 SER E 30 SER~? 42.45 NA NA D1069 J 217 ASP E 35 ASP~? 33.25 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 5.80 7.64 -43.44 6.92 9.05 -42.34 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 1.41 8.63 -41.51 1.21 9.99 -39.50 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1avf_c05 GASTRICSIN user 10 3 # 10 J 32 ASP E 37 ASP~? 33.39 NA NA D1069 J 35 SER E 34 SER~? 36.48 NA NA D1069 J 217 ASP D 35 ASP~? 33.74 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 1.08 9.58 -47.46 1.38 11.36 -45.92 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1avf_c05 GASTRICSIN user 11 3 # 11 J 32 ASP E 37 ASP~? 33.39 NA NA D1069 J 35 SER E 38 SER~? 28.19 NA NA D1069 J 217 ASP E 35 ASP~? 33.25 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 0.51 9.62 -53.61 2.82 10.07 -54.28 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1avf_c05 GASTRICSIN user 12 3 # 12 J 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 J 35 SER F 30 SER~? 41.37 O ACT B1069 J 217 ASP F 35 ASP~? 38.96 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1avf_c05 GASTRICSIN user 13 3 # 13 J 32 ASP F 37 ASP~? 40.42 NA NA D1069 J 35 SER F 34 SER~? 40.55 NA NA D1069 J 217 ASP A 35 ASP~? 45.42 NA NA D1069 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1avf_c05 source 1avf GASTRICSIN : 13 hits 1avf_c05 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 31 ASP~? 41.79 O ACT B1069 35 SER A 30 SER~? 40.12 CH3 ACT B1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 66.00 46.17 80.29 64.31 47.92 79.91 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 63.61 40.10 74.06 64.05 42.07 74.70 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 35 SER B 30 SER~? 40.67 CH3 ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 66.00 46.17 80.29 64.31 47.92 79.91 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 63.61 40.10 74.06 64.05 42.07 74.70 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP B 37 ASP~? 39.88 NA NA D1069 35 SER B 34 SER~? 44.97 NA NA D1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 66.00 46.17 80.29 64.31 47.92 79.91 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 63.61 40.10 74.06 64.05 42.07 74.70 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1bbs_c06 RENIN user 5 3 # 5 32 ASP C 31 ASP~? 40.83 NA NA D1069 35 SER C 30 SER~? 42.91 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 66.00 46.17 80.29 64.31 47.92 79.91 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1bbs_c06 RENIN user 6 3 # 6 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 34 SER~? 36.89 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 66.00 46.17 80.29 64.31 47.92 79.91 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1bbs_c06 RENIN user 7 3 # 7 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 38 SER~? 28.14 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 66.00 46.17 80.29 64.31 47.92 79.91 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1bbs_c06 RENIN user 8 3 # 8 32 ASP D 31 ASP~? 40.40 NA NA D1069 35 SER D 30 SER~? 41.47 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 66.00 46.17 80.29 64.31 47.92 79.91 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1bbs_c06 RENIN user 9 3 # 9 32 ASP D 37 ASP~? 34.01 NA NA D1069 35 SER D 34 SER~? 37.31 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 66.00 46.17 80.29 64.31 47.92 79.91 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1bbs_c06 RENIN user 10 3 # 10 32 ASP E 31 ASP~? 40.09 NA NA D1069 35 SER E 30 SER~? 42.45 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 66.00 46.17 80.29 64.31 47.92 79.91 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1bbs_c06 RENIN user 11 3 # 11 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 66.00 46.17 80.29 64.31 47.92 79.91 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1bbs_c06 RENIN user 12 3 # 12 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 38 SER~? 28.19 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 66.00 46.17 80.29 64.31 47.92 79.91 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1bbs_c06 RENIN user 13 3 # 13 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 35 SER F 30 SER~? 41.37 O ACT B1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 66.00 46.17 80.29 64.31 47.92 79.91 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 63.61 40.10 74.06 64.05 42.07 74.70 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1bbs_c06 RENIN user 14 3 # 14 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 66.00 46.17 80.29 64.31 47.92 79.91 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 63.61 40.10 74.06 64.05 42.07 74.70 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1bbs_c06 RENIN user 15 3 # 15 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 38 SER~? 34.44 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 66.00 46.17 80.29 64.31 47.92 79.91 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 63.61 40.10 74.06 64.05 42.07 74.70 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1bbs_c06 source 1bbs RENIN : 15 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 31 ASP~? 41.79 O ACT B1069 35 SER A 30 SER~? 40.12 CH3 ACT B1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 66.00 46.17 80.29 64.31 47.92 79.91 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 63.61 40.10 74.06 64.05 42.07 74.70 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 66.00 46.17 80.29 64.31 47.92 79.91 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 35 SER B 30 SER~? 40.67 CH3 ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 66.00 46.17 80.29 64.31 47.92 79.91 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 63.61 40.10 74.06 64.05 42.07 74.70 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP B 37 ASP~? 39.88 NA NA D1069 35 SER B 34 SER~? 44.97 NA NA D1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 66.00 46.17 80.29 64.31 47.92 79.91 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 63.61 40.10 74.06 64.05 42.07 74.70 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1bbs_c07 RENIN user 5 3 # 5 32 ASP C 31 ASP~? 40.83 NA NA D1069 35 SER C 30 SER~? 42.91 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 66.00 46.17 80.29 64.31 47.92 79.91 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1bbs_c07 RENIN user 6 3 # 6 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 34 SER~? 36.89 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 66.00 46.17 80.29 64.31 47.92 79.91 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1bbs_c07 RENIN user 7 3 # 7 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 38 SER~? 28.14 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 66.00 46.17 80.29 64.31 47.92 79.91 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1bbs_c07 RENIN user 8 3 # 8 32 ASP D 31 ASP~? 40.40 NA NA D1069 35 SER D 30 SER~? 41.47 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 66.00 46.17 80.29 64.31 47.92 79.91 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1bbs_c07 RENIN user 9 3 # 9 32 ASP D 37 ASP~? 34.01 NA NA D1069 35 SER D 34 SER~? 37.31 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 66.00 46.17 80.29 64.31 47.92 79.91 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1bbs_c07 RENIN user 10 3 # 10 32 ASP E 31 ASP~? 40.09 NA NA D1069 35 SER E 30 SER~? 42.45 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 66.00 46.17 80.29 64.31 47.92 79.91 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 63.61 40.10 74.06 64.05 42.07 74.70 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1bbs_c07 RENIN user 11 3 # 11 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 66.00 46.17 80.29 64.31 47.92 79.91 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1bbs_c07 RENIN user 12 3 # 12 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 38 SER~? 28.19 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 66.00 46.17 80.29 64.31 47.92 79.91 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1bbs_c07 RENIN user 13 3 # 13 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 35 SER F 30 SER~? 41.37 O ACT B1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 66.00 46.17 80.29 64.31 47.92 79.91 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 63.61 40.10 74.06 64.05 42.07 74.70 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1bbs_c07 RENIN user 14 3 # 14 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 66.00 46.17 80.29 64.31 47.92 79.91 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 63.61 40.10 74.06 64.05 42.07 74.70 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1bbs_c07 RENIN user 15 3 # 15 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 38 SER~? 34.44 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 61.19 45.85 78.73 62.86 45.48 77.48 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 66.00 46.17 80.29 64.31 47.92 79.91 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 63.61 40.10 74.06 64.05 42.07 74.70 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1bbs_c07 source 1bbs RENIN : 15 hits 1bbs_c07 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 42 GLN~? 39.09 NA NA D1069 A 91 LEU A 39 LEU~? 39.64 NA NA D1069 A 133 GLU A 45 GLU~? 42.99 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -21.84 25.72 -57.34 -19.68 25.85 -56.88 coo 38.58 45.09 70.44 38.28 45.21 72.59 -21.30 21.65 -53.36 -19.16 22.24 -53.15 coo 44.05 36.87 70.65 43.15 38.64 69.97 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 47 GLN~? 34.25 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU A 45 GLU~? 42.99 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 38.58 45.09 70.44 38.28 45.21 72.59 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 44.05 36.87 70.65 43.15 38.64 69.97 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 47 GLN~? 34.25 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 38.58 45.09 70.44 38.28 45.21 72.59 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 44.05 36.87 70.65 43.15 38.64 69.97 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 49 GLN~? 33.84 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -23.88 23.73 -70.51 -22.44 25.27 -70.20 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 44.05 36.87 70.65 43.15 38.64 69.97 -16.47 28.07 -74.52 -14.99 28.14 -72.96 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN A 52 GLN~? 37.34 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -29.33 21.76 -72.56 -29.33 23.89 -72.44 coo 38.58 45.09 70.44 38.28 45.21 72.59 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 44.05 36.87 70.65 43.15 38.64 69.97 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN A 57 GLN~? 24.51 NA NA D1069 A 91 LEU A 61 LEU~? 23.78 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 38.58 45.09 70.44 38.28 45.21 72.59 -22.60 12.27 -84.26 -20.61 12.12 -83.35 coo 44.05 36.87 70.65 43.15 38.64 69.97 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN A 59 GLN~? 34.47 NA NA D1069 A 91 LEU A 61 LEU~? 23.78 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo 38.58 45.09 70.44 38.28 45.21 72.59 -22.60 12.27 -84.26 -20.61 12.12 -83.35 coo 44.05 36.87 70.65 43.15 38.64 69.97 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN B 47 GLN~? 24.93 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 38.58 45.09 70.44 38.28 45.21 72.59 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 44.05 36.87 70.65 43.15 38.64 69.97 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN B 47 GLN~? 24.93 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 38.58 45.09 70.44 38.28 45.21 72.59 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 44.05 36.87 70.65 43.15 38.64 69.97 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN B 49 GLN~? 30.98 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -24.04 12.01 -67.93 -25.65 13.45 -67.68 coo 38.58 45.09 70.44 38.28 45.21 72.59 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 44.05 36.87 70.65 43.15 38.64 69.97 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN B 52 GLN~? 25.40 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 38.58 45.09 70.44 38.28 45.21 72.59 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 44.05 36.87 70.65 43.15 38.64 69.97 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN B 52 GLN~? 25.40 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 38.58 45.09 70.44 38.28 45.21 72.59 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 44.05 36.87 70.65 43.15 38.64 69.97 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN B 57 GLN~? 21.78 NA NA D1069 A 91 LEU B 61 LEU~? 19.87 NA NA D1069 A 133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.32 17.01 -83.68 -12.30 18.91 -82.46 coo 44.05 36.87 70.65 43.15 38.64 69.97 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN B 59 GLN~? 18.99 NA NA D1069 A 91 LEU B 62 LEU~? 15.33 NA NA D1069 A 133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -16.22 9.84 -81.57 -17.94 8.86 -80.67 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 44.05 36.87 70.65 43.15 38.64 69.97 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 15 3 # 15 A 50 GLN C 42 GLN~? 24.55 NA NA D1069 A 91 LEU C 39 LEU~? 27.57 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 5.41 -3.76 -59.03 4.20 -5.36 -58.36 coo 38.58 45.09 70.44 38.28 45.21 72.59 2.77 -0.77 -54.40 1.34 -2.28 -53.70 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 16 3 # 16 A 50 GLN C 47 GLN~? 17.45 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 38.58 45.09 70.44 38.28 45.21 72.59 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 17 3 # 17 A 50 GLN C 47 GLN~? 17.45 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 38.58 45.09 70.44 38.28 45.21 72.59 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 44.05 36.87 70.65 43.15 38.64 69.97 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 18 3 # 18 A 50 GLN C 49 GLN~? 11.67 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 38.58 45.09 70.44 38.28 45.21 72.59 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 19 3 # 19 A 50 GLN C 49 GLN~? 11.67 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 38.58 45.09 70.44 38.28 45.21 72.59 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 20 3 # 20 A 50 GLN C 57 GLN~? -4.09 NA NA D1069s A 91 LEU C 61 LEU~? 8.23 NA NA D1069 A 133 GLU C 55 GLU~? 12.72 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 1.28 9.88 -85.46 -0.51 9.71 -84.21 coo 44.05 36.87 70.65 43.15 38.64 69.97 8.93 8.59 -77.67 8.56 10.55 -76.69 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 21 3 # 21 A 50 GLN D 47 GLN~? 19.58 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 38.58 45.09 70.44 38.28 45.21 72.59 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 22 3 # 22 A 50 GLN D 47 GLN~? 19.58 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 38.58 45.09 70.44 38.28 45.21 72.59 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 44.05 36.87 70.65 43.15 38.64 69.97 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 23 3 # 23 A 50 GLN D 52 GLN~? 13.91 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 38.58 45.09 70.44 38.28 45.21 72.59 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 44.05 36.87 70.65 43.15 38.64 69.97 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 24 3 # 24 A 50 GLN D 52 GLN~? 13.91 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 38.58 45.09 70.44 38.28 45.21 72.59 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 44.05 36.87 70.65 43.15 38.64 69.97 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 25 3 # 25 A 50 GLN D 57 GLN~? -4.24 NA NA D1069s A 91 LEU D 61 LEU~? 7.44 NA NA D1069 A 133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 38.58 45.09 70.44 38.28 45.21 72.59 4.78 -2.11 -85.44 5.74 -0.46 -84.33 coo 44.05 36.87 70.65 43.15 38.64 69.97 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 26 3 # 26 A 50 GLN D 59 GLN~? 11.86 NA NA D1069 A 91 LEU D 62 LEU~? 12.06 NA NA D1069 A 133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -1.57 -7.56 -84.06 -3.05 -8.26 -85.53 coo 38.58 45.09 70.44 38.28 45.21 72.59 3.24 -6.52 -88.42 1.99 -8.01 -87.44 coo 44.05 36.87 70.65 43.15 38.64 69.97 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 27 3 # 27 A 50 GLN E 42 GLN~? 22.20 NA NA D1069 A 91 LEU E 39 LEU~? 26.71 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 2.18 7.59 -60.56 4.31 7.40 -60.07 coo 38.58 45.09 70.44 38.28 45.21 72.59 1.19 4.92 -54.90 3.28 4.46 -54.59 coo 44.05 36.87 70.65 43.15 38.64 69.97 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 28 3 # 28 A 50 GLN E 47 GLN~? 16.16 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 38.58 45.09 70.44 38.28 45.21 72.59 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 44.05 36.87 70.65 43.15 38.64 69.97 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 29 3 # 29 A 50 GLN E 47 GLN~? 16.16 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 38.58 45.09 70.44 38.28 45.21 72.59 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 44.05 36.87 70.65 43.15 38.64 69.97 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 30 3 # 30 A 50 GLN E 49 GLN~? 13.17 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 38.58 45.09 70.44 38.28 45.21 72.59 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 44.05 36.87 70.65 43.15 38.64 69.97 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 31 3 # 31 A 50 GLN E 49 GLN~? 13.17 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 38.58 45.09 70.44 38.28 45.21 72.59 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 44.05 36.87 70.65 43.15 38.64 69.97 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 32 3 # 32 A 50 GLN E 52 GLN~? 13.85 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -6.20 10.29 -73.32 -5.15 12.02 -72.67 coo 38.58 45.09 70.44 38.28 45.21 72.59 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 44.05 36.87 70.65 43.15 38.64 69.97 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 33 3 # 33 A 50 GLN E 57 GLN~? -4.15 NA NA D1069s A 91 LEU E 61 LEU~? 8.30 NA NA D1069 A 133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 38.58 45.09 70.44 38.28 45.21 72.59 -6.61 0.80 -86.61 -5.72 -1.04 -85.99 coo 44.05 36.87 70.65 43.15 38.64 69.97 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 34 3 # 34 A 50 GLN E 59 GLN~? 11.22 NA NA D1069 A 91 LEU B 62 LEU~? 15.33 NA NA D1069 A 133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -8.54 8.13 -83.40 -8.26 10.00 -82.37 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 44.05 36.87 70.65 43.15 38.64 69.97 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 35 3 # 35 A 50 GLN F 42 GLN~? 30.81 NA NA D1069 A 91 LEU F 39 LEU~? 35.92 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -13.65 15.93 -57.57 -14.32 14.09 -56.56 coo 38.58 45.09 70.44 38.28 45.21 72.59 -17.24 17.34 -53.43 -17.89 15.35 -52.85 coo 44.05 36.87 70.65 43.15 38.64 69.97 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 36 3 # 36 A 50 GLN F 47 GLN~? 33.35 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -18.85 24.82 -64.98 -20.45 24.10 -66.19 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 44.05 36.87 70.65 43.15 38.64 69.97 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 37 3 # 37 A 50 GLN F 49 GLN~? 22.45 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 38.58 45.09 70.44 38.28 45.21 72.59 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 44.05 36.87 70.65 43.15 38.64 69.97 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 38 3 # 38 A 50 GLN F 49 GLN~? 22.45 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 44.05 36.87 70.65 43.15 38.64 69.97 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 39 3 # 39 A 50 GLN F 52 GLN~? 25.43 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 43.58 43.67 66.73 42.32 42.78 68.15 -12.27 24.30 -72.03 -10.74 23.17 -71.15 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 44.05 36.87 70.65 43.15 38.64 69.97 -16.47 28.07 -74.52 -14.99 28.14 -72.96 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 39 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 42 GLN~? 39.09 NA NA D1069 B 591 LEU A 39 LEU~? 39.64 NA NA D1069 B 633 GLU A 45 GLU~? 42.99 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -21.84 25.72 -57.34 -19.68 25.85 -56.88 coo 86.70 48.66 52.61 87.15 48.69 50.51 -21.30 21.65 -53.36 -19.16 22.24 -53.15 coo 95.42 44.52 54.43 93.46 45.31 54.70 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 47 GLN~? 34.25 NA NA D1069 B 591 LEU A 50 LEU~? 30.48 NA NA D1069 B 633 GLU A 45 GLU~? 42.99 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 86.70 48.66 52.61 87.15 48.69 50.51 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 95.42 44.52 54.43 93.46 45.31 54.70 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 47 GLN~? 34.25 NA NA D1069 B 591 LEU A 50 LEU~? 30.48 NA NA D1069 B 633 GLU B 45 GLU~? 30.22 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 86.70 48.66 52.61 87.15 48.69 50.51 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 95.42 44.52 54.43 93.46 45.31 54.70 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN A 49 GLN~? 33.84 NA NA D1069 B 591 LEU F 50 LEU~? 29.71 NA NA D1069 B 633 GLU F 55 GLU~? 30.88 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -23.88 23.73 -70.51 -22.44 25.27 -70.20 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 95.42 44.52 54.43 93.46 45.31 54.70 -16.47 28.07 -74.52 -14.99 28.14 -72.96 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN A 52 GLN~? 37.34 NA NA D1069 B 591 LEU A 50 LEU~? 30.48 NA NA D1069 B 633 GLU A 55 GLU~? 31.92 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -29.33 21.76 -72.56 -29.33 23.89 -72.44 coo 86.70 48.66 52.61 87.15 48.69 50.51 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 95.42 44.52 54.43 93.46 45.31 54.70 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 47 GLN~? 24.93 NA NA D1069 B 591 LEU B 50 LEU~? 25.59 NA NA D1069 B 633 GLU B 45 GLU~? 30.22 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 86.70 48.66 52.61 87.15 48.69 50.51 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 95.42 44.52 54.43 93.46 45.31 54.70 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN B 47 GLN~? 24.93 NA NA D1069 B 591 LEU B 50 LEU~? 25.59 NA NA D1069 B 633 GLU F 45 GLU~? 25.79 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 86.70 48.66 52.61 87.15 48.69 50.51 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 95.42 44.52 54.43 93.46 45.31 54.70 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 8 3 # 8 B 550 GLN B 49 GLN~? 30.98 NA NA D1069 B 591 LEU A 50 LEU~? 30.48 NA NA D1069 B 633 GLU A 55 GLU~? 31.92 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -24.04 12.01 -67.93 -25.65 13.45 -67.68 coo 86.70 48.66 52.61 87.15 48.69 50.51 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 95.42 44.52 54.43 93.46 45.31 54.70 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 9 3 # 9 B 550 GLN B 52 GLN~? 25.40 NA NA D1069 B 591 LEU B 50 LEU~? 25.59 NA NA D1069 B 633 GLU B 45 GLU~? 30.22 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 86.70 48.66 52.61 87.15 48.69 50.51 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 95.42 44.52 54.43 93.46 45.31 54.70 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 10 3 # 10 B 550 GLN B 52 GLN~? 25.40 NA NA D1069 B 591 LEU B 50 LEU~? 25.59 NA NA D1069 B 633 GLU B 55 GLU~? 15.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 86.70 48.66 52.61 87.15 48.69 50.51 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 95.42 44.52 54.43 93.46 45.31 54.70 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 11 3 # 11 B 550 GLN B 57 GLN~? 21.78 NA NA D1069 B 591 LEU B 61 LEU~? 19.87 NA NA D1069 B 633 GLU B 55 GLU~? 15.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.32 17.01 -83.68 -12.30 18.91 -82.46 coo 95.42 44.52 54.43 93.46 45.31 54.70 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 12 3 # 12 B 550 GLN B 59 GLN~? 18.99 NA NA D1069 B 591 LEU B 62 LEU~? 15.33 NA NA D1069 B 633 GLU E 55 GLU~? 12.74 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -16.22 9.84 -81.57 -17.94 8.86 -80.67 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 95.42 44.52 54.43 93.46 45.31 54.70 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 13 3 # 13 B 550 GLN C 42 GLN~? 24.55 NA NA D1069 B 591 LEU C 39 LEU~? 27.57 NA NA D1069 B 633 GLU C 45 GLU~? 22.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 5.41 -3.76 -59.03 4.20 -5.36 -58.36 coo 86.70 48.66 52.61 87.15 48.69 50.51 2.77 -0.77 -54.40 1.34 -2.28 -53.70 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 14 3 # 14 B 550 GLN C 47 GLN~? 17.45 NA NA D1069 B 591 LEU C 50 LEU~? 11.53 NA NA D1069 B 633 GLU C 45 GLU~? 22.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 86.70 48.66 52.61 87.15 48.69 50.51 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 15 3 # 15 B 550 GLN C 47 GLN~? 17.45 NA NA D1069 B 591 LEU C 50 LEU~? 11.53 NA NA D1069 B 633 GLU E 45 GLU~? 20.97 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 86.70 48.66 52.61 87.15 48.69 50.51 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 95.42 44.52 54.43 93.46 45.31 54.70 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 16 3 # 16 B 550 GLN C 49 GLN~? 11.67 NA NA D1069 B 591 LEU C 50 LEU~? 11.53 NA NA D1069 B 633 GLU C 45 GLU~? 22.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 86.70 48.66 52.61 87.15 48.69 50.51 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 17 3 # 17 B 550 GLN C 49 GLN~? 11.67 NA NA D1069 B 591 LEU D 50 LEU~? 11.93 NA NA D1069 B 633 GLU C 45 GLU~? 22.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 86.70 48.66 52.61 87.15 48.69 50.51 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 18 3 # 18 B 550 GLN C 57 GLN~? -4.09 NA NA D1069s B 591 LEU C 61 LEU~? 8.23 NA NA D1069 B 633 GLU C 55 GLU~? 12.72 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 1.28 9.88 -85.46 -0.51 9.71 -84.21 coo 95.42 44.52 54.43 93.46 45.31 54.70 8.93 8.59 -77.67 8.56 10.55 -76.69 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 19 3 # 19 B 550 GLN D 47 GLN~? 19.58 NA NA D1069 B 591 LEU D 50 LEU~? 11.93 NA NA D1069 B 633 GLU C 45 GLU~? 22.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 86.70 48.66 52.61 87.15 48.69 50.51 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 20 3 # 20 B 550 GLN D 47 GLN~? 19.58 NA NA D1069 B 591 LEU D 50 LEU~? 11.93 NA NA D1069 B 633 GLU D 45 GLU~? 19.29 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 86.70 48.66 52.61 87.15 48.69 50.51 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 95.42 44.52 54.43 93.46 45.31 54.70 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 21 3 # 21 B 550 GLN D 52 GLN~? 13.91 NA NA D1069 B 591 LEU D 50 LEU~? 11.93 NA NA D1069 B 633 GLU D 45 GLU~? 19.29 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 86.70 48.66 52.61 87.15 48.69 50.51 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 95.42 44.52 54.43 93.46 45.31 54.70 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 22 3 # 22 B 550 GLN D 52 GLN~? 13.91 NA NA D1069 B 591 LEU D 50 LEU~? 11.93 NA NA D1069 B 633 GLU D 55 GLU~? 12.40 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 86.70 48.66 52.61 87.15 48.69 50.51 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 95.42 44.52 54.43 93.46 45.31 54.70 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 23 3 # 23 B 550 GLN D 57 GLN~? -4.24 NA NA D1069s B 591 LEU D 61 LEU~? 7.44 NA NA D1069 B 633 GLU D 55 GLU~? 12.40 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 86.70 48.66 52.61 87.15 48.69 50.51 4.78 -2.11 -85.44 5.74 -0.46 -84.33 coo 95.42 44.52 54.43 93.46 45.31 54.70 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 24 3 # 24 B 550 GLN D 59 GLN~? 11.86 NA NA D1069 B 591 LEU D 62 LEU~? 12.06 NA NA D1069 B 633 GLU D 55 GLU~? 12.40 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -1.57 -7.56 -84.06 -3.05 -8.26 -85.53 coo 86.70 48.66 52.61 87.15 48.69 50.51 3.24 -6.52 -88.42 1.99 -8.01 -87.44 coo 95.42 44.52 54.43 93.46 45.31 54.70 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 25 3 # 25 B 550 GLN E 42 GLN~? 22.20 NA NA D1069 B 591 LEU E 39 LEU~? 26.71 NA NA D1069 B 633 GLU E 45 GLU~? 20.97 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 2.18 7.59 -60.56 4.31 7.40 -60.07 coo 86.70 48.66 52.61 87.15 48.69 50.51 1.19 4.92 -54.90 3.28 4.46 -54.59 coo 95.42 44.52 54.43 93.46 45.31 54.70 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 26 3 # 26 B 550 GLN E 47 GLN~? 16.16 NA NA D1069 B 591 LEU E 50 LEU~? 11.34 NA NA D1069 B 633 GLU D 45 GLU~? 19.29 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 86.70 48.66 52.61 87.15 48.69 50.51 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 95.42 44.52 54.43 93.46 45.31 54.70 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 27 3 # 27 B 550 GLN E 47 GLN~? 16.16 NA NA D1069 B 591 LEU E 50 LEU~? 11.34 NA NA D1069 B 633 GLU E 45 GLU~? 20.97 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 86.70 48.66 52.61 87.15 48.69 50.51 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 95.42 44.52 54.43 93.46 45.31 54.70 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 28 3 # 28 B 550 GLN E 49 GLN~? 13.17 NA NA D1069 B 591 LEU C 50 LEU~? 11.53 NA NA D1069 B 633 GLU E 45 GLU~? 20.97 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 86.70 48.66 52.61 87.15 48.69 50.51 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 95.42 44.52 54.43 93.46 45.31 54.70 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 29 3 # 29 B 550 GLN E 49 GLN~? 13.17 NA NA D1069 B 591 LEU E 50 LEU~? 11.34 NA NA D1069 B 633 GLU E 45 GLU~? 20.97 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 86.70 48.66 52.61 87.15 48.69 50.51 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 95.42 44.52 54.43 93.46 45.31 54.70 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 30 3 # 30 B 550 GLN E 52 GLN~? 13.85 NA NA D1069 B 591 LEU E 50 LEU~? 11.34 NA NA D1069 B 633 GLU E 55 GLU~? 12.74 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -6.20 10.29 -73.32 -5.15 12.02 -72.67 coo 86.70 48.66 52.61 87.15 48.69 50.51 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 95.42 44.52 54.43 93.46 45.31 54.70 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 31 3 # 31 B 550 GLN E 57 GLN~? -4.15 NA NA D1069s B 591 LEU E 61 LEU~? 8.30 NA NA D1069 B 633 GLU E 55 GLU~? 12.74 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 86.70 48.66 52.61 87.15 48.69 50.51 -6.61 0.80 -86.61 -5.72 -1.04 -85.99 coo 95.42 44.52 54.43 93.46 45.31 54.70 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 32 3 # 32 B 550 GLN E 59 GLN~? 11.22 NA NA D1069 B 591 LEU B 62 LEU~? 15.33 NA NA D1069 B 633 GLU B 55 GLU~? 15.33 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -8.54 8.13 -83.40 -8.26 10.00 -82.37 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 95.42 44.52 54.43 93.46 45.31 54.70 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 33 3 # 33 B 550 GLN F 47 GLN~? 33.35 NA NA D1069 B 591 LEU F 50 LEU~? 29.71 NA NA D1069 B 633 GLU F 45 GLU~? 25.79 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -18.85 24.82 -64.98 -20.45 24.10 -66.19 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 95.42 44.52 54.43 93.46 45.31 54.70 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 34 3 # 34 B 550 GLN F 49 GLN~? 22.45 NA NA D1069 B 591 LEU B 50 LEU~? 25.59 NA NA D1069 B 633 GLU F 45 GLU~? 25.79 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 86.70 48.66 52.61 87.15 48.69 50.51 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 95.42 44.52 54.43 93.46 45.31 54.70 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 35 3 # 35 B 550 GLN F 49 GLN~? 22.45 NA NA D1069 B 591 LEU F 50 LEU~? 29.71 NA NA D1069 B 633 GLU F 45 GLU~? 25.79 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 95.42 44.52 54.43 93.46 45.31 54.70 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 36 3 # 36 B 550 GLN F 52 GLN~? 25.43 NA NA D1069 B 591 LEU F 50 LEU~? 29.71 NA NA D1069 B 633 GLU F 55 GLU~? 30.88 NA NA D1069 coo 88.06 44.34 57.19 89.06 45.53 55.74 -12.27 24.30 -72.03 -10.74 23.17 -71.15 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 95.42 44.52 54.43 93.46 45.31 54.70 -16.47 28.07 -74.52 -14.99 28.14 -72.96 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 36 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 42 GLN~? 39.09 NA NA D1069 C1091 LEU A 39 LEU~? 39.64 NA NA D1069 C1133 GLU A 45 GLU~? 42.99 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -21.84 25.72 -57.34 -19.68 25.85 -56.88 coo 65.83 38.95 47.05 65.46 38.90 49.20 -21.30 21.65 -53.36 -19.16 22.24 -53.15 coo 63.14 29.39 46.25 63.84 31.31 45.74 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 47 GLN~? 34.25 NA NA D1069 C1091 LEU A 50 LEU~? 30.48 NA NA D1069 C1133 GLU A 45 GLU~? 42.99 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 65.83 38.95 47.05 65.46 38.90 49.20 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 63.14 29.39 46.25 63.84 31.31 45.74 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 47 GLN~? 34.25 NA NA D1069 C1091 LEU A 50 LEU~? 30.48 NA NA D1069 C1133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 65.83 38.95 47.05 65.46 38.90 49.20 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 63.14 29.39 46.25 63.84 31.31 45.74 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN A 49 GLN~? 33.84 NA NA D1069 C1091 LEU F 50 LEU~? 29.71 NA NA D1069 C1133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -23.88 23.73 -70.51 -22.44 25.27 -70.20 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 63.14 29.39 46.25 63.84 31.31 45.74 -16.47 28.07 -74.52 -14.99 28.14 -72.96 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN A 52 GLN~? 37.34 NA NA D1069 C1091 LEU A 50 LEU~? 30.48 NA NA D1069 C1133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -29.33 21.76 -72.56 -29.33 23.89 -72.44 coo 65.83 38.95 47.05 65.46 38.90 49.20 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 63.14 29.39 46.25 63.84 31.31 45.74 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN A 57 GLN~? 24.51 NA NA D1069 C1091 LEU A 61 LEU~? 23.78 NA NA D1069 C1133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 65.83 38.95 47.05 65.46 38.90 49.20 -22.60 12.27 -84.26 -20.61 12.12 -83.35 coo 63.14 29.39 46.25 63.84 31.31 45.74 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN A 59 GLN~? 34.47 NA NA D1069 C1091 LEU A 61 LEU~? 23.78 NA NA D1069 C1133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo 65.83 38.95 47.05 65.46 38.90 49.20 -22.60 12.27 -84.26 -20.61 12.12 -83.35 coo 63.14 29.39 46.25 63.84 31.31 45.74 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN B 47 GLN~? 24.93 NA NA D1069 C1091 LEU B 50 LEU~? 25.59 NA NA D1069 C1133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 65.83 38.95 47.05 65.46 38.90 49.20 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 63.14 29.39 46.25 63.84 31.31 45.74 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN B 47 GLN~? 24.93 NA NA D1069 C1091 LEU B 50 LEU~? 25.59 NA NA D1069 C1133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 65.83 38.95 47.05 65.46 38.90 49.20 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 63.14 29.39 46.25 63.84 31.31 45.74 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN B 49 GLN~? 30.98 NA NA D1069 C1091 LEU A 50 LEU~? 30.48 NA NA D1069 C1133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -24.04 12.01 -67.93 -25.65 13.45 -67.68 coo 65.83 38.95 47.05 65.46 38.90 49.20 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 63.14 29.39 46.25 63.84 31.31 45.74 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 11 3 # 11 C1050 GLN B 52 GLN~? 25.40 NA NA D1069 C1091 LEU B 50 LEU~? 25.59 NA NA D1069 C1133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 65.83 38.95 47.05 65.46 38.90 49.20 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 63.14 29.39 46.25 63.84 31.31 45.74 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 12 3 # 12 C1050 GLN B 52 GLN~? 25.40 NA NA D1069 C1091 LEU B 50 LEU~? 25.59 NA NA D1069 C1133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 65.83 38.95 47.05 65.46 38.90 49.20 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 63.14 29.39 46.25 63.84 31.31 45.74 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 13 3 # 13 C1050 GLN B 57 GLN~? 21.78 NA NA D1069 C1091 LEU B 61 LEU~? 19.87 NA NA D1069 C1133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.32 17.01 -83.68 -12.30 18.91 -82.46 coo 63.14 29.39 46.25 63.84 31.31 45.74 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 14 3 # 14 C1050 GLN B 59 GLN~? 18.99 NA NA D1069 C1091 LEU B 61 LEU~? 19.87 NA NA D1069 C1133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -16.22 9.84 -81.57 -17.94 8.86 -80.67 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.32 17.01 -83.68 -12.30 18.91 -82.46 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 15 3 # 15 C1050 GLN B 59 GLN~? 18.99 NA NA D1069 C1091 LEU B 62 LEU~? 15.33 NA NA D1069 C1133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -16.22 9.84 -81.57 -17.94 8.86 -80.67 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 16 3 # 16 C1050 GLN C 42 GLN~? 24.55 NA NA D1069 C1091 LEU C 39 LEU~? 27.57 NA NA D1069 C1133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 5.41 -3.76 -59.03 4.20 -5.36 -58.36 coo 65.83 38.95 47.05 65.46 38.90 49.20 2.77 -0.77 -54.40 1.34 -2.28 -53.70 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 17 3 # 17 C1050 GLN C 47 GLN~? 17.45 NA NA D1069 C1091 LEU C 50 LEU~? 11.53 NA NA D1069 C1133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 65.83 38.95 47.05 65.46 38.90 49.20 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 18 3 # 18 C1050 GLN C 47 GLN~? 17.45 NA NA D1069 C1091 LEU C 50 LEU~? 11.53 NA NA D1069 C1133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 65.83 38.95 47.05 65.46 38.90 49.20 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 63.14 29.39 46.25 63.84 31.31 45.74 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 19 3 # 19 C1050 GLN C 49 GLN~? 11.67 NA NA D1069 C1091 LEU C 50 LEU~? 11.53 NA NA D1069 C1133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 65.83 38.95 47.05 65.46 38.90 49.20 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 20 3 # 20 C1050 GLN C 49 GLN~? 11.67 NA NA D1069 C1091 LEU D 50 LEU~? 11.93 NA NA D1069 C1133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 21 3 # 21 C1050 GLN C 57 GLN~? -4.09 NA NA D1069s C1091 LEU C 61 LEU~? 8.23 NA NA D1069 C1133 GLU C 55 GLU~? 12.72 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 1.28 9.88 -85.46 -0.51 9.71 -84.21 coo 63.14 29.39 46.25 63.84 31.31 45.74 8.93 8.59 -77.67 8.56 10.55 -76.69 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 22 3 # 22 C1050 GLN D 47 GLN~? 19.58 NA NA D1069 C1091 LEU D 50 LEU~? 11.93 NA NA D1069 C1133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 23 3 # 23 C1050 GLN D 47 GLN~? 19.58 NA NA D1069 C1091 LEU D 50 LEU~? 11.93 NA NA D1069 C1133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 63.14 29.39 46.25 63.84 31.31 45.74 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 24 3 # 24 C1050 GLN D 52 GLN~? 13.91 NA NA D1069 C1091 LEU D 50 LEU~? 11.93 NA NA D1069 C1133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 63.14 29.39 46.25 63.84 31.31 45.74 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 25 3 # 25 C1050 GLN D 52 GLN~? 13.91 NA NA D1069 C1091 LEU D 50 LEU~? 11.93 NA NA D1069 C1133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 63.14 29.39 46.25 63.84 31.31 45.74 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 26 3 # 26 C1050 GLN D 57 GLN~? -4.24 NA NA D1069s C1091 LEU D 61 LEU~? 7.44 NA NA D1069 C1133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 65.83 38.95 47.05 65.46 38.90 49.20 4.78 -2.11 -85.44 5.74 -0.46 -84.33 coo 63.14 29.39 46.25 63.84 31.31 45.74 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 27 3 # 27 C1050 GLN D 59 GLN~? 11.86 NA NA D1069 C1091 LEU D 61 LEU~? 7.44 NA NA D1069 C1133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -1.57 -7.56 -84.06 -3.05 -8.26 -85.53 coo 65.83 38.95 47.05 65.46 38.90 49.20 4.78 -2.11 -85.44 5.74 -0.46 -84.33 coo 63.14 29.39 46.25 63.84 31.31 45.74 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 28 3 # 28 C1050 GLN D 59 GLN~? 11.86 NA NA D1069 C1091 LEU D 62 LEU~? 12.06 NA NA D1069 C1133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -1.57 -7.56 -84.06 -3.05 -8.26 -85.53 coo 65.83 38.95 47.05 65.46 38.90 49.20 3.24 -6.52 -88.42 1.99 -8.01 -87.44 coo 63.14 29.39 46.25 63.84 31.31 45.74 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 29 3 # 29 C1050 GLN E 42 GLN~? 22.20 NA NA D1069 C1091 LEU E 39 LEU~? 26.71 NA NA D1069 C1133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 2.18 7.59 -60.56 4.31 7.40 -60.07 coo 65.83 38.95 47.05 65.46 38.90 49.20 1.19 4.92 -54.90 3.28 4.46 -54.59 coo 63.14 29.39 46.25 63.84 31.31 45.74 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 30 3 # 30 C1050 GLN E 47 GLN~? 16.16 NA NA D1069 C1091 LEU E 50 LEU~? 11.34 NA NA D1069 C1133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 63.14 29.39 46.25 63.84 31.31 45.74 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 31 3 # 31 C1050 GLN E 47 GLN~? 16.16 NA NA D1069 C1091 LEU E 50 LEU~? 11.34 NA NA D1069 C1133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 63.14 29.39 46.25 63.84 31.31 45.74 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 32 3 # 32 C1050 GLN E 49 GLN~? 13.17 NA NA D1069 C1091 LEU C 50 LEU~? 11.53 NA NA D1069 C1133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 65.83 38.95 47.05 65.46 38.90 49.20 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 63.14 29.39 46.25 63.84 31.31 45.74 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 33 3 # 33 C1050 GLN E 49 GLN~? 13.17 NA NA D1069 C1091 LEU E 50 LEU~? 11.34 NA NA D1069 C1133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 63.14 29.39 46.25 63.84 31.31 45.74 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 34 3 # 34 C1050 GLN E 52 GLN~? 13.85 NA NA D1069 C1091 LEU E 50 LEU~? 11.34 NA NA D1069 C1133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -6.20 10.29 -73.32 -5.15 12.02 -72.67 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 35 3 # 35 C1050 GLN E 57 GLN~? -4.15 NA NA D1069s C1091 LEU E 61 LEU~? 8.30 NA NA D1069 C1133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 65.83 38.95 47.05 65.46 38.90 49.20 -6.61 0.80 -86.61 -5.72 -1.04 -85.99 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 36 3 # 36 C1050 GLN E 59 GLN~? 11.22 NA NA D1069 C1091 LEU B 62 LEU~? 15.33 NA NA D1069 C1133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -8.54 8.13 -83.40 -8.26 10.00 -82.37 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 63.14 29.39 46.25 63.84 31.31 45.74 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 37 3 # 37 C1050 GLN F 42 GLN~? 30.81 NA NA D1069 C1091 LEU F 39 LEU~? 35.92 NA NA D1069 C1133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -13.65 15.93 -57.57 -14.32 14.09 -56.56 coo 65.83 38.95 47.05 65.46 38.90 49.20 -17.24 17.34 -53.43 -17.89 15.35 -52.85 coo 63.14 29.39 46.25 63.84 31.31 45.74 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 38 3 # 38 C1050 GLN F 47 GLN~? 33.35 NA NA D1069 C1091 LEU F 50 LEU~? 29.71 NA NA D1069 C1133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -18.85 24.82 -64.98 -20.45 24.10 -66.19 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 63.14 29.39 46.25 63.84 31.31 45.74 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 39 3 # 39 C1050 GLN F 49 GLN~? 22.45 NA NA D1069 C1091 LEU B 50 LEU~? 25.59 NA NA D1069 C1133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 65.83 38.95 47.05 65.46 38.90 49.20 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 63.14 29.39 46.25 63.84 31.31 45.74 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 40 3 # 40 C1050 GLN F 49 GLN~? 22.45 NA NA D1069 C1091 LEU F 50 LEU~? 29.71 NA NA D1069 C1133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 63.14 29.39 46.25 63.84 31.31 45.74 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 41 3 # 41 C1050 GLN F 52 GLN~? 25.43 NA NA D1069 C1091 LEU F 50 LEU~? 29.71 NA NA D1069 C1133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 68.29 34.44 43.03 66.67 34.74 44.37 -12.27 24.30 -72.03 -10.74 23.17 -71.15 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 63.14 29.39 46.25 63.84 31.31 45.74 -16.47 28.07 -74.52 -14.99 28.14 -72.96 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 41 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 42 GLN~? 39.09 NA NA D1069 A 91 LEU A 39 LEU~? 39.64 NA NA D1069 A 133 GLU A 45 GLU~? 42.99 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -21.84 25.72 -57.34 -19.68 25.85 -56.88 coo 35.40 53.22 73.30 35.37 54.87 74.74 -21.30 21.65 -53.36 -19.16 22.24 -53.15 coo 45.08 56.04 70.60 43.15 55.19 70.77 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 47 GLN~? 34.25 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU A 45 GLU~? 42.99 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 35.40 53.22 73.30 35.37 54.87 74.74 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 45.08 56.04 70.60 43.15 55.19 70.77 -28.22 26.22 -60.76 -30.15 26.07 -61.66 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 47 GLN~? 34.25 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 35.40 53.22 73.30 35.37 54.87 74.74 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 45.08 56.04 70.60 43.15 55.19 70.77 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 49 GLN~? 33.84 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -23.88 23.73 -70.51 -22.44 25.27 -70.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 45.08 56.04 70.60 43.15 55.19 70.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN A 52 GLN~? 37.34 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -29.33 21.76 -72.56 -29.33 23.89 -72.44 coo 35.40 53.22 73.30 35.37 54.87 74.74 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 45.08 56.04 70.60 43.15 55.19 70.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN A 57 GLN~? 24.51 NA NA D1069 A 91 LEU A 61 LEU~? 23.78 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 35.40 53.22 73.30 35.37 54.87 74.74 -22.60 12.27 -84.26 -20.61 12.12 -83.35 coo 45.08 56.04 70.60 43.15 55.19 70.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN A 59 GLN~? 34.47 NA NA D1069 A 91 LEU A 61 LEU~? 23.78 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 -22.60 12.27 -84.26 -20.61 12.12 -83.35 coo 45.08 56.04 70.60 43.15 55.19 70.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN A 59 GLN~? 34.47 NA NA D1069 A 91 LEU A 62 LEU~? 29.47 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 -27.39 11.88 -86.63 -28.30 10.28 -85.33 coo 45.08 56.04 70.60 43.15 55.19 70.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN B 42 GLN~? 38.96 NA NA D1069 A 91 LEU B 39 LEU~? 39.26 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -25.88 13.67 -56.90 -26.78 15.40 -56.02 coo 35.40 53.22 73.30 35.37 54.87 74.74 -22.65 15.85 -52.90 -23.28 17.77 -52.68 coo 45.08 56.04 70.60 43.15 55.19 70.77 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN B 47 GLN~? 24.93 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 35.40 53.22 73.30 35.37 54.87 74.74 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 45.08 56.04 70.60 43.15 55.19 70.77 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN B 47 GLN~? 24.93 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 35.40 53.22 73.30 35.37 54.87 74.74 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 45.08 56.04 70.60 43.15 55.19 70.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN B 49 GLN~? 30.98 NA NA D1069 A 91 LEU A 50 LEU~? 30.48 NA NA D1069 A 133 GLU A 55 GLU~? 31.92 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -24.04 12.01 -67.93 -25.65 13.45 -67.68 coo 35.40 53.22 73.30 35.37 54.87 74.74 -23.78 18.26 -68.12 -22.40 16.64 -68.05 coo 45.08 56.04 70.60 43.15 55.19 70.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN B 52 GLN~? 25.40 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU B 45 GLU~? 30.22 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 35.40 53.22 73.30 35.37 54.87 74.74 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 45.08 56.04 70.60 43.15 55.19 70.77 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN B 52 GLN~? 25.40 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 35.40 53.22 73.30 35.37 54.87 74.74 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 45.08 56.04 70.60 43.15 55.19 70.77 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 15 3 # 15 A 50 GLN B 57 GLN~? 21.78 NA NA D1069 A 91 LEU B 61 LEU~? 19.87 NA NA D1069 A 133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 35.40 53.22 73.30 35.37 54.87 74.74 -12.32 17.01 -83.68 -12.30 18.91 -82.46 coo 45.08 56.04 70.60 43.15 55.19 70.77 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 16 3 # 16 A 50 GLN B 59 GLN~? 18.99 NA NA D1069 A 91 LEU B 62 LEU~? 15.33 NA NA D1069 A 133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -16.22 9.84 -81.57 -17.94 8.86 -80.67 coo 35.40 53.22 73.30 35.37 54.87 74.74 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 45.08 56.04 70.60 43.15 55.19 70.77 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 17 3 # 17 A 50 GLN C 42 GLN~? 24.55 NA NA D1069 A 91 LEU C 39 LEU~? 27.57 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 5.41 -3.76 -59.03 4.20 -5.36 -58.36 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.77 -0.77 -54.40 1.34 -2.28 -53.70 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 18 3 # 18 A 50 GLN C 47 GLN~? 17.45 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 19 3 # 19 A 50 GLN C 47 GLN~? 17.45 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 20 3 # 20 A 50 GLN C 49 GLN~? 11.67 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 21 3 # 21 A 50 GLN C 49 GLN~? 11.67 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 35.40 53.22 73.30 35.37 54.87 74.74 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 22 3 # 22 A 50 GLN C 57 GLN~? -4.09 NA NA D1069s A 91 LEU C 61 LEU~? 8.23 NA NA D1069 A 133 GLU C 55 GLU~? 12.72 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 35.40 53.22 73.30 35.37 54.87 74.74 1.28 9.88 -85.46 -0.51 9.71 -84.21 coo 45.08 56.04 70.60 43.15 55.19 70.77 8.93 8.59 -77.67 8.56 10.55 -76.69 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 23 3 # 23 A 50 GLN D 42 GLN~? 23.24 NA NA D1069 A 91 LEU D 39 LEU~? 26.75 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -5.90 0.78 -59.73 -6.53 2.66 -58.93 coo 35.40 53.22 73.30 35.37 54.87 74.74 -2.79 0.38 -54.11 -1.54 1.88 -55.11 coo 45.08 56.04 70.60 43.15 55.19 70.77 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 24 3 # 24 A 50 GLN D 47 GLN~? 19.58 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU C 45 GLU~? 22.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 35.40 53.22 73.30 35.37 54.87 74.74 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.55 -0.98 -62.99 10.23 -2.79 -62.14 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 25 3 # 25 A 50 GLN D 47 GLN~? 19.58 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 35.40 53.22 73.30 35.37 54.87 74.74 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 45.08 56.04 70.60 43.15 55.19 70.77 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 26 3 # 26 A 50 GLN D 52 GLN~? 13.91 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 35.40 53.22 73.30 35.37 54.87 74.74 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 45.08 56.04 70.60 43.15 55.19 70.77 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 27 3 # 27 A 50 GLN D 52 GLN~? 13.91 NA NA D1069 A 91 LEU D 50 LEU~? 11.93 NA NA D1069 A 133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 35.40 53.22 73.30 35.37 54.87 74.74 -0.02 -1.70 -69.68 1.52 -0.25 -69.99 coo 45.08 56.04 70.60 43.15 55.19 70.77 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 28 3 # 28 A 50 GLN D 57 GLN~? -4.24 NA NA D1069s A 91 LEU D 61 LEU~? 7.44 NA NA D1069 A 133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 35.40 53.22 73.30 35.37 54.87 74.74 4.78 -2.11 -85.44 5.74 -0.46 -84.33 coo 45.08 56.04 70.60 43.15 55.19 70.77 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 29 3 # 29 A 50 GLN D 59 GLN~? 11.86 NA NA D1069 A 91 LEU D 62 LEU~? 12.06 NA NA D1069 A 133 GLU D 55 GLU~? 12.40 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -1.57 -7.56 -84.06 -3.05 -8.26 -85.53 coo 35.40 53.22 73.30 35.37 54.87 74.74 3.24 -6.52 -88.42 1.99 -8.01 -87.44 coo 45.08 56.04 70.60 43.15 55.19 70.77 0.42 -8.60 -77.55 2.42 -8.94 -76.88 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 30 3 # 30 A 50 GLN E 42 GLN~? 22.20 NA NA D1069 A 91 LEU E 39 LEU~? 26.71 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 2.18 7.59 -60.56 4.31 7.40 -60.07 coo 35.40 53.22 73.30 35.37 54.87 74.74 1.19 4.92 -54.90 3.28 4.46 -54.59 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 31 3 # 31 A 50 GLN E 47 GLN~? 16.16 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU D 45 GLU~? 19.29 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 45.08 56.04 70.60 43.15 55.19 70.77 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 32 3 # 32 A 50 GLN E 47 GLN~? 16.16 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 33 3 # 33 A 50 GLN E 49 GLN~? 13.17 NA NA D1069 A 91 LEU C 50 LEU~? 11.53 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.45 4.22 -69.97 0.68 5.34 -70.21 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 34 3 # 34 A 50 GLN E 49 GLN~? 13.17 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU E 45 GLU~? 20.97 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 35 3 # 35 A 50 GLN E 52 GLN~? 13.85 NA NA D1069 A 91 LEU E 50 LEU~? 11.34 NA NA D1069 A 133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -6.20 10.29 -73.32 -5.15 12.02 -72.67 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.69 3.37 -70.14 -2.97 1.40 -70.64 coo 45.08 56.04 70.60 43.15 55.19 70.77 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 36 3 # 36 A 50 GLN E 57 GLN~? -4.15 NA NA D1069s A 91 LEU E 61 LEU~? 8.30 NA NA D1069 A 133 GLU E 55 GLU~? 12.74 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 35.40 53.22 73.30 35.37 54.87 74.74 -6.61 0.80 -86.61 -5.72 -1.04 -85.99 coo 45.08 56.04 70.60 43.15 55.19 70.77 -10.03 7.67 -78.86 -11.90 6.81 -79.44 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 37 3 # 37 A 50 GLN E 59 GLN~? 11.22 NA NA D1069 A 91 LEU B 62 LEU~? 15.33 NA NA D1069 A 133 GLU B 55 GLU~? 15.33 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -8.54 8.13 -83.40 -8.26 10.00 -82.37 coo 35.40 53.22 73.30 35.37 54.87 74.74 -12.28 12.21 -85.95 -10.63 10.74 -86.25 coo 45.08 56.04 70.60 43.15 55.19 70.77 -15.58 8.63 -77.02 -13.81 8.49 -78.16 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 38 3 # 38 A 50 GLN F 42 GLN~? 30.81 NA NA D1069 A 91 LEU F 39 LEU~? 35.92 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -13.65 15.93 -57.57 -14.32 14.09 -56.56 coo 35.40 53.22 73.30 35.37 54.87 74.74 -17.24 17.34 -53.43 -17.89 15.35 -52.85 coo 45.08 56.04 70.60 43.15 55.19 70.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 39 3 # 39 A 50 GLN F 47 GLN~? 33.35 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -18.85 24.82 -64.98 -20.45 24.10 -66.19 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 45.08 56.04 70.60 43.15 55.19 70.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 40 3 # 40 A 50 GLN F 49 GLN~? 22.45 NA NA D1069 A 91 LEU B 50 LEU~? 25.59 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 35.40 53.22 73.30 35.37 54.87 74.74 -17.97 14.94 -68.14 -17.09 16.91 -68.45 coo 45.08 56.04 70.60 43.15 55.19 70.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 41 3 # 41 A 50 GLN F 49 GLN~? 22.45 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 45 GLU~? 25.79 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 45.08 56.04 70.60 43.15 55.19 70.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 42 3 # 42 A 50 GLN F 52 GLN~? 25.43 NA NA D1069 A 91 LEU F 50 LEU~? 29.71 NA NA D1069 A 133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -12.27 24.30 -72.03 -10.74 23.17 -71.15 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.85 21.24 -68.98 -20.95 20.87 -69.69 coo 45.08 56.04 70.60 43.15 55.19 70.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 43 3 # 43 A 50 GLN F 57 GLN~? 28.62 NA NA D1069 A 91 LEU F 61 LEU~? 32.18 NA NA D1069 A 133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 35.40 53.22 73.30 35.37 54.87 74.74 -22.94 25.15 -84.39 -23.99 23.59 -83.16 coo 45.08 56.04 70.60 43.15 55.19 70.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 44 3 # 44 A 50 GLN F 59 GLN~? 28.82 NA NA D1069 A 91 LEU F 61 LEU~? 32.18 NA NA D1069 A 133 GLU F 55 GLU~? 30.88 NA NA D1069 coo 38.23 53.34 67.59 38.84 53.87 69.56 -15.57 28.01 -81.79 -13.40 27.96 -81.83 coo 35.40 53.22 73.30 35.37 54.87 74.74 -22.94 25.15 -84.39 -23.99 23.59 -83.16 coo 45.08 56.04 70.60 43.15 55.19 70.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 44 hits 1bsj_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 65 ARG B 13 ARG~? 20.17 CH3 ACT B1069 A 85 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 65 ARG F 13 ARG~? 20.80 CH3 ACT B1069 A 85 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 65 ARG D 13 ARG~? 25.10 OXT ACT B1069 A 85 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 65 ARG E 13 ARG~? 38.24 OXT ACT B1069 A 85 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1c54_c00 RIBONUCLEASE SA user 5 3 # 5 A 54 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 65 ARG F 13 ARG~? 20.80 CH3 ACT B1069 A 85 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -19.58 14.64 -22.09 -21.60 14.41 -21.58 1c54_c00 source 1c54 RIBONUCLEASE SA : 5 hits 1c54_c00 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 35 ASP~? 46.31 NA NA D1069 264 GLU A 45 GLU~? 42.99 NA NA D1069 328 ASP A 35 ASP~? 45.42 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 59.69 92.71 39.85 58.53 92.03 41.47 -28.22 26.22 -60.76 -30.15 26.07 -61.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP C 35 ASP~? 34.97 NA NA D1069 264 GLU D 45 GLU~? 19.29 NA NA D1069 328 ASP D 37 ASP~? 34.01 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 59.69 92.71 39.85 58.53 92.03 41.47 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 45.39 90.72 40.63 45.07 89.14 41.90 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP C 37 ASP~? 33.08 NA NA D1069 264 GLU E 45 GLU~? 20.97 NA NA D1069 328 ASP E 35 ASP~? 33.25 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP D 35 ASP~? 33.74 NA NA D1069 264 GLU C 45 GLU~? 22.33 NA NA D1069 328 ASP C 35 ASP~? 34.97 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP D 35 ASP~? 33.74 NA NA D1069 264 GLU C 45 GLU~? 22.33 NA NA D1069 328 ASP E 35 ASP~? 33.25 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP D 35 ASP~? 33.74 NA NA D1069 264 GLU E 45 GLU~? 20.97 NA NA D1069 328 ASP E 35 ASP~? 33.25 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP D 37 ASP~? 34.01 NA NA D1069 264 GLU C 45 GLU~? 22.33 NA NA D1069 328 ASP C 35 ASP~? 34.97 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 59.69 92.71 39.85 58.53 92.03 41.47 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP F 35 ASP~? 38.96 NA NA D1069 264 GLU B 45 GLU~? 30.22 NA NA D1069 328 ASP B 37 ASP~? 39.88 NA NA D1069 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 45.39 90.72 40.63 45.07 89.14 41.90 -22.23 9.61 -49.11 -20.62 9.20 -47.75 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 8 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 41 GLY~? 42.76 NA NA D1069 A 228 SER A 38 SER~? 45.54 NA NA D1069 A 549 ASP A 35 ASP~? 45.42 NA NA D1069 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -26.92 24.12 -56.03 -26.24 23.69 -56.21 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 41 GLY~? 34.47 NA NA D1069 A 228 SER B 38 SER~? 40.72 NA NA D1069 A 549 ASP B 35 ASP~? 46.31 NA NA D1069 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -22.56 10.02 -56.25 -22.41 10.83 -56.35 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY C 41 GLY~? 24.75 NA NA D1069 A 228 SER C 38 SER~? 28.14 NA NA D1069 A 549 ASP C 35 ASP~? 34.97 NA NA D1069 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 8.36 0.13 -58.10 7.51 0.13 -58.17 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY D 41 GLY~? 25.54 NA NA D1069 A 228 SER D 38 SER~? 31.09 NA NA D1069 A 549 ASP D 35 ASP~? 33.74 NA NA D1069 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -5.35 -5.01 -57.39 -4.87 -4.30 -57.44 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -6.55 -2.47 -53.10 -8.33 -1.87 -51.58 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY E 41 GLY~? 24.88 NA NA D1069 A 228 SER E 38 SER~? 28.19 NA NA D1069 A 549 ASP E 35 ASP~? 33.25 NA NA D1069 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -2.85 9.52 -57.57 -2.50 8.81 -57.70 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY F 41 GLY~? 33.16 NA NA D1069 A 228 SER F 38 SER~? 34.44 NA NA D1069 A 549 ASP F 35 ASP~? 38.96 NA NA D1069 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -12.66 20.89 -56.77 -13.36 20.53 -56.84 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.17 14.97 -47.64 -14.21 13.34 -46.63 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 41 GLY~? 42.76 NA NA D1069 B1228 SER A 38 SER~? 45.54 NA NA D1069 B1549 ASP A 35 ASP~? 45.42 NA NA D1069 coo 126.34 72.75 125.66 125.95 73.27 126.11 -26.92 24.12 -56.03 -26.24 23.69 -56.21 coo 131.65 74.68 129.41 130.31 72.73 128.82 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo 134.72 69.43 130.42 133.03 70.65 130.08 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 41 GLY~? 34.47 NA NA D1069 B1228 SER B 38 SER~? 40.72 NA NA D1069 B1549 ASP B 35 ASP~? 46.31 NA NA D1069 coo 126.34 72.75 125.66 125.95 73.27 126.11 -22.56 10.02 -56.25 -22.41 10.83 -56.35 coo 131.65 74.68 129.41 130.31 72.73 128.82 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo 134.72 69.43 130.42 133.03 70.65 130.08 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY C 41 GLY~? 24.75 NA NA D1069 B1228 SER C 38 SER~? 28.14 NA NA D1069 B1549 ASP C 35 ASP~? 34.97 NA NA D1069 coo 126.34 72.75 125.66 125.95 73.27 126.11 8.36 0.13 -58.10 7.51 0.13 -58.17 coo 131.65 74.68 129.41 130.31 72.73 128.82 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 134.72 69.43 130.42 133.03 70.65 130.08 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY D 41 GLY~? 25.54 NA NA D1069 B1228 SER D 38 SER~? 31.09 NA NA D1069 B1549 ASP D 35 ASP~? 33.74 NA NA D1069 coo 126.34 72.75 125.66 125.95 73.27 126.11 -5.35 -5.01 -57.39 -4.87 -4.30 -57.44 coo 131.65 74.68 129.41 130.31 72.73 128.82 -6.55 -2.47 -53.10 -8.33 -1.87 -51.58 coo 134.72 69.43 130.42 133.03 70.65 130.08 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY E 41 GLY~? 24.88 NA NA D1069 B1228 SER E 38 SER~? 28.19 NA NA D1069 B1549 ASP E 35 ASP~? 33.25 NA NA D1069 coo 126.34 72.75 125.66 125.95 73.27 126.11 -2.85 9.52 -57.57 -2.50 8.81 -57.70 coo 131.65 74.68 129.41 130.31 72.73 128.82 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 134.72 69.43 130.42 133.03 70.65 130.08 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY F 41 GLY~? 33.16 NA NA D1069 B1228 SER F 38 SER~? 34.44 NA NA D1069 B1549 ASP F 35 ASP~? 38.96 NA NA D1069 coo 126.34 72.75 125.66 125.95 73.27 126.11 -12.66 20.89 -56.77 -13.36 20.53 -56.84 coo 131.65 74.68 129.41 130.31 72.73 128.82 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.17 14.97 -47.64 -14.21 13.34 -46.63 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 31 ASP~? 41.79 O ACT B1069 37 SER A 30 SER~? 40.12 CH3 ACT B1069 216 ASP A 35 ASP~? 45.42 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 12.23 24.31 30.40 14.55 23.96 31.03 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 13.93 25.52 22.10 14.75 24.44 23.75 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 37 ASP~? 48.68 NA NA D1069 37 SER A 34 SER~? 48.00 O ACT B1069 216 ASP B 35 ASP~? 46.31 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 12.23 24.31 30.40 14.55 23.96 31.03 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 13.93 25.52 22.10 14.75 24.44 23.75 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP B 31 ASP~? 42.18 CH3 ACT B1069 37 SER B 30 SER~? 40.67 CH3 ACT B1069 216 ASP B 35 ASP~? 46.31 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 12.23 24.31 30.40 14.55 23.96 31.03 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 13.93 25.52 22.10 14.75 24.44 23.75 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP C 31 ASP~? 40.83 NA NA D1069 37 SER C 30 SER~? 42.91 NA NA D1069 216 ASP C 35 ASP~? 34.97 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 12.23 24.31 30.40 14.55 23.96 31.03 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP C 35 ASP~? 34.97 NA NA D1069 37 SER C 34 SER~? 36.89 NA NA D1069 216 ASP E 35 ASP~? 33.25 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 12.23 24.31 30.40 14.55 23.96 31.03 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP C 37 ASP~? 33.08 NA NA D1069 37 SER C 34 SER~? 36.89 NA NA D1069 216 ASP E 35 ASP~? 33.25 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 12.23 24.31 30.40 14.55 23.96 31.03 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 3 # 7 34 ASP C 37 ASP~? 33.08 NA NA D1069 37 SER C 38 SER~? 28.14 NA NA D1069 216 ASP C 35 ASP~? 34.97 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 12.23 24.31 30.40 14.55 23.96 31.03 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 3 # 8 34 ASP D 31 ASP~? 40.40 NA NA D1069 37 SER D 30 SER~? 41.47 NA NA D1069 216 ASP D 35 ASP~? 33.74 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 12.23 24.31 30.40 14.55 23.96 31.03 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 13.93 25.52 22.10 14.75 24.44 23.75 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 9 3 # 9 34 ASP D 37 ASP~? 34.01 NA NA D1069 37 SER D 34 SER~? 37.31 NA NA D1069 216 ASP C 35 ASP~? 34.97 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 12.23 24.31 30.40 14.55 23.96 31.03 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 10 3 # 10 34 ASP E 31 ASP~? 40.09 NA NA D1069 37 SER E 30 SER~? 42.45 NA NA D1069 216 ASP E 35 ASP~? 33.25 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 12.23 24.31 30.40 14.55 23.96 31.03 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 11 3 # 11 34 ASP E 37 ASP~? 33.39 NA NA D1069 37 SER E 34 SER~? 36.48 NA NA D1069 216 ASP D 35 ASP~? 33.74 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 12.23 24.31 30.40 14.55 23.96 31.03 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 13.93 25.52 22.10 14.75 24.44 23.75 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 12 3 # 12 34 ASP E 37 ASP~? 33.39 NA NA D1069 37 SER E 38 SER~? 28.19 NA NA D1069 216 ASP E 35 ASP~? 33.25 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 12.23 24.31 30.40 14.55 23.96 31.03 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 13.93 25.52 22.10 14.75 24.44 23.75 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 13 3 # 13 34 ASP F 31 ASP~? 42.55 OXT ACT B1069 37 SER F 30 SER~? 41.37 O ACT B1069 216 ASP F 35 ASP~? 38.96 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 12.23 24.31 30.40 14.55 23.96 31.03 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 13.93 25.52 22.10 14.75 24.44 23.75 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 14 3 # 14 34 ASP F 37 ASP~? 40.42 NA NA D1069 37 SER F 34 SER~? 40.55 NA NA D1069 216 ASP A 35 ASP~? 45.42 NA NA D1069 coo 16.90 26.20 29.49 16.22 24.50 28.41 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 12.23 24.31 30.40 14.55 23.96 31.03 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 13.93 25.52 22.10 14.75 24.44 23.75 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 14 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 12 GLU~? 11.83 O ACT B1069 A 89 GLU A 5 GLU~? 4.25 O ACT B1069 A 120 SER B 3 SER~? 8.11 CH3 ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -12.91 21.95 -1.38 -14.15 21.05 0.13 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.25 25.44 -1.76 -24.43 24.37 -1.48 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 12 GLU~? 11.83 O ACT B1069 A 89 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 120 SER B 15 SER~? 18.52 CH3 ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -23.57 17.59 -17.96 -22.72 15.36 -17.43 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 12 GLU~? 11.83 O ACT B1069 A 89 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 120 SER F 15 SER~? 18.74 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -16.65 14.44 -18.28 -15.27 16.35 -17.73 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 5 GLU~? 7.35 CH3 ACT B1069 A 89 GLU F 5 GLU~? 4.67 OXT ACT B1069 A 120 SER F 3 SER~? 9.64 CH3 ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -26.27 20.06 -2.00 -26.37 18.13 -2.87 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -16.48 12.29 -1.23 -17.71 12.65 0.50 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.61 10.54 -1.90 -24.99 10.44 -2.58 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 89 GLU A 12 GLU~? 11.83 O ACT B1069 A 120 SER A 15 SER~? 18.46 O ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -17.50 21.98 -18.17 -19.80 22.08 -17.54 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 89 GLU B 5 GLU~? 7.35 CH3 ACT B1069 A 120 SER F 3 SER~? 9.64 CH3 ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -26.27 20.06 -2.00 -26.37 18.13 -2.87 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.61 10.54 -1.90 -24.99 10.44 -2.58 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 89 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 120 SER F 15 SER~? 18.74 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -16.65 14.44 -18.28 -15.27 16.35 -17.73 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 89 GLU C 5 GLU~? 25.63 OXT ACT B1069 A 120 SER E 3 SER~? 32.62 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -0.43 -3.40 -2.74 -1.54 -2.58 -1.10 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.87 -2.43 -3.07 9.41 -0.57 -3.09 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 89 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 120 SER D 15 SER~? 29.04 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -2.29 4.33 -19.60 -2.69 2.08 -18.89 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 89 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 120 SER E 15 SER~? 31.11 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -31.18 6.91 75.60 -32.39 8.51 74.91 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 5.12 4.34 -19.70 3.25 5.78 -19.17 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 89 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 120 SER C 15 SER~? 34.57 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -31.18 6.91 75.60 -32.39 8.51 74.91 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -34.73 8.57 68.21 -33.63 9.08 70.28 1.50 -2.25 -19.56 3.70 -1.35 -19.01 ULMN 3 1cns_c00 CHITINASE user 12 3 # 12 A 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 89 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 120 SER C 3 SER~? 20.83 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -6.40 -1.33 -3.63 -8.43 -0.54 -4.77 ULMN 3 1cns_c00 CHITINASE user 13 3 # 13 A 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 89 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 120 SER E 15 SER~? 31.11 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -31.18 6.91 75.60 -32.39 8.51 74.91 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 5.12 4.34 -19.70 3.25 5.78 -19.17 ULMN 3 1cns_c00 CHITINASE user 14 3 # 14 A 67 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 89 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 120 SER C 15 SER~? 34.57 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -31.18 6.91 75.60 -32.39 8.51 74.91 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -34.73 8.57 68.21 -33.63 9.08 70.28 1.50 -2.25 -19.56 3.70 -1.35 -19.01 ULMN 3 1cns_c00 CHITINASE user 15 3 # 15 A 67 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 89 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 120 SER D 15 SER~? 29.04 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -2.29 4.33 -19.60 -2.69 2.08 -18.89 ULMN 3 1cns_c00 CHITINASE user 16 3 # 16 A 67 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 89 GLU E 5 GLU~? 30.85 OXT ACT B1069 A 120 SER D 3 SER~? 18.95 OXT ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -31.18 6.91 75.60 -32.39 8.51 74.91 9.19 3.53 -3.57 10.09 3.91 -1.63 coo -34.73 8.57 68.21 -33.63 9.08 70.28 2.14 10.59 -3.07 -0.19 11.09 -3.36 ULMN 3 1cns_c00 CHITINASE user 17 3 # 17 A 67 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 89 GLU A 12 GLU~? 11.83 O ACT B1069 A 120 SER A 15 SER~? 18.46 O ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -17.50 21.98 -18.17 -19.80 22.08 -17.54 ULMN 3 1cns_c00 CHITINASE user 18 3 # 18 A 67 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 89 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 120 SER B 15 SER~? 18.52 CH3 ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -23.57 17.59 -17.96 -22.72 15.36 -17.43 ULMN 3 1cns_c00 CHITINASE user 19 3 # 19 A 67 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 89 GLU F 5 GLU~? 4.67 OXT ACT B1069 A 120 SER A 3 SER~? 8.16 O ACT B1069 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -16.48 12.29 -1.23 -17.71 12.65 0.50 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.33 17.80 -2.05 -10.39 20.20 -2.10 1cns_c00 source 1cns CHITINASE : 19 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 12 GLU~? 11.83 O ACT B1069 B 89 GLU A 5 GLU~? 4.25 O ACT B1069 B 120 SER B 3 SER~? 8.11 CH3 ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -12.91 21.95 -1.38 -14.15 21.05 0.13 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -22.25 25.44 -1.76 -24.43 24.37 -1.48 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 12 GLU~? 11.83 O ACT B1069 B 89 GLU B 12 GLU~? 11.90 CH3 ACT B1069 B 120 SER B 15 SER~? 18.52 CH3 ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.57 17.59 -17.96 -22.72 15.36 -17.43 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 12 GLU~? 11.83 O ACT B1069 B 89 GLU F 12 GLU~? 12.40 OXT ACT B1069 B 120 SER F 15 SER~? 18.74 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -16.65 14.44 -18.28 -15.27 16.35 -17.73 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 12 GLU~? 11.90 CH3 ACT B1069 B 89 GLU A 12 GLU~? 11.83 O ACT B1069 B 120 SER A 15 SER~? 18.46 O ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -17.50 21.98 -18.17 -19.80 22.08 -17.54 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 12 GLU~? 11.90 CH3 ACT B1069 B 89 GLU B 5 GLU~? 7.35 CH3 ACT B1069 B 120 SER F 3 SER~? 9.64 CH3 ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -26.27 20.06 -2.00 -26.37 18.13 -2.87 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -22.61 10.54 -1.90 -24.99 10.44 -2.58 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU B 12 GLU~? 11.90 CH3 ACT B1069 B 89 GLU F 12 GLU~? 12.40 OXT ACT B1069 B 120 SER F 15 SER~? 18.74 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -16.65 14.44 -18.28 -15.27 16.35 -17.73 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 89 GLU C 5 GLU~? 25.63 OXT ACT B1069 B 120 SER E 3 SER~? 32.62 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -0.43 -3.40 -2.74 -1.54 -2.58 -1.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.87 -2.43 -3.07 9.41 -0.57 -3.09 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 89 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 120 SER D 15 SER~? 29.04 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -2.29 4.33 -19.60 -2.69 2.08 -18.89 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 89 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 120 SER D 15 SER~? 29.04 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -2.29 4.33 -19.60 -2.69 2.08 -18.89 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 89 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 120 SER E 15 SER~? 31.11 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 5.12 4.34 -19.70 3.25 5.78 -19.17 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 89 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 120 SER C 15 SER~? 34.57 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 1.50 -2.25 -19.56 3.70 -1.35 -19.01 ULMN 3 1cns_c01 CHITINASE user 12 3 # 12 B 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 89 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 120 SER E 15 SER~? 31.11 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 5.12 4.34 -19.70 3.25 5.78 -19.17 ULMN 3 1cns_c01 CHITINASE user 13 3 # 13 B 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 89 GLU D 5 GLU~? 18.82 OXT ACT B1069 B 120 SER C 3 SER~? 20.83 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -6.40 -1.33 -3.63 -8.43 -0.54 -4.77 ULMN 3 1cns_c01 CHITINASE user 14 3 # 14 B 67 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 89 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 120 SER E 15 SER~? 31.11 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 5.12 4.34 -19.70 3.25 5.78 -19.17 ULMN 3 1cns_c01 CHITINASE user 15 3 # 15 B 67 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 89 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 120 SER C 15 SER~? 34.57 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 1.50 -2.25 -19.56 3.70 -1.35 -19.01 ULMN 3 1cns_c01 CHITINASE user 16 3 # 16 B 67 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 89 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 120 SER D 15 SER~? 29.04 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -2.29 4.33 -19.60 -2.69 2.08 -18.89 ULMN 3 1cns_c01 CHITINASE user 17 3 # 17 B 67 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 89 GLU E 5 GLU~? 30.85 OXT ACT B1069 B 120 SER D 3 SER~? 18.95 OXT ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 9.19 3.53 -3.57 10.09 3.91 -1.63 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 2.14 10.59 -3.07 -0.19 11.09 -3.36 ULMN 3 1cns_c01 CHITINASE user 18 3 # 18 B 67 GLU F 12 GLU~? 12.40 OXT ACT B1069 B 89 GLU A 12 GLU~? 11.83 O ACT B1069 B 120 SER A 15 SER~? 18.46 O ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -17.50 21.98 -18.17 -19.80 22.08 -17.54 ULMN 3 1cns_c01 CHITINASE user 19 3 # 19 B 67 GLU F 12 GLU~? 12.40 OXT ACT B1069 B 89 GLU B 12 GLU~? 11.90 CH3 ACT B1069 B 120 SER B 15 SER~? 18.52 CH3 ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -23.57 17.59 -17.96 -22.72 15.36 -17.43 ULMN 3 1cns_c01 CHITINASE user 20 3 # 20 B 67 GLU F 12 GLU~? 12.40 OXT ACT B1069 B 89 GLU F 5 GLU~? 4.67 OXT ACT B1069 B 120 SER A 3 SER~? 8.16 O ACT B1069 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -16.48 12.29 -1.23 -17.71 12.65 0.50 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.33 17.80 -2.05 -10.39 20.20 -2.10 1cns_c01 source 1cns CHITINASE : 20 hits 1cns_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 31 ASP~? 41.79 O ACT B1069 A 35 SER A 30 SER~? 40.12 CH3 ACT B1069 A 218 ASP A 35 ASP~? 45.42 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 43.58 20.85 5.15 44.62 23.01 5.76 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 44.05 16.99 12.67 44.05 18.89 11.74 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP A 37 ASP~? 48.68 NA NA D1069 A 35 SER A 34 SER~? 48.00 O ACT B1069 A 218 ASP B 35 ASP~? 46.31 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 43.58 20.85 5.15 44.62 23.01 5.76 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 44.05 16.99 12.67 44.05 18.89 11.74 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 35 SER B 30 SER~? 40.67 CH3 ACT B1069 A 218 ASP B 35 ASP~? 46.31 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 43.58 20.85 5.15 44.62 23.01 5.76 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 44.05 16.99 12.67 44.05 18.89 11.74 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP C 31 ASP~? 40.83 NA NA D1069 A 35 SER C 30 SER~? 42.91 NA NA D1069 A 218 ASP C 35 ASP~? 34.97 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 43.58 20.85 5.15 44.62 23.01 5.76 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 44.05 16.99 12.67 44.05 18.89 11.74 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 5 3 # 5 A 32 ASP C 37 ASP~? 33.08 NA NA D1069 A 35 SER C 34 SER~? 36.89 NA NA D1069 A 218 ASP E 35 ASP~? 33.25 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 43.58 20.85 5.15 44.62 23.01 5.76 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 44.05 16.99 12.67 44.05 18.89 11.74 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 6 3 # 6 A 32 ASP C 37 ASP~? 33.08 NA NA D1069 A 35 SER C 38 SER~? 28.14 NA NA D1069 A 218 ASP C 35 ASP~? 34.97 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 43.58 20.85 5.15 44.62 23.01 5.76 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 44.05 16.99 12.67 44.05 18.89 11.74 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 7 3 # 7 A 32 ASP D 31 ASP~? 40.40 NA NA D1069 A 35 SER D 30 SER~? 41.47 NA NA D1069 A 218 ASP D 35 ASP~? 33.74 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 43.58 20.85 5.15 44.62 23.01 5.76 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 44.05 16.99 12.67 44.05 18.89 11.74 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 8 3 # 8 A 32 ASP D 37 ASP~? 34.01 NA NA D1069 A 35 SER D 34 SER~? 37.31 NA NA D1069 A 218 ASP C 35 ASP~? 34.97 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 43.58 20.85 5.15 44.62 23.01 5.76 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 44.05 16.99 12.67 44.05 18.89 11.74 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 9 3 # 9 A 32 ASP E 31 ASP~? 40.09 NA NA D1069 A 35 SER E 30 SER~? 42.45 NA NA D1069 A 218 ASP E 35 ASP~? 33.25 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 43.58 20.85 5.15 44.62 23.01 5.76 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 44.05 16.99 12.67 44.05 18.89 11.74 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 10 3 # 10 A 32 ASP E 37 ASP~? 33.39 NA NA D1069 A 35 SER E 34 SER~? 36.48 NA NA D1069 A 218 ASP D 35 ASP~? 33.74 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 43.58 20.85 5.15 44.62 23.01 5.76 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 44.05 16.99 12.67 44.05 18.89 11.74 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 11 3 # 11 A 32 ASP E 37 ASP~? 33.39 NA NA D1069 A 35 SER E 38 SER~? 28.19 NA NA D1069 A 218 ASP E 35 ASP~? 33.25 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 43.58 20.85 5.15 44.62 23.01 5.76 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 44.05 16.99 12.67 44.05 18.89 11.74 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 12 3 # 12 A 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 35 SER F 30 SER~? 41.37 O ACT B1069 A 218 ASP F 35 ASP~? 38.96 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 43.58 20.85 5.15 44.62 23.01 5.76 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 44.05 16.99 12.67 44.05 18.89 11.74 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 13 3 # 13 A 32 ASP F 37 ASP~? 40.42 NA NA D1069 A 35 SER F 34 SER~? 40.55 NA NA D1069 A 218 ASP A 35 ASP~? 45.42 NA NA D1069 coo 47.22 22.34 8.57 45.16 22.02 9.13 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 43.58 20.85 5.15 44.62 23.01 5.76 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 44.05 16.99 12.67 44.05 18.89 11.74 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1eag_c04 source 1eag PEPTIDE INHIBITOR : 13 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 31 ASP~? 41.79 O ACT B1069 P 35 SER A 30 SER~? 40.12 CH3 ACT B1069 P 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 7.57 37.60 10.00 8.86 37.02 12.03 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 4.04 29.97 8.82 4.78 31.15 10.46 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 37 ASP~? 48.68 NA NA D1069 P 35 SER A 34 SER~? 48.00 O ACT B1069 P 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 7.57 37.60 10.00 8.86 37.02 12.03 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 4.04 29.97 8.82 4.78 31.15 10.46 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 P 35 SER B 30 SER~? 40.67 CH3 ACT B1069 P 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 7.57 37.60 10.00 8.86 37.02 12.03 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 4.04 29.97 8.82 4.78 31.15 10.46 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP C 31 ASP~? 40.83 NA NA D1069 P 35 SER C 30 SER~? 42.91 NA NA D1069 P 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 7.57 37.60 10.00 8.86 37.02 12.03 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 4.04 29.97 8.82 4.78 31.15 10.46 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 3 # 5 P 32 ASP C 37 ASP~? 33.08 NA NA D1069 P 35 SER C 34 SER~? 36.89 NA NA D1069 P 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 7.57 37.60 10.00 8.86 37.02 12.03 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 4.04 29.97 8.82 4.78 31.15 10.46 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 6 3 # 6 P 32 ASP C 37 ASP~? 33.08 NA NA D1069 P 35 SER C 38 SER~? 28.14 NA NA D1069 P 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 7.57 37.60 10.00 8.86 37.02 12.03 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 4.04 29.97 8.82 4.78 31.15 10.46 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 7 3 # 7 P 32 ASP D 31 ASP~? 40.40 NA NA D1069 P 35 SER D 30 SER~? 41.47 NA NA D1069 P 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 7.57 37.60 10.00 8.86 37.02 12.03 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 4.04 29.97 8.82 4.78 31.15 10.46 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 8 3 # 8 P 32 ASP D 37 ASP~? 34.01 NA NA D1069 P 35 SER D 34 SER~? 37.31 NA NA D1069 P 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 7.57 37.60 10.00 8.86 37.02 12.03 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 4.04 29.97 8.82 4.78 31.15 10.46 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 9 3 # 9 P 32 ASP E 31 ASP~? 40.09 NA NA D1069 P 35 SER E 30 SER~? 42.45 NA NA D1069 P 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 7.57 37.60 10.00 8.86 37.02 12.03 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 4.04 29.97 8.82 4.78 31.15 10.46 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 10 3 # 10 P 32 ASP E 37 ASP~? 33.39 NA NA D1069 P 35 SER E 34 SER~? 36.48 NA NA D1069 P 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 7.57 37.60 10.00 8.86 37.02 12.03 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 4.04 29.97 8.82 4.78 31.15 10.46 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 11 3 # 11 P 32 ASP E 37 ASP~? 33.39 NA NA D1069 P 35 SER E 38 SER~? 28.19 NA NA D1069 P 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 7.57 37.60 10.00 8.86 37.02 12.03 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 4.04 29.97 8.82 4.78 31.15 10.46 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 12 3 # 12 P 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 P 35 SER F 30 SER~? 41.37 O ACT B1069 P 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 7.57 37.60 10.00 8.86 37.02 12.03 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 4.04 29.97 8.82 4.78 31.15 10.46 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 13 3 # 13 P 32 ASP F 37 ASP~? 40.42 NA NA D1069 P 35 SER F 34 SER~? 40.55 NA NA D1069 P 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 10.15 33.41 11.98 7.98 33.66 12.07 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 7.57 37.60 10.00 8.86 37.02 12.03 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 4.04 29.97 8.82 4.78 31.15 10.46 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 13 hits 1eed_c04 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 13 ARG~? 16.17 O ACT B1069 A 201 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 204 HIS A 18 HIS~? 22.68 O ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -10.09 25.69 -13.97 -8.66 24.41 -11.55 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 A 201 HIS A 18 HIS~? 22.68 O ACT B1069 A 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 A 201 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG C 13 ARG~? 33.47 OXT ACT B1069 A 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 204 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 coo -15.08 14.90 41.58 -16.70 13.64 42.02 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 A 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 6 3 # 6 A 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 A 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -15.08 14.90 41.58 -16.70 13.64 42.02 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 7 3 # 7 A 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 A 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -15.44 20.23 39.72 -16.43 18.87 38.47 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 8 3 # 8 A 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 A 201 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -15.44 20.23 39.72 -16.43 18.87 38.47 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 9 3 # 9 A 197 ARG F 13 ARG~? 20.80 CH3 ACT B1069 A 201 HIS A 18 HIS~? 22.68 O ACT B1069 A 204 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 10 3 # 10 A 197 ARG F 13 ARG~? 20.80 CH3 ACT B1069 A 201 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 204 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -19.58 14.64 -22.09 -21.60 14.41 -21.58 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 10 hits 1g8f_c00 naa= 3 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 1 3 # 1 A 130 ASP A 31 ASP~? 41.79 O ACT B1069 A 153 ASN A 32 ASN~? 43.02 O ACT B1069 A 189 GLN A 33 GLN~? 46.07 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 29.93 52.22 70.56 29.34 51.93 68.54 -19.92 20.96 -42.86 -17.84 20.80 -42.35 coo 26.19 47.96 71.25 25.92 49.81 70.24 -26.54 22.46 -43.89 -27.08 20.57 -44.75 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 2 3 # 2 A 130 ASP A 31 ASP~? 41.79 O ACT B1069 A 153 ASN A 32 ASN~? 43.02 O ACT B1069 A 189 GLN F 33 GLN~? 43.93 O ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 29.93 52.22 70.56 29.34 51.93 68.54 -19.92 20.96 -42.86 -17.84 20.80 -42.35 coo 26.19 47.96 71.25 25.92 49.81 70.24 -13.15 21.85 -44.13 -12.80 23.49 -42.78 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 3 3 # 3 A 130 ASP A 35 ASP~? 45.42 NA NA D1069 A 153 ASN A 32 ASN~? 43.02 O ACT B1069 A 189 GLN A 33 GLN~? 46.07 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 29.93 52.22 70.56 29.34 51.93 68.54 -19.92 20.96 -42.86 -17.84 20.80 -42.35 coo 26.19 47.96 71.25 25.92 49.81 70.24 -26.54 22.46 -43.89 -27.08 20.57 -44.75 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 4 3 # 4 A 130 ASP A 35 ASP~? 45.42 NA NA D1069 A 153 ASN A 32 ASN~? 43.02 O ACT B1069 A 189 GLN F 33 GLN~? 43.93 O ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 29.93 52.22 70.56 29.34 51.93 68.54 -19.92 20.96 -42.86 -17.84 20.80 -42.35 coo 26.19 47.96 71.25 25.92 49.81 70.24 -13.15 21.85 -44.13 -12.80 23.49 -42.78 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 5 3 # 5 A 130 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 153 ASN B 32 ASN~? 44.46 CH3 ACT B1069 A 189 GLN A 33 GLN~? 46.07 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 29.93 52.22 70.56 29.34 51.93 68.54 -23.06 16.63 -42.50 -22.29 18.12 -43.71 coo 26.19 47.96 71.25 25.92 49.81 70.24 -26.54 22.46 -43.89 -27.08 20.57 -44.75 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 6 3 # 6 A 130 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 153 ASN B 32 ASN~? 44.46 CH3 ACT B1069 A 189 GLN B 33 GLN~? 41.67 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 29.93 52.22 70.56 29.34 51.93 68.54 -23.06 16.63 -42.50 -22.29 18.12 -43.71 coo 26.19 47.96 71.25 25.92 49.81 70.24 -20.43 12.31 -42.13 -19.82 11.23 -40.43 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 7 3 # 7 A 130 ASP B 35 ASP~? 46.31 NA NA D1069 A 153 ASN B 32 ASN~? 44.46 CH3 ACT B1069 A 189 GLN A 33 GLN~? 46.07 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 29.93 52.22 70.56 29.34 51.93 68.54 -23.06 16.63 -42.50 -22.29 18.12 -43.71 coo 26.19 47.96 71.25 25.92 49.81 70.24 -26.54 22.46 -43.89 -27.08 20.57 -44.75 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 8 3 # 8 A 130 ASP B 35 ASP~? 46.31 NA NA D1069 A 153 ASN B 32 ASN~? 44.46 CH3 ACT B1069 A 189 GLN B 33 GLN~? 41.67 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 29.93 52.22 70.56 29.34 51.93 68.54 -23.06 16.63 -42.50 -22.29 18.12 -43.71 coo 26.19 47.96 71.25 25.92 49.81 70.24 -20.43 12.31 -42.13 -19.82 11.23 -40.43 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 9 3 # 9 A 130 ASP C 31 ASP~? 40.83 NA NA D1069 A 153 ASN C 32 ASN~? 38.18 NA NA D1069 A 189 GLN C 28 GLN~? 44.54 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.88 -1.65 -44.11 1.31 -2.92 -43.47 coo 26.19 47.96 71.25 25.92 49.81 70.24 1.84 -6.02 -38.32 -0.13 -6.23 -37.56 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 10 3 # 10 A 130 ASP C 31 ASP~? 40.83 NA NA D1069 A 153 ASN C 32 ASN~? 38.18 NA NA D1069 A 189 GLN C 33 GLN~? 38.59 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.88 -1.65 -44.11 1.31 -2.92 -43.47 coo 26.19 47.96 71.25 25.92 49.81 70.24 8.76 1.53 -45.48 10.23 2.19 -44.07 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 11 3 # 11 A 130 ASP C 31 ASP~? 40.83 NA NA D1069 A 153 ASN C 32 ASN~? 38.18 NA NA D1069 A 189 GLN D 33 GLN~? 40.54 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.88 -1.65 -44.11 1.31 -2.92 -43.47 coo 26.19 47.96 71.25 25.92 49.81 70.24 -2.07 -3.14 -42.91 -1.84 -4.59 -41.36 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 12 3 # 12 A 130 ASP C 35 ASP~? 34.97 NA NA D1069 A 153 ASN C 32 ASN~? 38.18 NA NA D1069 A 189 GLN C 33 GLN~? 38.59 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.88 -1.65 -44.11 1.31 -2.92 -43.47 coo 26.19 47.96 71.25 25.92 49.81 70.24 8.76 1.53 -45.48 10.23 2.19 -44.07 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 13 3 # 13 A 130 ASP C 35 ASP~? 34.97 NA NA D1069 A 153 ASN C 32 ASN~? 38.18 NA NA D1069 A 189 GLN D 33 GLN~? 40.54 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.88 -1.65 -44.11 1.31 -2.92 -43.47 coo 26.19 47.96 71.25 25.92 49.81 70.24 -2.07 -3.14 -42.91 -1.84 -4.59 -41.36 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 14 3 # 14 A 130 ASP D 31 ASP~? 40.40 NA NA D1069 A 153 ASN D 32 ASN~? 35.97 NA NA D1069 A 189 GLN D 28 GLN~? 41.49 OXT ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 29.93 52.22 70.56 29.34 51.93 68.54 -2.45 1.96 -43.96 -0.91 2.51 -45.29 coo 26.19 47.96 71.25 25.92 49.81 70.24 -6.14 5.69 -38.34 -5.46 7.56 -37.62 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 15 3 # 15 A 130 ASP D 31 ASP~? 40.40 NA NA D1069 A 153 ASN D 32 ASN~? 35.97 NA NA D1069 A 189 GLN D 33 GLN~? 40.54 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 29.93 52.22 70.56 29.34 51.93 68.54 -2.45 1.96 -43.96 -0.91 2.51 -45.29 coo 26.19 47.96 71.25 25.92 49.81 70.24 -2.07 -3.14 -42.91 -1.84 -4.59 -41.36 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 16 3 # 16 A 130 ASP D 31 ASP~? 40.40 NA NA D1069 A 153 ASN D 32 ASN~? 35.97 NA NA D1069 A 189 GLN E 33 GLN~? 40.15 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 29.93 52.22 70.56 29.34 51.93 68.54 -2.45 1.96 -43.96 -0.91 2.51 -45.29 coo 26.19 47.96 71.25 25.92 49.81 70.24 -1.95 6.50 -43.37 -2.54 7.57 -41.51 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 17 3 # 17 A 130 ASP D 35 ASP~? 33.74 NA NA D1069 A 153 ASN D 32 ASN~? 35.97 NA NA D1069 A 189 GLN D 33 GLN~? 40.54 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 29.93 52.22 70.56 29.34 51.93 68.54 -2.45 1.96 -43.96 -0.91 2.51 -45.29 coo 26.19 47.96 71.25 25.92 49.81 70.24 -2.07 -3.14 -42.91 -1.84 -4.59 -41.36 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 18 3 # 18 A 130 ASP D 35 ASP~? 33.74 NA NA D1069 A 153 ASN D 32 ASN~? 35.97 NA NA D1069 A 189 GLN E 33 GLN~? 40.15 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 29.93 52.22 70.56 29.34 51.93 68.54 -2.45 1.96 -43.96 -0.91 2.51 -45.29 coo 26.19 47.96 71.25 25.92 49.81 70.24 -1.95 6.50 -43.37 -2.54 7.57 -41.51 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 19 3 # 19 A 130 ASP E 31 ASP~? 40.09 NA NA D1069 A 153 ASN E 32 ASN~? 37.73 NA NA D1069 A 189 GLN C 33 GLN~? 38.59 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.49 3.56 -44.42 4.29 2.46 -43.78 coo 26.19 47.96 71.25 25.92 49.81 70.24 8.76 1.53 -45.48 10.23 2.19 -44.07 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 20 3 # 20 A 130 ASP E 31 ASP~? 40.09 NA NA D1069 A 153 ASN E 32 ASN~? 37.73 NA NA D1069 A 189 GLN E 33 GLN~? 40.15 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.49 3.56 -44.42 4.29 2.46 -43.78 coo 26.19 47.96 71.25 25.92 49.81 70.24 -1.95 6.50 -43.37 -2.54 7.57 -41.51 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 21 3 # 21 A 130 ASP E 35 ASP~? 33.25 NA NA D1069 A 153 ASN E 32 ASN~? 37.73 NA NA D1069 A 189 GLN C 33 GLN~? 38.59 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.49 3.56 -44.42 4.29 2.46 -43.78 coo 26.19 47.96 71.25 25.92 49.81 70.24 8.76 1.53 -45.48 10.23 2.19 -44.07 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 22 3 # 22 A 130 ASP E 35 ASP~? 33.25 NA NA D1069 A 153 ASN E 32 ASN~? 37.73 NA NA D1069 A 189 GLN E 33 GLN~? 40.15 NA NA D1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 29.93 52.22 70.56 29.34 51.93 68.54 2.49 3.56 -44.42 4.29 2.46 -43.78 coo 26.19 47.96 71.25 25.92 49.81 70.24 -1.95 6.50 -43.37 -2.54 7.57 -41.51 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 23 3 # 23 A 130 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 153 ASN F 32 ASN~? 43.23 CH3 ACT B1069 A 189 GLN B 33 GLN~? 41.67 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 29.93 52.22 70.56 29.34 51.93 68.54 -17.15 16.45 -42.97 -18.10 14.62 -42.37 coo 26.19 47.96 71.25 25.92 49.81 70.24 -20.43 12.31 -42.13 -19.82 11.23 -40.43 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 24 3 # 24 A 130 ASP F 35 ASP~? 38.96 NA NA D1069 A 153 ASN F 32 ASN~? 43.23 CH3 ACT B1069 A 189 GLN B 33 GLN~? 41.67 CH3 ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 29.93 52.22 70.56 29.34 51.93 68.54 -17.15 16.45 -42.97 -18.10 14.62 -42.37 coo 26.19 47.96 71.25 25.92 49.81 70.24 -20.43 12.31 -42.13 -19.82 11.23 -40.43 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 25 3 # 25 A 130 ASP F 35 ASP~? 38.96 NA NA D1069 A 153 ASN F 32 ASN~? 43.23 CH3 ACT B1069 A 189 GLN F 33 GLN~? 43.93 O ACT B1069 coo 27.45 53.97 73.24 26.29 54.34 71.54 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 29.93 52.22 70.56 29.34 51.93 68.54 -17.15 16.45 -42.97 -18.10 14.62 -42.37 coo 26.19 47.96 71.25 25.92 49.81 70.24 -13.15 21.85 -44.13 -12.80 23.49 -42.78 1ga8_c00 source 1ga8 GALACTOSYL TRANSFERASE LGTC : 25 hits 1ga8_c00 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN B 47 GLN~? 24.93 NA NA D1069 A 296 GLU F 45 GLU~? 25.79 NA NA D1069 A 383 TYR E 48 TYR~? 17.09 NA NA D1069 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 40.93 4.45 2.36 38.91 3.75 2.26 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 30.54 7.22 6.23 31.38 5.79 3.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN F 42 GLN~? 30.81 NA NA D1069 A 296 GLU F 45 GLU~? 25.79 NA NA D1069 A 383 TYR E 48 TYR~? 17.09 NA NA D1069 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -13.65 15.93 -57.57 -14.32 14.09 -56.56 coo 40.93 4.45 2.36 38.91 3.75 2.26 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 30.54 7.22 6.23 31.38 5.79 3.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN F 49 GLN~? 22.45 NA NA D1069 A 296 GLU F 45 GLU~? 25.79 NA NA D1069 A 383 TYR E 48 TYR~? 17.09 NA NA D1069 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 40.93 4.45 2.36 38.91 3.75 2.26 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 30.54 7.22 6.23 31.38 5.79 3.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 3 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 31 ASP~? 41.79 O ACT B1069 A 327 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 339 ARG C 13 ARG~? 33.47 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 35 ASP~? 45.42 NA NA D1069 A 327 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 339 ARG C 13 ARG~? 33.47 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 35 ASP~? 45.42 NA NA D1069 A 327 GLU D 55 GLU~? 12.40 NA NA D1069 A 339 ARG D 56 ARG~? 10.15 NA NA D1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 75.11 41.01 160.30 76.65 40.06 161.41 0.42 -8.60 -77.55 2.42 -8.94 -76.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 37 ASP~? 48.68 NA NA D1069 A 327 GLU A 5 GLU~? 4.25 O ACT B1069 A 339 ARG A 7 ARG~? 9.33 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 75.11 41.01 160.30 76.65 40.06 161.41 -12.91 21.95 -1.38 -14.15 21.05 0.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 -11.74 15.04 -6.24 -13.56 12.56 -6.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 37 ASP~? 48.68 NA NA D1069 A 327 GLU F 5 GLU~? 4.67 OXT ACT B1069 A 339 ARG A 7 ARG~? 9.33 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 75.11 41.01 160.30 76.65 40.06 161.41 -16.48 12.29 -1.23 -17.71 12.65 0.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -11.74 15.04 -6.24 -13.56 12.56 -6.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 327 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 339 ARG D 7 ARG~? 28.00 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.77 8.93 -7.43 7.03 6.86 -7.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 35 ASP~? 46.31 NA NA D1069 A 327 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 339 ARG C 13 ARG~? 33.47 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 35 ASP~? 46.31 NA NA D1069 A 327 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 339 ARG C 7 ARG~? 19.09 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 -6.20 1.88 -7.39 -5.63 4.84 -7.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 37 ASP~? 39.88 NA NA D1069 A 327 GLU A 5 GLU~? 4.25 O ACT B1069 A 339 ARG B 7 ARG~? 8.67 O ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 -12.91 21.95 -1.38 -14.15 21.05 0.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 -19.45 25.45 -6.07 -16.42 24.98 -5.80 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP C 31 ASP~? 40.83 NA NA D1069 A 327 GLU A 12 GLU~? 11.83 O ACT B1069 A 339 ARG A 13 ARG~? 16.17 O ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 82.23 40.35 159.87 85.09 40.67 161.01 -10.09 25.69 -13.97 -8.66 24.41 -11.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP C 37 ASP~? 33.08 NA NA D1069 A 327 GLU C 5 GLU~? 25.63 OXT ACT B1069 A 339 ARG C 7 ARG~? 19.09 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.43 -3.40 -2.74 -1.54 -2.58 -1.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 -6.20 1.88 -7.39 -5.63 4.84 -7.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP C 37 ASP~? 33.08 NA NA D1069 A 327 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 339 ARG C 7 ARG~? 19.09 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 -6.20 1.88 -7.39 -5.63 4.84 -7.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP C 37 ASP~? 33.08 NA NA D1069 A 327 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 339 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 -18.65 6.83 -15.20 -21.43 5.64 -15.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP D 37 ASP~? 34.01 NA NA D1069 A 327 GLU A 12 GLU~? 11.83 O ACT B1069 A 339 ARG A 13 ARG~? 16.17 O ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 82.23 40.35 159.87 85.09 40.67 161.01 -10.09 25.69 -13.97 -8.66 24.41 -11.55 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP D 37 ASP~? 34.01 NA NA D1069 A 327 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 339 ARG D 7 ARG~? 28.00 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.77 8.93 -7.43 7.03 6.86 -7.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP D 37 ASP~? 34.01 NA NA D1069 A 327 GLU E 5 GLU~? 30.85 OXT ACT B1069 A 339 ARG D 7 ARG~? 28.00 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 9.19 3.53 -3.57 10.09 3.91 -1.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.77 8.93 -7.43 7.03 6.86 -7.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP E 31 ASP~? 40.09 NA NA D1069 A 327 GLU A 5 GLU~? 4.25 O ACT B1069 A 339 ARG B 7 ARG~? 8.67 O ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 75.11 41.01 160.30 76.65 40.06 161.41 -12.91 21.95 -1.38 -14.15 21.05 0.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 -19.45 25.45 -6.07 -16.42 24.98 -5.80 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP F 37 ASP~? 40.42 NA NA D1069 A 327 GLU B 5 GLU~? 7.35 CH3 ACT B1069 A 339 ARG F 7 ARG~? 8.59 CH3 ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 -26.27 20.06 -2.00 -26.37 18.13 -2.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -24.79 13.40 -5.76 -25.67 16.36 -5.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP F 37 ASP~? 40.42 NA NA D1069 A 327 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 339 ARG C 13 ARG~? 33.47 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP F 37 ASP~? 40.42 NA NA D1069 A 327 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 339 ARG C 7 ARG~? 19.09 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 -6.20 1.88 -7.39 -5.63 4.84 -7.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP F 37 ASP~? 40.42 NA NA D1069 A 327 GLU D 5 GLU~? 18.82 OXT ACT B1069 A 339 ARG D 7 ARG~? 28.00 OXT ACT B1069 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.77 8.93 -7.43 7.03 6.86 -7.43 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 21 hits 1hto_c00 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 34 SER~? 48.00 O ACT B1069 A 173 ARG A 40 ARG~? 46.07 NA NA D1069 A 211 ASP A 31 ASP~? 41.79 O ACT B1069 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 18.77 77.82 11.69 20.55 80.22 10.73 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 34 SER~? 44.97 NA NA D1069 A 173 ARG B 40 ARG~? 36.76 NA NA D1069 A 211 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 18.77 77.82 11.69 20.55 80.22 10.73 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER C 34 SER~? 36.89 NA NA D1069 A 173 ARG C 40 ARG~? 30.54 NA NA D1069 A 211 ASP C 31 ASP~? 40.83 NA NA D1069 coo 22.72 76.24 0.23 24.60 76.86 -1.25 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 18.77 77.82 11.69 20.55 80.22 10.73 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 5.67 -5.91 -43.09 6.81 -7.53 -42.25 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER D 34 SER~? 37.31 NA NA D1069 A 173 ARG D 40 ARG~? 31.12 NA NA D1069 A 211 ASP D 31 ASP~? 40.40 NA NA D1069 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 18.77 77.82 11.69 20.55 80.22 10.73 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER F 34 SER~? 40.55 NA NA D1069 A 173 ARG F 40 ARG~? 40.52 NA NA D1069 A 211 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 18.77 77.82 11.69 20.55 80.22 10.73 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER F 38 SER~? 34.44 NA NA D1069 A 173 ARG E 40 ARG~? 29.89 NA NA D1069 A 211 ASP F 37 ASP~? 40.42 NA NA D1069 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 18.77 77.82 11.69 20.55 80.22 10.73 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -11.97 21.18 -49.82 -12.35 22.97 -48.70 1ig8_c00 source 1ig8 HEXOKINASE PII : 6 hits 1ig8_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 13 ARG~? 16.17 O ACT B1069 A 201 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 204 HIS A 18 HIS~? 22.68 O ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -10.09 25.69 -13.97 -8.66 24.41 -11.55 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 A 201 HIS A 18 HIS~? 22.68 O ACT B1069 A 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 A 201 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG C 13 ARG~? 33.47 OXT ACT B1069 A 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 204 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 A 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 A 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1j70_c00 ATP SULPHURYLASE user 7 3 # 7 A 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 A 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1j70_c00 ATP SULPHURYLASE user 8 3 # 8 A 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 A 201 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1j70_c00 ATP SULPHURYLASE user 9 3 # 9 A 197 ARG F 13 ARG~? 20.80 CH3 ACT B1069 A 201 HIS A 18 HIS~? 22.68 O ACT B1069 A 204 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 1j70_c00 ATP SULPHURYLASE user 10 3 # 10 A 197 ARG F 13 ARG~? 20.80 CH3 ACT B1069 A 201 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 204 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -19.58 14.64 -22.09 -21.60 14.41 -21.58 1j70_c00 source 1j70 ATP SULPHURYLASE : 10 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 13 ARG~? 16.17 O ACT B1069 B 201 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 204 HIS A 18 HIS~? 22.68 O ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -10.09 25.69 -13.97 -8.66 24.41 -11.55 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 B 201 HIS A 18 HIS~? 22.68 O ACT B1069 B 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 B 201 HIS F 18 HIS~? 22.80 CH3 ACT B1069 B 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG C 13 ARG~? 33.47 OXT ACT B1069 B 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 204 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 coo -8.48 114.03 24.38 -10.47 114.55 23.97 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 B 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 B 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo -8.48 114.03 24.38 -10.47 114.55 23.97 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1j70_c01 ATP SULPHURYLASE user 7 3 # 7 B 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 B 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -6.99 108.94 26.28 -8.54 109.57 27.55 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1j70_c01 ATP SULPHURYLASE user 8 3 # 8 B 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 B 201 HIS D 18 HIS~? 32.59 OXT ACT B1069 B 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -18.85 104.93 27.44 -18.03 106.58 29.88 13.07 1.77 -16.33 14.59 4.19 -15.10 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -6.99 108.94 26.28 -8.54 109.57 27.55 4.68 1.62 -23.48 4.77 -0.36 -22.80 1j70_c01 source 1j70 ATP SULPHURYLASE : 8 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 13 ARG~? 16.17 O ACT B1069 C 201 HIS B 18 HIS~? 22.64 CH3 ACT B1069 C 204 HIS A 18 HIS~? 22.68 O ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 -10.09 25.69 -13.97 -8.66 24.41 -11.55 coo 20.16 5.55 18.86 20.00 7.59 19.34 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 24.92 3.29 16.90 24.41 4.92 15.69 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 C 201 HIS A 18 HIS~? 22.68 O ACT B1069 C 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo 20.16 5.55 18.86 20.00 7.59 19.34 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 24.92 3.29 16.90 24.41 4.92 15.69 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG B 13 ARG~? 20.17 CH3 ACT B1069 C 201 HIS F 18 HIS~? 22.80 CH3 ACT B1069 C 204 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 -29.58 23.13 -14.77 -28.38 25.80 -15.87 coo 20.16 5.55 18.86 20.00 7.59 19.34 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 24.92 3.29 16.90 24.41 4.92 15.69 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG C 13 ARG~? 33.47 OXT ACT B1069 C 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 C 204 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 coo 20.16 5.55 18.86 20.00 7.59 19.34 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 24.92 3.29 16.90 24.41 4.92 15.69 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 C 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 C 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo 20.16 5.55 18.86 20.00 7.59 19.34 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG D 13 ARG~? 25.10 OXT ACT B1069 C 201 HIS E 18 HIS~? 36.76 OXT ACT B1069 C 204 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo 20.16 5.55 18.86 20.00 7.59 19.34 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1j70_c02 ATP SULPHURYLASE user 7 3 # 7 C 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 C 201 HIS C 18 HIS~? 33.75 OXT ACT B1069 C 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 13.07 1.77 -16.33 14.59 4.19 -15.10 coo 20.16 5.55 18.86 20.00 7.59 19.34 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 24.92 3.29 16.90 24.41 4.92 15.69 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 1j70_c02 ATP SULPHURYLASE user 8 3 # 8 C 197 ARG E 13 ARG~? 38.24 OXT ACT B1069 C 201 HIS D 18 HIS~? 32.59 OXT ACT B1069 C 204 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo 30.92 14.23 15.70 28.82 13.90 13.48 13.07 1.77 -16.33 14.59 4.19 -15.10 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 24.92 3.29 16.90 24.41 4.92 15.69 4.68 1.62 -23.48 4.77 -0.36 -22.80 1j70_c02 source 1j70 ATP SULPHURYLASE : 8 hits 1j70_c02 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU E 55 GLU~? 12.74 NA NA D1069 A 56 LYS E 58 LYS~? 12.90 NA NA D1069 A 258 ARG B 56 ARG~? 24.39 NA NA D1069 coo 42.33 1.56 26.99 42.38 2.91 28.66 -10.03 7.67 -78.86 -11.90 6.81 -79.44 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -21.57 11.48 -78.51 -22.99 9.40 -76.67 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU E 55 GLU~? 12.74 NA NA D1069 B 56 LYS E 58 LYS~? 12.90 NA NA D1069 B 258 ARG B 56 ARG~? 24.39 NA NA D1069 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -10.03 7.67 -78.86 -11.90 6.81 -79.44 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 2.64 1.83 34.81 1.56 1.13 32.02 -21.57 11.48 -78.51 -22.99 9.40 -76.67 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU E 55 GLU~? 12.74 NA NA D1069 C 56 LYS E 58 LYS~? 12.90 NA NA D1069 C 258 ARG B 56 ARG~? 24.39 NA NA D1069 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -10.03 7.67 -78.86 -11.90 6.81 -79.44 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -21.57 11.48 -78.51 -22.99 9.40 -76.67 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU E 55 GLU~? 12.74 NA NA D1069 D 56 LYS E 58 LYS~? 12.90 NA NA D1069 D 258 ARG B 56 ARG~? 24.39 NA NA D1069 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -10.03 7.67 -78.86 -11.90 6.81 -79.44 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -21.57 11.48 -78.51 -22.99 9.40 -76.67 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 1 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 163 ARG E 7 ARG~? 30.80 OXT ACT B1069 A 222 ARG C 13 ARG~? 33.47 OXT ACT B1069 coo 51.27 81.34 48.31 51.67 80.79 50.28 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 48.06 78.22 50.94 48.51 78.27 53.98 4.93 -4.34 -8.45 2.17 -4.93 -7.13 coo 54.85 84.16 52.60 54.26 81.23 53.34 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 1kim_c00 source 1kim THYMIDINE KINASE : 1 hits 1kim_c00 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 35 ASP~? 45.42 NA NA D1069 A 265 GLU A 45 GLU~? 42.99 NA NA D1069 A 369 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -28.22 26.22 -60.76 -30.15 26.07 -61.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 35 ASP~? 45.42 NA NA D1069 A 265 GLU F 45 GLU~? 25.79 NA NA D1069 A 369 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 35 ASP~? 46.31 NA NA D1069 A 265 GLU A 45 GLU~? 42.99 NA NA D1069 A 369 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 17.36 23.57 72.04 18.68 21.92 71.98 -28.22 26.22 -60.76 -30.15 26.07 -61.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 35 ASP~? 46.31 NA NA D1069 A 265 GLU B 45 GLU~? 30.22 NA NA D1069 A 369 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 17.36 23.57 72.04 18.68 21.92 71.98 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 35 ASP~? 34.97 NA NA D1069 A 265 GLU C 45 GLU~? 22.33 NA NA D1069 A 369 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 35 ASP~? 34.97 NA NA D1069 A 265 GLU D 45 GLU~? 19.29 NA NA D1069 A 369 ASP D 35 ASP~? 33.74 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 35 ASP~? 33.74 NA NA D1069 A 265 GLU D 45 GLU~? 19.29 NA NA D1069 A 369 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP D 35 ASP~? 33.74 NA NA D1069 A 265 GLU E 45 GLU~? 20.97 NA NA D1069 A 369 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP E 35 ASP~? 33.25 NA NA D1069 A 265 GLU C 45 GLU~? 22.33 NA NA D1069 A 369 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP E 35 ASP~? 33.25 NA NA D1069 A 265 GLU E 45 GLU~? 20.97 NA NA D1069 A 369 ASP D 35 ASP~? 33.74 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP F 35 ASP~? 38.96 NA NA D1069 A 265 GLU B 45 GLU~? 30.22 NA NA D1069 A 369 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP F 35 ASP~? 38.96 NA NA D1069 A 265 GLU F 45 GLU~? 25.79 NA NA D1069 A 369 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 12 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 37 ASP~? 48.68 NA NA D1069 A 279 GLU B 45 GLU~? 30.22 NA NA D1069 A 369 ASP A 31 ASP~? 41.79 O ACT B1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 37 ASP~? 39.88 NA NA D1069 A 279 GLU F 45 GLU~? 25.79 NA NA D1069 A 369 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 16.54 46.37 63.94 14.77 45.79 62.95 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP C 37 ASP~? 33.08 NA NA D1069 A 279 GLU E 45 GLU~? 20.97 NA NA D1069 A 369 ASP C 31 ASP~? 40.83 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 16.54 46.37 63.94 14.77 45.79 62.95 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.67 -5.91 -43.09 6.81 -7.53 -42.25 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP D 37 ASP~? 34.01 NA NA D1069 A 279 GLU C 45 GLU~? 22.33 NA NA D1069 A 369 ASP D 31 ASP~? 40.40 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 16.54 46.37 63.94 14.77 45.79 62.95 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP E 37 ASP~? 33.39 NA NA D1069 A 279 GLU C 45 GLU~? 22.33 NA NA D1069 A 369 ASP D 31 ASP~? 40.40 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 16.54 46.37 63.94 14.77 45.79 62.95 9.55 -0.98 -62.99 10.23 -2.79 -62.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP E 37 ASP~? 33.39 NA NA D1069 A 279 GLU D 45 GLU~? 19.29 NA NA D1069 A 369 ASP E 31 ASP~? 40.09 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP E 37 ASP~? 33.39 NA NA D1069 A 279 GLU F 45 GLU~? 25.79 NA NA D1069 A 369 ASP D 31 ASP~? 40.40 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 16.54 46.37 63.94 14.77 45.79 62.95 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP E 37 ASP~? 33.39 NA NA D1069 A 279 GLU F 45 GLU~? 25.79 NA NA D1069 A 369 ASP E 31 ASP~? 40.09 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 16.54 46.37 63.94 14.77 45.79 62.95 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP F 35 ASP~? 38.96 NA NA D1069 A 279 GLU E 45 GLU~? 20.97 NA NA D1069 A 369 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 16.54 46.37 63.94 14.77 45.79 62.95 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP F 37 ASP~? 40.42 NA NA D1069 A 279 GLU A 45 GLU~? 42.99 NA NA D1069 A 369 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 11.74 38.14 80.19 10.63 36.40 80.65 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 16.54 46.37 63.94 14.77 45.79 62.95 -28.22 26.22 -60.76 -30.15 26.07 -61.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.67 13.66 -41.84 -10.91 12.80 -40.94 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 10 hits 1m53_c06 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 31 ASP~? 41.79 O ACT B1069 35 SER A 30 SER~? 40.12 CH3 ACT B1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 16.04 14.72 33.82 17.27 13.71 31.95 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 20.65 22.00 33.80 20.06 20.56 32.39 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 16.04 14.72 33.82 17.27 13.71 31.95 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 20.65 22.00 33.80 20.06 20.56 32.39 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 35 SER B 30 SER~? 40.67 CH3 ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 16.04 14.72 33.82 17.27 13.71 31.95 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 20.65 22.00 33.80 20.06 20.56 32.39 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP C 31 ASP~? 40.83 NA NA D1069 35 SER C 30 SER~? 42.91 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 16.04 14.72 33.82 17.27 13.71 31.95 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 20.65 22.00 33.80 20.06 20.56 32.39 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 3 # 5 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 34 SER~? 36.89 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 16.04 14.72 33.82 17.27 13.71 31.95 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 20.65 22.00 33.80 20.06 20.56 32.39 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 3 # 6 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 38 SER~? 28.14 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 16.04 14.72 33.82 17.27 13.71 31.95 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 20.65 22.00 33.80 20.06 20.56 32.39 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 3 # 7 32 ASP D 31 ASP~? 40.40 NA NA D1069 35 SER D 30 SER~? 41.47 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 16.04 14.72 33.82 17.27 13.71 31.95 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 20.65 22.00 33.80 20.06 20.56 32.39 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 8 3 # 8 32 ASP D 37 ASP~? 34.01 NA NA D1069 35 SER D 34 SER~? 37.31 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 16.04 14.72 33.82 17.27 13.71 31.95 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 20.65 22.00 33.80 20.06 20.56 32.39 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 9 3 # 9 32 ASP E 31 ASP~? 40.09 NA NA D1069 35 SER E 30 SER~? 42.45 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 16.04 14.72 33.82 17.27 13.71 31.95 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 20.65 22.00 33.80 20.06 20.56 32.39 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 10 3 # 10 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 16.04 14.72 33.82 17.27 13.71 31.95 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 20.65 22.00 33.80 20.06 20.56 32.39 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 11 3 # 11 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 35 SER F 30 SER~? 41.37 O ACT B1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 16.04 14.72 33.82 17.27 13.71 31.95 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 20.65 22.00 33.80 20.06 20.56 32.39 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 12 3 # 12 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 20.97 14.47 32.28 19.66 15.96 31.62 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 16.04 14.72 33.82 17.27 13.71 31.95 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 20.65 22.00 33.80 20.06 20.56 32.39 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 12 hits 1mpp_c04 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN A 52 GLN~? 37.34 NA NA D1069 328 ASN A 51 ASN~? 34.27 NA NA D1069 409 GLU A 55 GLU~? 31.92 NA NA D1069 coo 45.09 114.33 52.30 45.59 116.18 51.29 -29.33 21.76 -72.56 -29.33 23.89 -72.44 coo 41.10 116.46 52.80 42.09 116.00 54.64 -28.79 17.13 -69.58 -28.71 15.77 -67.97 coo 42.69 118.64 56.27 44.58 118.34 55.45 -29.83 14.81 -75.23 -29.77 12.78 -75.77 ULMN 3 1myr_c00 MYROSINASE user 2 3 # 2 187 GLN B 49 GLN~? 30.98 NA NA D1069 328 ASN B 46 ASN~? 32.72 NA NA D1069 409 GLU B 45 GLU~? 30.22 NA NA D1069 coo 45.09 114.33 52.30 45.59 116.18 51.29 -24.04 12.01 -67.93 -25.65 13.45 -67.68 coo 41.10 116.46 52.80 42.09 116.00 54.64 -21.42 15.21 -63.35 -23.25 15.93 -62.53 coo 42.69 118.64 56.27 44.58 118.34 55.45 -25.09 10.14 -63.28 -24.58 8.57 -64.65 ULMN 3 1myr_c00 MYROSINASE user 3 3 # 3 187 GLN D 42 GLN~? 23.24 NA NA D1069 328 ASN D 46 ASN~? 15.85 NA NA D1069 409 GLU D 45 GLU~? 19.29 NA NA D1069 coo 45.09 114.33 52.30 45.59 116.18 51.29 -5.90 0.78 -59.73 -6.53 2.66 -58.93 coo 41.10 116.46 52.80 42.09 116.00 54.64 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 42.69 118.64 56.27 44.58 118.34 55.45 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1myr_c00 MYROSINASE user 4 3 # 4 187 GLN D 49 GLN~? 15.47 NA NA D1069 328 ASN D 46 ASN~? 15.85 NA NA D1069 409 GLU D 45 GLU~? 19.29 NA NA D1069 coo 45.09 114.33 52.30 45.59 116.18 51.29 -6.39 -2.58 -68.67 -7.11 -0.75 -67.84 coo 41.10 116.46 52.80 42.09 116.00 54.64 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 42.69 118.64 56.27 44.58 118.34 55.45 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1myr_c00 MYROSINASE user 5 3 # 5 187 GLN E 47 GLN~? 16.16 NA NA D1069 328 ASN D 46 ASN~? 15.85 NA NA D1069 409 GLU D 45 GLU~? 19.29 NA NA D1069 coo 45.09 114.33 52.30 45.59 116.18 51.29 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 41.10 116.46 52.80 42.09 116.00 54.64 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 42.69 118.64 56.27 44.58 118.34 55.45 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 ULMN 3 1myr_c00 MYROSINASE user 6 3 # 6 187 GLN F 52 GLN~? 25.43 NA NA D1069 328 ASN F 51 ASN~? 32.81 NA NA D1069 409 GLU F 55 GLU~? 30.88 NA NA D1069 coo 45.09 114.33 52.30 45.59 116.18 51.29 -12.27 24.30 -72.03 -10.74 23.17 -71.15 coo 41.10 116.46 52.80 42.09 116.00 54.64 -16.64 25.99 -69.86 -17.87 26.72 -68.26 coo 42.69 118.64 56.27 44.58 118.34 55.45 -16.47 28.07 -74.52 -14.99 28.14 -72.96 1myr_c00 source 1myr MYROSINASE : 6 hits 1myr_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 40 ARG~? 46.07 NA NA D1069 A 101 ASP A 37 ASP~? 48.68 NA NA D1069 A 132 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.37 24.94 11.48 12.48 24.45 13.28 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 16.14 18.17 13.37 15.92 19.81 14.71 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 40 ARG~? 46.07 NA NA D1069 A 101 ASP B 35 ASP~? 46.31 NA NA D1069 A 132 ASP A 37 ASP~? 48.68 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.37 24.94 11.48 12.48 24.45 13.28 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 16.14 18.17 13.37 15.92 19.81 14.71 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 40 ARG~? 36.76 NA NA D1069 A 101 ASP B 37 ASP~? 39.88 NA NA D1069 A 132 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.37 24.94 11.48 12.48 24.45 13.28 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 16.14 18.17 13.37 15.92 19.81 14.71 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 40 ARG~? 36.76 NA NA D1069 A 101 ASP F 35 ASP~? 38.96 NA NA D1069 A 132 ASP B 37 ASP~? 39.88 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.37 24.94 11.48 12.48 24.45 13.28 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 16.14 18.17 13.37 15.92 19.81 14.71 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG C 40 ARG~? 30.54 NA NA D1069 A 101 ASP C 37 ASP~? 33.08 NA NA D1069 A 132 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.37 24.94 11.48 12.48 24.45 13.28 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 16.14 18.17 13.37 15.92 19.81 14.71 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG C 40 ARG~? 30.54 NA NA D1069 A 101 ASP E 35 ASP~? 33.25 NA NA D1069 A 132 ASP C 37 ASP~? 33.08 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.37 24.94 11.48 12.48 24.45 13.28 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 16.14 18.17 13.37 15.92 19.81 14.71 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG D 40 ARG~? 31.12 NA NA D1069 A 101 ASP C 35 ASP~? 34.97 NA NA D1069 A 132 ASP D 37 ASP~? 34.01 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.37 24.94 11.48 12.48 24.45 13.28 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 16.14 18.17 13.37 15.92 19.81 14.71 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG D 40 ARG~? 31.12 NA NA D1069 A 101 ASP D 37 ASP~? 34.01 NA NA D1069 A 132 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.37 24.94 11.48 12.48 24.45 13.28 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 16.14 18.17 13.37 15.92 19.81 14.71 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 A 99 ARG E 40 ARG~? 29.89 NA NA D1069 A 101 ASP D 35 ASP~? 33.74 NA NA D1069 A 132 ASP E 37 ASP~? 33.39 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 11.37 24.94 11.48 12.48 24.45 13.28 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 16.14 18.17 13.37 15.92 19.81 14.71 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 A 99 ARG F 40 ARG~? 40.52 NA NA D1069 A 101 ASP A 35 ASP~? 45.42 NA NA D1069 A 132 ASP F 37 ASP~? 40.42 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.37 24.94 11.48 12.48 24.45 13.28 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 16.14 18.17 13.37 15.92 19.81 14.71 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 A 99 ARG F 40 ARG~? 40.52 NA NA D1069 A 101 ASP F 37 ASP~? 40.42 NA NA D1069 A 132 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.61 22.83 17.30 14.06 21.71 15.78 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.37 24.94 11.48 12.48 24.45 13.28 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 16.14 18.17 13.37 15.92 19.81 14.71 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 11 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 40 ARG~? 46.07 NA NA D1069 B 101 ASP A 37 ASP~? 48.68 NA NA D1069 B 132 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.74 0.51 12.98 10.75 1.32 14.67 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 6.93 7.52 14.08 7.18 6.08 15.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 40 ARG~? 46.07 NA NA D1069 B 101 ASP B 35 ASP~? 46.31 NA NA D1069 B 132 ASP A 37 ASP~? 48.68 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.74 0.51 12.98 10.75 1.32 14.67 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 6.93 7.52 14.08 7.18 6.08 15.65 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 40 ARG~? 36.76 NA NA D1069 B 101 ASP B 37 ASP~? 39.88 NA NA D1069 B 132 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.74 0.51 12.98 10.75 1.32 14.67 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 6.93 7.52 14.08 7.18 6.08 15.65 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 40 ARG~? 36.76 NA NA D1069 B 101 ASP F 35 ASP~? 38.96 NA NA D1069 B 132 ASP B 37 ASP~? 39.88 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.74 0.51 12.98 10.75 1.32 14.67 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 6.93 7.52 14.08 7.18 6.08 15.65 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 40 ARG~? 30.54 NA NA D1069 B 101 ASP C 37 ASP~? 33.08 NA NA D1069 B 132 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.74 0.51 12.98 10.75 1.32 14.67 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 6.93 7.52 14.08 7.18 6.08 15.65 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG C 40 ARG~? 30.54 NA NA D1069 B 101 ASP E 35 ASP~? 33.25 NA NA D1069 B 132 ASP C 37 ASP~? 33.08 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.74 0.51 12.98 10.75 1.32 14.67 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 6.93 7.52 14.08 7.18 6.08 15.65 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG D 40 ARG~? 31.12 NA NA D1069 B 101 ASP C 35 ASP~? 34.97 NA NA D1069 B 132 ASP D 37 ASP~? 34.01 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.74 0.51 12.98 10.75 1.32 14.67 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 6.93 7.52 14.08 7.18 6.08 15.65 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG D 40 ARG~? 31.12 NA NA D1069 B 101 ASP D 37 ASP~? 34.01 NA NA D1069 B 132 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.74 0.51 12.98 10.75 1.32 14.67 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 6.93 7.52 14.08 7.18 6.08 15.65 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG E 40 ARG~? 29.89 NA NA D1069 B 101 ASP D 35 ASP~? 33.74 NA NA D1069 B 132 ASP E 37 ASP~? 33.39 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 11.74 0.51 12.98 10.75 1.32 14.67 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 6.93 7.52 14.08 7.18 6.08 15.65 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 B 99 ARG F 40 ARG~? 40.52 NA NA D1069 B 101 ASP A 35 ASP~? 45.42 NA NA D1069 B 132 ASP F 37 ASP~? 40.42 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.74 0.51 12.98 10.75 1.32 14.67 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 6.93 7.52 14.08 7.18 6.08 15.65 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 B 99 ARG F 40 ARG~? 40.52 NA NA D1069 B 101 ASP F 37 ASP~? 40.42 NA NA D1069 B 132 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.61 3.43 18.38 9.11 4.29 16.86 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.74 0.51 12.98 10.75 1.32 14.67 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 6.93 7.52 14.08 7.18 6.08 15.65 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 11 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 40 ARG~? 46.07 NA NA D1069 A 101 ASP A 37 ASP~? 48.68 NA NA D1069 A 132 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.19 25.00 11.76 12.16 24.45 13.59 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 16.04 18.11 13.43 15.88 19.70 14.83 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 40 ARG~? 46.07 NA NA D1069 A 101 ASP B 35 ASP~? 46.31 NA NA D1069 A 132 ASP A 37 ASP~? 48.68 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.19 25.00 11.76 12.16 24.45 13.59 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 16.04 18.11 13.43 15.88 19.70 14.83 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 40 ARG~? 36.76 NA NA D1069 A 101 ASP B 37 ASP~? 39.88 NA NA D1069 A 132 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.19 25.00 11.76 12.16 24.45 13.59 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 16.04 18.11 13.43 15.88 19.70 14.83 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 40 ARG~? 36.76 NA NA D1069 A 101 ASP F 35 ASP~? 38.96 NA NA D1069 A 132 ASP B 37 ASP~? 39.88 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.19 25.00 11.76 12.16 24.45 13.59 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 16.04 18.11 13.43 15.88 19.70 14.83 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG C 40 ARG~? 30.54 NA NA D1069 A 101 ASP C 37 ASP~? 33.08 NA NA D1069 A 132 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.19 25.00 11.76 12.16 24.45 13.59 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 16.04 18.11 13.43 15.88 19.70 14.83 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG C 40 ARG~? 30.54 NA NA D1069 A 101 ASP E 35 ASP~? 33.25 NA NA D1069 A 132 ASP C 37 ASP~? 33.08 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.19 25.00 11.76 12.16 24.45 13.59 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 16.04 18.11 13.43 15.88 19.70 14.83 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG D 40 ARG~? 31.12 NA NA D1069 A 101 ASP C 35 ASP~? 34.97 NA NA D1069 A 132 ASP D 37 ASP~? 34.01 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.19 25.00 11.76 12.16 24.45 13.59 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 16.04 18.11 13.43 15.88 19.70 14.83 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG D 40 ARG~? 31.12 NA NA D1069 A 101 ASP D 37 ASP~? 34.01 NA NA D1069 A 132 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.19 25.00 11.76 12.16 24.45 13.59 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 16.04 18.11 13.43 15.88 19.70 14.83 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 A 99 ARG E 40 ARG~? 29.89 NA NA D1069 A 101 ASP D 35 ASP~? 33.74 NA NA D1069 A 132 ASP E 37 ASP~? 33.39 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 11.19 25.00 11.76 12.16 24.45 13.59 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 16.04 18.11 13.43 15.88 19.70 14.83 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 A 99 ARG E 40 ARG~? 29.89 NA NA D1069 A 101 ASP E 37 ASP~? 33.39 NA NA D1069 A 132 ASP D 35 ASP~? 33.74 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 11.19 25.00 11.76 12.16 24.45 13.59 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 16.04 18.11 13.43 15.88 19.70 14.83 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 A 99 ARG F 40 ARG~? 40.52 NA NA D1069 A 101 ASP A 35 ASP~? 45.42 NA NA D1069 A 132 ASP F 37 ASP~? 40.42 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.19 25.00 11.76 12.16 24.45 13.59 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 16.04 18.11 13.43 15.88 19.70 14.83 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 12 3 # 12 A 99 ARG F 40 ARG~? 40.52 NA NA D1069 A 101 ASP F 37 ASP~? 40.42 NA NA D1069 A 132 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.50 22.77 17.24 14.00 21.62 15.86 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.19 25.00 11.76 12.16 24.45 13.59 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 16.04 18.11 13.43 15.88 19.70 14.83 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 12 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 40 ARG~? 46.07 NA NA D1069 B 101 ASP A 37 ASP~? 48.68 NA NA D1069 B 132 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.83 0.33 13.01 10.88 1.04 14.81 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 6.85 7.33 14.07 7.10 5.88 15.60 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 40 ARG~? 46.07 NA NA D1069 B 101 ASP B 35 ASP~? 46.31 NA NA D1069 B 132 ASP A 37 ASP~? 48.68 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -28.83 19.27 -52.87 -28.76 20.36 -49.98 coo 11.83 0.33 13.01 10.88 1.04 14.81 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 6.85 7.33 14.07 7.10 5.88 15.60 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 40 ARG~? 36.76 NA NA D1069 B 101 ASP B 37 ASP~? 39.88 NA NA D1069 B 132 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.83 0.33 13.01 10.88 1.04 14.81 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 6.85 7.33 14.07 7.10 5.88 15.60 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 40 ARG~? 36.76 NA NA D1069 B 101 ASP F 35 ASP~? 38.96 NA NA D1069 B 132 ASP B 37 ASP~? 39.88 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -16.98 10.60 -53.04 -17.44 11.09 -50.03 coo 11.83 0.33 13.01 10.88 1.04 14.81 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 6.85 7.33 14.07 7.10 5.88 15.60 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 40 ARG~? 30.54 NA NA D1069 B 101 ASP C 37 ASP~? 33.08 NA NA D1069 B 132 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.83 0.33 13.01 10.88 1.04 14.81 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 6.85 7.33 14.07 7.10 5.88 15.60 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG C 40 ARG~? 30.54 NA NA D1069 B 101 ASP E 35 ASP~? 33.25 NA NA D1069 B 132 ASP C 37 ASP~? 33.08 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 8.12 4.87 -54.73 7.68 4.14 -51.76 coo 11.83 0.33 13.01 10.88 1.04 14.81 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 6.85 7.33 14.07 7.10 5.88 15.60 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG D 40 ARG~? 31.12 NA NA D1069 B 101 ASP C 35 ASP~? 34.97 NA NA D1069 B 132 ASP D 37 ASP~? 34.01 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.83 0.33 13.01 10.88 1.04 14.81 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 6.85 7.33 14.07 7.10 5.88 15.60 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG D 40 ARG~? 31.12 NA NA D1069 B 101 ASP D 37 ASP~? 34.01 NA NA D1069 B 132 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 coo 11.83 0.33 13.01 10.88 1.04 14.81 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 6.85 7.33 14.07 7.10 5.88 15.60 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG E 40 ARG~? 29.89 NA NA D1069 B 101 ASP D 35 ASP~? 33.74 NA NA D1069 B 132 ASP E 37 ASP~? 33.39 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -5.59 5.26 -52.86 -8.61 5.84 -52.81 coo 11.83 0.33 13.01 10.88 1.04 14.81 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 6.85 7.33 14.07 7.10 5.88 15.60 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 B 99 ARG F 40 ARG~? 40.52 NA NA D1069 B 101 ASP A 35 ASP~? 45.42 NA NA D1069 B 132 ASP F 37 ASP~? 40.42 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.83 0.33 13.01 10.88 1.04 14.81 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 6.85 7.33 14.07 7.10 5.88 15.60 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 B 99 ARG F 40 ARG~? 40.52 NA NA D1069 B 101 ASP F 37 ASP~? 40.42 NA NA D1069 B 132 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.48 3.09 18.25 9.01 4.07 16.77 -15.45 24.99 -53.23 -13.33 26.42 -51.43 coo 11.83 0.33 13.01 10.88 1.04 14.81 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 6.85 7.33 14.07 7.10 5.88 15.60 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 11 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER D 38 SER~? 31.09 NA NA D1069 A 154 ASP C 35 ASP~? 34.97 NA NA D1069 A 261 ARG D 40 ARG~? 31.12 NA NA D1069 coo 16.10 74.10 3.11 17.18 73.52 5.20 -6.55 -2.47 -53.10 -8.33 -1.87 -51.58 coo 16.07 84.71 8.14 15.20 82.81 8.14 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 10.59 77.85 4.81 13.09 76.36 5.76 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER D 38 SER~? 31.09 NA NA D1069 A 154 ASP D 31 ASP~? 40.40 NA NA D1069 A 261 ARG E 40 ARG~? 29.89 NA NA D1069 coo 16.10 74.10 3.11 17.18 73.52 5.20 -6.55 -2.47 -53.10 -8.33 -1.87 -51.58 coo 16.07 84.71 8.14 15.20 82.81 8.14 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 10.59 77.85 4.81 13.09 76.36 5.76 -5.59 5.26 -52.86 -8.61 5.84 -52.81 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 2 hits 1o98_c00 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 58 LYS~? 28.69 NA NA D1069 A 208 GLN F 57 GLN~? 28.62 NA NA D1069 A 209 LYS F 58 LYS~? 35.64 NA NA D1069 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -25.52 13.14 -80.97 -27.21 10.04 -75.84 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -20.50 26.74 -80.77 -22.51 29.51 -75.51 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS B 58 LYS~? 13.19 NA NA D1069 A 208 GLN F 57 GLN~? 28.62 NA NA D1069 A 209 LYS F 58 LYS~? 35.64 NA NA D1069 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -13.02 13.58 -80.48 -8.51 12.30 -79.00 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -20.50 26.74 -80.77 -22.51 29.51 -75.51 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS C 58 LYS~? 11.96 NA NA D1069 A 208 GLN E 59 GLN~? 11.22 NA NA D1069 A 209 LYS B 58 LYS~? 13.19 NA NA D1069 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 4.28 9.49 -82.02 3.93 12.91 -77.18 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -8.54 8.13 -83.40 -8.26 10.00 -82.37 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -13.02 13.58 -80.48 -8.51 12.30 -79.00 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS F 58 LYS~? 35.64 NA NA D1069 A 208 GLN A 57 GLN~? 24.51 NA NA D1069 A 209 LYS A 58 LYS~? 28.69 NA NA D1069 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -25.52 13.14 -80.97 -27.21 10.04 -75.84 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 A 175 LYS F 58 LYS~? 35.64 NA NA D1069 A 208 GLN B 57 GLN~? 21.78 NA NA D1069 A 209 LYS B 58 LYS~? 13.19 NA NA D1069 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -13.02 13.58 -80.48 -8.51 12.30 -79.00 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 5 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 58 LYS~? 28.69 NA NA D1069 B 208 GLN F 57 GLN~? 28.62 NA NA D1069 B 209 LYS F 58 LYS~? 35.64 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -25.52 13.14 -80.97 -27.21 10.04 -75.84 coo 113.93 46.99 13.56 113.37 48.52 14.95 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 115.66 49.12 8.60 111.19 49.52 4.73 -20.50 26.74 -80.77 -22.51 29.51 -75.51 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS B 58 LYS~? 13.19 NA NA D1069 B 208 GLN F 57 GLN~? 28.62 NA NA D1069 B 209 LYS F 58 LYS~? 35.64 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -13.02 13.58 -80.48 -8.51 12.30 -79.00 coo 113.93 46.99 13.56 113.37 48.52 14.95 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 115.66 49.12 8.60 111.19 49.52 4.73 -20.50 26.74 -80.77 -22.51 29.51 -75.51 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS C 58 LYS~? 11.96 NA NA D1069 B 208 GLN D 57 GLN~? -4.24 NA NA D1069s B 209 LYS D 58 LYS~? 12.68 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 4.28 9.49 -82.02 3.93 12.91 -77.18 coo 113.93 46.99 13.56 113.37 48.52 14.95 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 115.66 49.12 8.60 111.19 49.52 4.73 3.16 -4.62 -82.15 7.67 -7.34 -78.86 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS C 58 LYS~? 11.96 NA NA D1069 B 208 GLN E 57 GLN~? -4.15 NA NA D1069s B 209 LYS E 58 LYS~? 12.90 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 4.28 9.49 -82.02 3.93 12.91 -77.18 coo 113.93 46.99 13.56 113.37 48.52 14.95 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 115.66 49.12 8.60 111.19 49.52 4.73 -8.17 3.03 -82.99 -12.72 1.37 -78.84 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 B 175 LYS D 58 LYS~? 12.68 NA NA D1069 B 208 GLN C 57 GLN~? -4.09 NA NA D1069s B 209 LYS C 58 LYS~? 11.96 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 3.16 -4.62 -82.15 7.67 -7.34 -78.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 115.66 49.12 8.60 111.19 49.52 4.73 4.28 9.49 -82.02 3.93 12.91 -77.18 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 B 175 LYS D 58 LYS~? 12.68 NA NA D1069 B 208 GLN E 57 GLN~? -4.15 NA NA D1069s B 209 LYS E 58 LYS~? 12.90 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 3.16 -4.62 -82.15 7.67 -7.34 -78.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 115.66 49.12 8.60 111.19 49.52 4.73 -8.17 3.03 -82.99 -12.72 1.37 -78.84 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 B 175 LYS E 58 LYS~? 12.90 NA NA D1069 B 208 GLN C 57 GLN~? -4.09 NA NA D1069s B 209 LYS C 58 LYS~? 11.96 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 113.93 46.99 13.56 113.37 48.52 14.95 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 115.66 49.12 8.60 111.19 49.52 4.73 4.28 9.49 -82.02 3.93 12.91 -77.18 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 B 175 LYS E 58 LYS~? 12.90 NA NA D1069 B 208 GLN D 57 GLN~? -4.24 NA NA D1069s B 209 LYS D 58 LYS~? 12.68 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 113.93 46.99 13.56 113.37 48.52 14.95 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 115.66 49.12 8.60 111.19 49.52 4.73 3.16 -4.62 -82.15 7.67 -7.34 -78.86 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 B 175 LYS E 58 LYS~? 12.90 NA NA D1069 B 208 GLN D 59 GLN~? 11.86 NA NA D1069 B 209 LYS D 58 LYS~? 12.68 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 113.93 46.99 13.56 113.37 48.52 14.95 -1.57 -7.56 -84.06 -3.05 -8.26 -85.53 coo 115.66 49.12 8.60 111.19 49.52 4.73 3.16 -4.62 -82.15 7.67 -7.34 -78.86 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 B 175 LYS F 58 LYS~? 35.64 NA NA D1069 B 208 GLN A 57 GLN~? 24.51 NA NA D1069 B 209 LYS A 58 LYS~? 28.69 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 113.93 46.99 13.56 113.37 48.52 14.95 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 115.66 49.12 8.60 111.19 49.52 4.73 -25.52 13.14 -80.97 -27.21 10.04 -75.84 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 B 175 LYS F 58 LYS~? 35.64 NA NA D1069 B 208 GLN B 57 GLN~? 21.78 NA NA D1069 B 209 LYS B 58 LYS~? 13.19 NA NA D1069 coo 105.03 46.01 19.55 106.59 42.35 15.55 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 113.93 46.99 13.56 113.37 48.52 14.95 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 115.66 49.12 8.60 111.19 49.52 4.73 -13.02 13.58 -80.48 -8.51 12.30 -79.00 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 11 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS B 58 LYS~? 13.19 NA NA D1069 C 208 GLN F 57 GLN~? 28.62 NA NA D1069 C 209 LYS F 58 LYS~? 35.64 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -13.02 13.58 -80.48 -8.51 12.30 -79.00 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 113.62 1.19 33.65 109.52 3.92 36.47 -20.50 26.74 -80.77 -22.51 29.51 -75.51 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS C 58 LYS~? 11.96 NA NA D1069 C 208 GLN E 57 GLN~? -4.15 NA NA D1069s C 209 LYS E 58 LYS~? 12.90 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 4.28 9.49 -82.02 3.93 12.91 -77.18 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 113.62 1.19 33.65 109.52 3.92 36.47 -8.17 3.03 -82.99 -12.72 1.37 -78.84 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS C 58 LYS~? 11.96 NA NA D1069 C 208 GLN E 59 GLN~? 11.22 NA NA D1069 C 209 LYS E 58 LYS~? 12.90 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 4.28 9.49 -82.02 3.93 12.91 -77.18 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -8.54 8.13 -83.40 -8.26 10.00 -82.37 coo 113.62 1.19 33.65 109.52 3.92 36.47 -8.17 3.03 -82.99 -12.72 1.37 -78.84 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS D 58 LYS~? 12.68 NA NA D1069 C 208 GLN C 57 GLN~? -4.09 NA NA D1069s C 209 LYS C 58 LYS~? 11.96 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 3.16 -4.62 -82.15 7.67 -7.34 -78.86 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 113.62 1.19 33.65 109.52 3.92 36.47 4.28 9.49 -82.02 3.93 12.91 -77.18 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS D 58 LYS~? 12.68 NA NA D1069 C 208 GLN C 59 GLN~? 11.31 NA NA D1069 C 209 LYS C 58 LYS~? 11.96 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 3.16 -4.62 -82.15 7.67 -7.34 -78.86 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 8.92 7.35 -83.30 10.49 5.92 -83.15 coo 113.62 1.19 33.65 109.52 3.92 36.47 4.28 9.49 -82.02 3.93 12.91 -77.18 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS E 58 LYS~? 12.90 NA NA D1069 C 208 GLN C 57 GLN~? -4.09 NA NA D1069s C 209 LYS C 58 LYS~? 11.96 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 1.00 5.23 -79.68 -0.98 5.68 -78.97 coo 113.62 1.19 33.65 109.52 3.92 36.47 4.28 9.49 -82.02 3.93 12.91 -77.18 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 C 175 LYS F 58 LYS~? 35.64 NA NA D1069 C 208 GLN A 57 GLN~? 24.51 NA NA D1069 C 209 LYS A 58 LYS~? 28.69 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 113.62 1.19 33.65 109.52 3.92 36.47 -25.52 13.14 -80.97 -27.21 10.04 -75.84 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 C 175 LYS F 58 LYS~? 35.64 NA NA D1069 C 208 GLN A 59 GLN~? 34.47 NA NA D1069 C 209 LYS A 58 LYS~? 28.69 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo 113.62 1.19 33.65 109.52 3.92 36.47 -25.52 13.14 -80.97 -27.21 10.04 -75.84 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 C 175 LYS F 58 LYS~? 35.64 NA NA D1069 C 208 GLN B 57 GLN~? 21.78 NA NA D1069 C 209 LYS B 58 LYS~? 13.19 NA NA D1069 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -20.50 26.74 -80.77 -22.51 29.51 -75.51 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -14.42 17.64 -78.43 -13.65 18.86 -76.83 coo 113.62 1.19 33.65 109.52 3.92 36.47 -13.02 13.58 -80.48 -8.51 12.30 -79.00 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 9 hits 1ohh_c08 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 65 ASP~? 23.30 NA NA D1069 A 96 GLU B 55 GLU~? 15.33 NA NA D1069 A 132 LYS B 58 LYS~? 13.19 NA NA D1069 coo 31.23 12.29 16.44 30.82 11.56 18.39 -22.39 10.35 -89.46 -21.06 10.15 -87.80 coo 26.82 3.20 24.36 27.99 4.86 24.98 -15.58 8.63 -77.02 -13.81 8.49 -78.16 coo 29.99 0.62 22.18 30.38 6.69 20.81 -13.02 13.58 -80.48 -8.51 12.30 -79.00 1onr_c00 source 1onr TRANSALDOLASE B : 1 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 65 ASP~? 23.30 NA NA D1069 B 96 GLU B 55 GLU~? 15.33 NA NA D1069 B 132 LYS B 58 LYS~? 13.19 NA NA D1069 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -22.39 10.35 -89.46 -21.06 10.15 -87.80 coo 26.69 48.45 7.18 27.85 50.13 7.74 -15.58 8.63 -77.02 -13.81 8.49 -78.16 coo 29.82 45.80 5.07 30.26 51.81 3.56 -13.02 13.58 -80.48 -8.51 12.30 -79.00 1onr_c01 source 1onr TRANSALDOLASE B : 1 hits 1onr_c01 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 44 GLN~? 43.08 NA NA D1069 294 GLU B 45 GLU~? 30.22 NA NA D1069 304 ARG A 40 ARG~? 46.07 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -29.17 20.14 -58.33 -30.48 20.48 -56.65 coo 22.84 13.44 52.91 20.84 13.18 52.38 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 8.71 17.11 46.51 7.23 17.64 49.20 -28.83 19.27 -52.87 -28.76 20.36 -49.98 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 57 GLN~? 24.51 NA NA D1069 294 GLU B 55 GLU~? 15.33 NA NA D1069 304 ARG A 56 ARG~? 34.66 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -21.62 16.63 -78.23 -20.16 15.81 -77.02 coo 22.84 13.44 52.91 20.84 13.18 52.38 -15.58 8.63 -77.02 -13.81 8.49 -78.16 coo 8.71 17.11 46.51 7.23 17.64 49.20 -27.95 21.09 -79.81 -27.41 23.73 -81.37 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN B 52 GLN~? 25.40 NA NA D1069 294 GLU B 45 GLU~? 30.22 NA NA D1069 304 ARG B 56 ARG~? 24.39 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -20.71 9.20 -71.79 -22.78 8.58 -71.68 coo 22.84 13.44 52.91 20.84 13.18 52.38 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 8.71 17.11 46.51 7.23 17.64 49.20 -21.57 11.48 -78.51 -22.99 9.40 -76.67 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN D 10 GLN~? 23.81 OXT ACT B1069 294 GLU D 5 GLU~? 18.82 OXT ACT B1069 304 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -0.17 12.04 -13.02 -0.43 12.72 -15.02 coo 22.84 13.44 52.91 20.84 13.18 52.38 -2.82 6.94 -2.98 -1.75 7.35 -1.21 coo 8.71 17.11 46.51 7.23 17.64 49.20 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN D 52 GLN~? 13.91 NA NA D1069 294 GLU D 45 GLU~? 19.29 NA NA D1069 304 ARG D 56 ARG~? 10.15 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -4.68 -6.78 -73.12 -6.80 -6.42 -72.84 coo 22.84 13.44 52.91 20.84 13.18 52.38 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 8.71 17.11 46.51 7.23 17.64 49.20 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN D 57 GLN~? -4.24 NA NA D1069s 294 GLU D 55 GLU~? 12.40 NA NA D1069 304 ARG C 56 ARG~? 9.44 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 2.76 0.03 -80.69 3.58 1.48 -79.32 coo 22.84 13.44 52.91 20.84 13.18 52.38 0.42 -8.60 -77.55 2.42 -8.94 -76.88 coo 8.71 17.11 46.51 7.23 17.64 49.20 7.82 2.72 -82.08 8.63 1.22 -84.68 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN E 44 GLN~? 24.76 NA NA D1069 294 GLU D 45 GLU~? 19.29 NA NA D1069 304 ARG E 40 ARG~? 29.89 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -6.48 7.16 -59.68 -7.74 8.35 -58.46 coo 22.84 13.44 52.91 20.84 13.18 52.38 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 8.71 17.11 46.51 7.23 17.64 49.20 -5.59 5.26 -52.86 -8.61 5.84 -52.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 8 3 # 8 111 GLN E 49 GLN~? 13.17 NA NA D1069 294 GLU E 45 GLU~? 20.97 NA NA D1069 304 ARG E 56 ARG~? 8.81 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 22.84 13.44 52.91 20.84 13.18 52.38 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 8.71 17.11 46.51 7.23 17.64 49.20 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 9 3 # 9 111 GLN E 52 GLN~? 13.85 NA NA D1069 294 GLU E 45 GLU~? 20.97 NA NA D1069 304 ARG E 56 ARG~? 8.81 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -6.20 10.29 -73.32 -5.15 12.02 -72.67 coo 22.84 13.44 52.91 20.84 13.18 52.38 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 8.71 17.11 46.51 7.23 17.64 49.20 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 10 3 # 10 111 GLN E 57 GLN~? -4.15 NA NA D1069s 294 GLU D 55 GLU~? 12.40 NA NA D1069 304 ARG E 56 ARG~? 8.81 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 22.84 13.44 52.91 20.84 13.18 52.38 0.42 -8.60 -77.55 2.42 -8.94 -76.88 coo 8.71 17.11 46.51 7.23 17.64 49.20 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 11 3 # 11 111 GLN F 52 GLN~? 25.43 NA NA D1069 294 GLU F 45 GLU~? 25.79 NA NA D1069 304 ARG F 56 ARG~? 22.05 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -12.27 24.30 -72.03 -10.74 23.17 -71.15 coo 22.84 13.44 52.91 20.84 13.18 52.38 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 8.71 17.11 46.51 7.23 17.64 49.20 -13.14 21.58 -79.47 -10.11 21.88 -78.75 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 12 3 # 12 111 GLN F 57 GLN~? 28.62 NA NA D1069 294 GLU F 55 GLU~? 30.88 NA NA D1069 304 ARG A 56 ARG~? 34.66 NA NA D1069 coo 15.89 18.45 46.53 15.82 16.91 48.02 -21.43 21.92 -79.78 -22.15 20.41 -78.53 coo 22.84 13.44 52.91 20.84 13.18 52.38 -16.47 28.07 -74.52 -14.99 28.14 -72.96 coo 8.71 17.11 46.51 7.23 17.64 49.20 -27.95 21.09 -79.81 -27.41 23.73 -81.37 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 12 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 15 SER~? 18.46 O ACT B1069 B 69 ALA A 17 ALA~? 23.19 O ACT B1069 B 241 ASN A 16 ASN~? 20.18 O ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 9.15 37.89 36.69 10.55 37.76 37.22 -14.45 24.45 -21.92 -13.14 23.74 -21.61 coo 10.91 43.03 38.47 11.81 41.82 36.93 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 19 SER~? 22.86 O ACT B1069 B 69 ALA A 17 ALA~? 23.19 O ACT B1069 B 241 ASN A 16 ASN~? 20.18 O ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo 9.15 37.89 36.69 10.55 37.76 37.22 -14.45 24.45 -21.92 -13.14 23.74 -21.61 coo 10.91 43.03 38.47 11.81 41.82 36.93 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 15 SER~? 18.52 CH3 ACT B1069 B 69 ALA B 17 ALA~? 22.86 CH3 ACT B1069 B 241 ASN B 16 ASN~? 19.42 CH3 ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 9.15 37.89 36.69 10.55 37.76 37.22 -27.45 19.34 -21.22 -27.35 20.76 -20.76 coo 10.91 43.03 38.47 11.81 41.82 36.93 -28.33 16.16 -18.08 -28.26 14.66 -16.54 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 19 SER~? 22.94 CH3 ACT B1069 B 69 ALA B 17 ALA~? 22.86 CH3 ACT B1069 B 241 ASN B 16 ASN~? 19.42 CH3 ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo 9.15 37.89 36.69 10.55 37.76 37.22 -27.45 19.34 -21.22 -27.35 20.76 -20.76 coo 10.91 43.03 38.47 11.81 41.82 36.93 -28.33 16.16 -18.08 -28.26 14.66 -16.54 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER C 15 SER~? 34.57 OXT ACT B1069 B 69 ALA C 17 ALA~? 36.82 OXT ACT B1069 B 241 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo 9.15 37.89 36.69 10.55 37.76 37.22 -0.31 -5.91 -23.22 -1.83 -5.90 -23.02 coo 10.91 43.03 38.47 11.81 41.82 36.93 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER C 19 SER~? 38.98 OXT ACT B1069 B 69 ALA C 17 ALA~? 36.82 OXT ACT B1069 B 241 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo 9.15 37.89 36.69 10.55 37.76 37.22 -0.31 -5.91 -23.22 -1.83 -5.90 -23.02 coo 10.91 43.03 38.47 11.81 41.82 36.93 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 7 3 # 7 B 1 SER D 15 SER~? 29.04 OXT ACT B1069 B 69 ALA D 17 ALA~? 28.82 OXT ACT B1069 B 241 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 9.15 37.89 36.69 10.55 37.76 37.22 -4.46 7.78 -23.16 -3.48 8.88 -22.83 coo 10.91 43.03 38.47 11.81 41.82 36.93 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 8 3 # 8 B 1 SER D 19 SER~? 31.20 OXT ACT B1069 B 69 ALA D 17 ALA~? 28.82 OXT ACT B1069 B 241 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo 9.15 37.89 36.69 10.55 37.76 37.22 -4.46 7.78 -23.16 -3.48 8.88 -22.83 coo 10.91 43.03 38.47 11.81 41.82 36.93 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 9 3 # 9 B 1 SER E 15 SER~? 31.11 OXT ACT B1069 B 69 ALA E 17 ALA~? 38.98 OXT ACT B1069 B 241 ASN E 16 ASN~? 36.35 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 9.15 37.89 36.69 10.55 37.76 37.22 9.15 4.32 -23.26 9.80 3.01 -22.93 coo 10.91 43.03 38.47 11.81 41.82 36.93 8.81 7.50 -20.10 10.01 8.86 -21.26 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 10 3 # 10 B 1 SER E 19 SER~? 33.62 OXT ACT B1069 B 69 ALA E 17 ALA~? 38.98 OXT ACT B1069 B 241 ASN E 16 ASN~? 36.35 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 4.93 7.31 -25.24 4.19 8.25 -23.12 coo 9.15 37.89 36.69 10.55 37.76 37.22 9.15 4.32 -23.26 9.80 3.01 -22.93 coo 10.91 43.03 38.47 11.81 41.82 36.93 8.81 7.50 -20.10 10.01 8.86 -21.26 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 11 3 # 11 B 1 SER F 15 SER~? 18.74 OXT ACT B1069 B 69 ALA F 17 ALA~? 23.53 OXT ACT B1069 B 241 ASN F 16 ASN~? 19.66 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 9.15 37.89 36.69 10.55 37.76 37.22 -16.28 10.44 -21.93 -17.45 9.71 -21.44 coo 10.91 43.03 38.47 11.81 41.82 36.93 -13.09 11.15 -18.82 -11.91 11.99 -17.22 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 12 3 # 12 B 1 SER F 19 SER~? 23.26 OXT ACT B1069 B 69 ALA F 17 ALA~? 23.53 OXT ACT B1069 B 241 ASN F 16 ASN~? 19.66 OXT ACT B1069 coo 13.24 41.94 33.13 13.08 39.54 33.17 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 9.15 37.89 36.69 10.55 37.76 37.22 -16.28 10.44 -21.93 -17.45 9.71 -21.44 coo 10.91 43.03 38.47 11.81 41.82 36.93 -13.09 11.15 -18.82 -11.91 11.99 -17.22 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 12 hits 1pnl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 67 ARG D 13 ARG~? 25.10 OXT ACT B1069 B 86 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -4.31 12.49 -16.74 -2.75 13.80 -19.09 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 67 ARG E 13 ARG~? 38.24 OXT ACT B1069 B 86 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 13.07 1.77 -16.33 14.59 4.19 -15.10 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 4.68 1.62 -23.48 4.77 -0.36 -22.80 1pyl_c01 source 1pyl RIBONUCLEASE : 2 hits 1pyl_c01 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 31 ASP~? 41.79 O ACT B1069 A 261 ASP B 37 ASP~? 39.88 NA NA D1069 A 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 34.02 79.89 42.60 34.73 78.01 41.86 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 31 ASP~? 41.79 O ACT B1069 A 261 ASP B 37 ASP~? 39.88 NA NA D1069 A 329 ASP F 37 ASP~? 40.42 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 34.02 79.89 42.60 34.73 78.01 41.86 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 37 ASP~? 48.68 NA NA D1069 A 261 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP A 31 ASP~? 41.79 O ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 37 ASP~? 48.68 NA NA D1069 A 261 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 37 ASP~? 48.68 NA NA D1069 A 261 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP B 35 ASP~? 46.31 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 261 ASP F 37 ASP~? 40.42 NA NA D1069 A 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 261 ASP F 37 ASP~? 40.42 NA NA D1069 A 329 ASP B 37 ASP~? 39.88 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP A 31 ASP~? 41.79 O ACT B1069 A 329 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP A 31 ASP~? 41.79 O ACT B1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP A 31 ASP~? 41.79 O ACT B1069 A 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP D 35 ASP~? 33.74 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP D 35 ASP~? 33.74 NA NA D1069 A 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP E 37 ASP~? 33.39 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 261 ASP E 37 ASP~? 33.39 NA NA D1069 A 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 31 ASP~? 40.83 NA NA D1069 A 261 ASP E 37 ASP~? 33.39 NA NA D1069 A 329 ASP C 37 ASP~? 33.08 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 34.02 79.89 42.60 34.73 78.01 41.86 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1qho_c05 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 261 ASP D 31 ASP~? 40.40 NA NA D1069 A 329 ASP C 31 ASP~? 40.83 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 34.02 79.89 42.60 34.73 78.01 41.86 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.67 -5.91 -43.09 6.81 -7.53 -42.25 ULMN 3 1qho_c05 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 261 ASP D 31 ASP~? 40.40 NA NA D1069 A 329 ASP E 31 ASP~? 40.09 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 34.02 79.89 42.60 34.73 78.01 41.86 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1qho_c05 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 261 ASP D 31 ASP~? 40.40 NA NA D1069 A 329 ASP E 35 ASP~? 33.25 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 34.02 79.89 42.60 34.73 78.01 41.86 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1qho_c05 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP D 6 ASP~? 18.23 OXT ACT B1069 A 261 ASP F 6 ASP~? 11.75 OXT ACT B1069 A 329 ASP A 6 ASP~? 11.36 O ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -0.05 12.02 -6.83 -0.93 13.40 -5.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 -20.77 8.67 -5.03 -20.07 6.91 -4.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -9.40 20.26 -5.39 -7.91 21.27 -4.18 ULMN 3 1qho_c05 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 261 ASP C 37 ASP~? 33.08 NA NA D1069 A 329 ASP D 37 ASP~? 34.01 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1qho_c05 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 261 ASP C 37 ASP~? 33.08 NA NA D1069 A 329 ASP E 37 ASP~? 33.39 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1qho_c05 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 261 ASP F 37 ASP~? 40.42 NA NA D1069 A 329 ASP E 37 ASP~? 33.39 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1qho_c05 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP D 37 ASP~? 34.01 NA NA D1069 A 261 ASP E 31 ASP~? 40.09 NA NA D1069 A 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP E 31 ASP~? 40.09 NA NA D1069 A 261 ASP D 37 ASP~? 34.01 NA NA D1069 A 329 ASP C 37 ASP~? 33.08 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1qho_c05 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP E 31 ASP~? 40.09 NA NA D1069 A 261 ASP D 37 ASP~? 34.01 NA NA D1069 A 329 ASP E 37 ASP~? 33.39 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1qho_c05 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP E 31 ASP~? 40.09 NA NA D1069 A 261 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP E 37 ASP~? 33.39 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1qho_c05 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP E 35 ASP~? 33.25 NA NA D1069 A 261 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP D 35 ASP~? 33.74 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP E 35 ASP~? 33.25 NA NA D1069 A 261 ASP F 35 ASP~? 38.96 NA NA D1069 A 329 ASP D 35 ASP~? 33.74 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 34.02 79.89 42.60 34.73 78.01 41.86 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP E 37 ASP~? 33.39 NA NA D1069 A 261 ASP C 31 ASP~? 40.83 NA NA D1069 A 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP E 37 ASP~? 33.39 NA NA D1069 A 261 ASP C 31 ASP~? 40.83 NA NA D1069 A 329 ASP E 31 ASP~? 40.09 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1qho_c05 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 261 ASP A 37 ASP~? 48.68 NA NA D1069 A 329 ASP B 37 ASP~? 39.88 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1qho_c05 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 261 ASP A 37 ASP~? 48.68 NA NA D1069 A 329 ASP F 37 ASP~? 40.42 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1qho_c05 ALPHA-AMYLASE user 33 3 # 33 A 228 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 261 ASP E 31 ASP~? 40.09 NA NA D1069 A 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 34 3 # 34 A 228 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 261 ASP E 35 ASP~? 33.25 NA NA D1069 A 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 35 3 # 35 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 261 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 329 ASP A 31 ASP~? 41.79 O ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 36 3 # 36 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 261 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 37 3 # 37 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 261 ASP D 35 ASP~? 33.74 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 1qho_c05 source 1qho ALPHA-AMYLASE : 37 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 37 ASP~? 48.68 NA NA D1069 A 260 ASP F 35 ASP~? 38.96 NA NA D1069 A 329 ASP A 31 ASP~? 41.79 O ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 30.73 81.29 37.61 31.23 82.07 35.69 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 37 ASP~? 48.68 NA NA D1069 A 260 ASP F 35 ASP~? 38.96 NA NA D1069 A 329 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 30.73 81.29 37.61 31.23 82.07 35.69 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 37 ASP~? 48.68 NA NA D1069 A 260 ASP F 37 ASP~? 40.42 NA NA D1069 A 329 ASP B 35 ASP~? 46.31 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 30.73 81.29 37.61 31.23 82.07 35.69 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 260 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP B 37 ASP~? 39.88 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 260 ASP F 35 ASP~? 38.96 NA NA D1069 A 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 35 ASP~? 46.31 NA NA D1069 A 260 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 329 ASP A 35 ASP~? 45.42 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 35 ASP~? 46.31 NA NA D1069 A 260 ASP F 37 ASP~? 40.42 NA NA D1069 A 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 260 ASP A 35 ASP~? 45.42 NA NA D1069 A 329 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 260 ASP A 35 ASP~? 45.42 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 260 ASP A 37 ASP~? 48.68 NA NA D1069 A 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP B 37 ASP~? 39.88 NA NA D1069 A 260 ASP D 31 ASP~? 40.40 NA NA D1069 A 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP C 31 ASP~? 40.83 NA NA D1069 A 260 ASP D 35 ASP~? 33.74 NA NA D1069 A 329 ASP C 37 ASP~? 33.08 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 30.73 81.29 37.61 31.23 82.07 35.69 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP C 35 ASP~? 34.97 NA NA D1069 A 260 ASP D 31 ASP~? 40.40 NA NA D1069 A 329 ASP E 35 ASP~? 33.25 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP C 35 ASP~? 34.97 NA NA D1069 A 260 ASP E 37 ASP~? 33.39 NA NA D1069 A 329 ASP D 37 ASP~? 34.01 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 30.73 81.29 37.61 31.23 82.07 35.69 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 260 ASP D 35 ASP~? 33.74 NA NA D1069 A 329 ASP C 31 ASP~? 40.83 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 30.73 81.29 37.61 31.23 82.07 35.69 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.67 -5.91 -43.09 6.81 -7.53 -42.25 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 260 ASP D 35 ASP~? 33.74 NA NA D1069 A 329 ASP E 31 ASP~? 40.09 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 30.73 81.29 37.61 31.23 82.07 35.69 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 260 ASP D 37 ASP~? 34.01 NA NA D1069 A 329 ASP C 31 ASP~? 40.83 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 30.73 81.29 37.61 31.23 82.07 35.69 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.67 -5.91 -43.09 6.81 -7.53 -42.25 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP C 37 ASP~? 33.08 NA NA D1069 A 260 ASP D 37 ASP~? 34.01 NA NA D1069 A 329 ASP E 35 ASP~? 33.25 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 30.73 81.29 37.61 31.23 82.07 35.69 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 260 ASP B 37 ASP~? 39.88 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 260 ASP C 31 ASP~? 40.83 NA NA D1069 A 329 ASP D 37 ASP~? 34.01 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 260 ASP C 35 ASP~? 34.97 NA NA D1069 A 329 ASP E 37 ASP~? 33.39 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1qho_c07 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP D 31 ASP~? 40.40 NA NA D1069 A 260 ASP F 35 ASP~? 38.96 NA NA D1069 A 329 ASP E 37 ASP~? 33.39 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 1qho_c07 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP D 35 ASP~? 33.74 NA NA D1069 A 260 ASP C 31 ASP~? 40.83 NA NA D1069 A 329 ASP E 35 ASP~? 33.25 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 30.73 81.29 37.61 31.23 82.07 35.69 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP D 37 ASP~? 34.01 NA NA D1069 A 260 ASP E 35 ASP~? 33.25 NA NA D1069 A 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP D 37 ASP~? 34.01 NA NA D1069 A 260 ASP E 37 ASP~? 33.39 NA NA D1069 A 329 ASP C 35 ASP~? 34.97 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1qho_c07 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP E 35 ASP~? 33.25 NA NA D1069 A 260 ASP D 37 ASP~? 34.01 NA NA D1069 A 329 ASP C 37 ASP~? 33.08 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 30.73 81.29 37.61 31.23 82.07 35.69 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1qho_c07 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP E 37 ASP~? 33.39 NA NA D1069 A 260 ASP C 35 ASP~? 34.97 NA NA D1069 A 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP E 37 ASP~? 33.39 NA NA D1069 A 260 ASP C 35 ASP~? 34.97 NA NA D1069 A 329 ASP E 31 ASP~? 40.09 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 260 ASP B 35 ASP~? 46.31 NA NA D1069 A 329 ASP F 37 ASP~? 40.42 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1qho_c07 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP F 35 ASP~? 38.96 NA NA D1069 A 260 ASP A 37 ASP~? 48.68 NA NA D1069 A 329 ASP B 37 ASP~? 39.88 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 30.73 81.29 37.61 31.23 82.07 35.69 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP F 35 ASP~? 38.96 NA NA D1069 A 260 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 329 ASP A 35 ASP~? 45.42 NA NA D1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1qho_c07 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 260 ASP B 35 ASP~? 46.31 NA NA D1069 A 329 ASP A 31 ASP~? 41.79 O ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 30.73 81.29 37.61 31.23 82.07 35.69 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1qho_c07 ALPHA-AMYLASE user 33 3 # 33 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 260 ASP B 35 ASP~? 46.31 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 30.73 81.29 37.61 31.23 82.07 35.69 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 34 3 # 34 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 260 ASP B 37 ASP~? 39.88 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 30.73 81.29 37.61 31.23 82.07 35.69 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 35 3 # 35 A 228 ASP F 37 ASP~? 40.42 NA NA D1069 A 260 ASP E 37 ASP~? 33.39 NA NA D1069 A 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 30.73 81.29 37.61 31.23 82.07 35.69 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.67 13.66 -41.84 -10.91 12.80 -40.94 1qho_c07 source 1qho ALPHA-AMYLASE : 35 hits 1qho_c07 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 31 ASP~? 41.79 O ACT B1069 35 SER A 30 SER~? 40.12 CH3 ACT B1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 12.20 12.71 75.45 13.69 13.84 74.03 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 5.22 15.03 71.43 7.19 14.88 70.83 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 35 ASP~? 45.42 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP A 31 ASP~? 41.79 O ACT B1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 12.20 12.71 75.45 13.69 13.84 74.03 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 34 SER~? 48.00 O ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 12.20 12.71 75.45 13.69 13.84 74.03 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP A 37 ASP~? 48.68 NA NA D1069 35 SER A 38 SER~? 45.54 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 12.20 12.71 75.45 13.69 13.84 74.03 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo 5.22 15.03 71.43 7.19 14.88 70.83 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 3 # 5 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 35 SER B 30 SER~? 40.67 CH3 ACT B1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 12.20 12.71 75.45 13.69 13.84 74.03 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 5.22 15.03 71.43 7.19 14.88 70.83 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 6 3 # 6 32 ASP B 35 ASP~? 46.31 NA NA D1069 35 SER B 34 SER~? 44.97 NA NA D1069 215 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 12.20 12.71 75.45 13.69 13.84 74.03 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 5.22 15.03 71.43 7.19 14.88 70.83 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 7 3 # 7 32 ASP B 37 ASP~? 39.88 NA NA D1069 35 SER B 38 SER~? 40.72 NA NA D1069 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 12.20 12.71 75.45 13.69 13.84 74.03 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo 5.22 15.03 71.43 7.19 14.88 70.83 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 8 3 # 8 32 ASP C 31 ASP~? 40.83 NA NA D1069 35 SER C 30 SER~? 42.91 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 12.20 12.71 75.45 13.69 13.84 74.03 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 9 3 # 9 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 34 SER~? 36.89 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 12.20 12.71 75.45 13.69 13.84 74.03 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 10 3 # 10 32 ASP C 37 ASP~? 33.08 NA NA D1069 35 SER C 38 SER~? 28.14 NA NA D1069 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 12.20 12.71 75.45 13.69 13.84 74.03 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 11 3 # 11 32 ASP D 31 ASP~? 40.40 NA NA D1069 35 SER D 30 SER~? 41.47 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 12.20 12.71 75.45 13.69 13.84 74.03 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 5.22 15.03 71.43 7.19 14.88 70.83 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 12 3 # 12 32 ASP D 35 ASP~? 33.74 NA NA D1069 35 SER D 34 SER~? 37.31 NA NA D1069 215 ASP D 31 ASP~? 40.40 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 12.20 12.71 75.45 13.69 13.84 74.03 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 5.22 15.03 71.43 7.19 14.88 70.83 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 13 3 # 13 32 ASP E 31 ASP~? 40.09 NA NA D1069 35 SER E 30 SER~? 42.45 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 12.20 12.71 75.45 13.69 13.84 74.03 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 14 3 # 14 32 ASP E 35 ASP~? 33.25 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP E 31 ASP~? 40.09 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 12.20 12.71 75.45 13.69 13.84 74.03 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 5.22 15.03 71.43 7.19 14.88 70.83 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 15 3 # 15 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 34 SER~? 36.48 NA NA D1069 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 12.20 12.71 75.45 13.69 13.84 74.03 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 5.22 15.03 71.43 7.19 14.88 70.83 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 16 3 # 16 32 ASP E 37 ASP~? 33.39 NA NA D1069 35 SER E 38 SER~? 28.19 NA NA D1069 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 12.20 12.71 75.45 13.69 13.84 74.03 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 17 3 # 17 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 35 SER F 30 SER~? 41.37 O ACT B1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 12.20 12.71 75.45 13.69 13.84 74.03 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 5.22 15.03 71.43 7.19 14.88 70.83 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 18 3 # 18 32 ASP F 35 ASP~? 38.96 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 12.20 12.71 75.45 13.69 13.84 74.03 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 5.22 15.03 71.43 7.19 14.88 70.83 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 19 3 # 19 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 34 SER~? 40.55 NA NA D1069 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 12.20 12.71 75.45 13.69 13.84 74.03 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 5.22 15.03 71.43 7.19 14.88 70.83 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 20 3 # 20 32 ASP F 37 ASP~? 40.42 NA NA D1069 35 SER F 38 SER~? 34.44 NA NA D1069 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo 11.85 17.24 72.81 11.09 15.37 72.36 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 12.20 12.71 75.45 13.69 13.84 74.03 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 5.22 15.03 71.43 7.19 14.88 70.83 -15.17 14.97 -47.64 -14.21 13.34 -46.63 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 20 hits 1rne_c04 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 31 ASP~? 41.79 O ACT B1069 A 37 SER A 30 SER~? 40.12 CH3 ACT B1069 A 214 ASP A 35 ASP~? 45.42 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 51.10 65.11 20.73 52.62 63.74 19.42 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 48.59 58.89 25.78 50.13 59.74 24.61 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP A 35 ASP~? 45.42 NA NA D1069 A 37 SER A 34 SER~? 48.00 O ACT B1069 A 214 ASP A 31 ASP~? 41.79 O ACT B1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 51.10 65.11 20.73 52.62 63.74 19.42 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 48.59 58.89 25.78 50.13 59.74 24.61 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP A 37 ASP~? 48.68 NA NA D1069 A 37 SER A 34 SER~? 48.00 O ACT B1069 A 214 ASP B 35 ASP~? 46.31 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 51.10 65.11 20.73 52.62 63.74 19.42 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 48.59 58.89 25.78 50.13 59.74 24.61 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP A 37 ASP~? 48.68 NA NA D1069 A 37 SER A 38 SER~? 45.54 NA NA D1069 A 214 ASP A 35 ASP~? 45.42 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 51.10 65.11 20.73 52.62 63.74 19.42 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo 48.59 58.89 25.78 50.13 59.74 24.61 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1sme_c04 PLASMEPSIN II user 5 3 # 5 A 34 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 37 SER B 30 SER~? 40.67 CH3 ACT B1069 A 214 ASP B 35 ASP~? 46.31 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 51.10 65.11 20.73 52.62 63.74 19.42 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 48.59 58.89 25.78 50.13 59.74 24.61 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1sme_c04 PLASMEPSIN II user 6 3 # 6 A 34 ASP B 35 ASP~? 46.31 NA NA D1069 A 37 SER B 34 SER~? 44.97 NA NA D1069 A 214 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 51.10 65.11 20.73 52.62 63.74 19.42 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 48.59 58.89 25.78 50.13 59.74 24.61 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 1sme_c04 PLASMEPSIN II user 7 3 # 7 A 34 ASP B 37 ASP~? 39.88 NA NA D1069 A 37 SER B 38 SER~? 40.72 NA NA D1069 A 214 ASP B 35 ASP~? 46.31 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 51.10 65.11 20.73 52.62 63.74 19.42 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo 48.59 58.89 25.78 50.13 59.74 24.61 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1sme_c04 PLASMEPSIN II user 8 3 # 8 A 34 ASP C 31 ASP~? 40.83 NA NA D1069 A 37 SER C 30 SER~? 42.91 NA NA D1069 A 214 ASP C 35 ASP~? 34.97 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 51.10 65.11 20.73 52.62 63.74 19.42 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 48.59 58.89 25.78 50.13 59.74 24.61 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1sme_c04 PLASMEPSIN II user 9 3 # 9 A 34 ASP C 37 ASP~? 33.08 NA NA D1069 A 37 SER C 34 SER~? 36.89 NA NA D1069 A 214 ASP E 35 ASP~? 33.25 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 51.10 65.11 20.73 52.62 63.74 19.42 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 48.59 58.89 25.78 50.13 59.74 24.61 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1sme_c04 PLASMEPSIN II user 10 3 # 10 A 34 ASP C 37 ASP~? 33.08 NA NA D1069 A 37 SER C 38 SER~? 28.14 NA NA D1069 A 214 ASP C 35 ASP~? 34.97 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 51.10 65.11 20.73 52.62 63.74 19.42 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 48.59 58.89 25.78 50.13 59.74 24.61 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1sme_c04 PLASMEPSIN II user 11 3 # 11 A 34 ASP D 31 ASP~? 40.40 NA NA D1069 A 37 SER D 30 SER~? 41.47 NA NA D1069 A 214 ASP D 35 ASP~? 33.74 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 51.10 65.11 20.73 52.62 63.74 19.42 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 48.59 58.89 25.78 50.13 59.74 24.61 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1sme_c04 PLASMEPSIN II user 12 3 # 12 A 34 ASP D 35 ASP~? 33.74 NA NA D1069 A 37 SER D 34 SER~? 37.31 NA NA D1069 A 214 ASP D 31 ASP~? 40.40 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 51.10 65.11 20.73 52.62 63.74 19.42 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 48.59 58.89 25.78 50.13 59.74 24.61 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1sme_c04 PLASMEPSIN II user 13 3 # 13 A 34 ASP D 37 ASP~? 34.01 NA NA D1069 A 37 SER D 34 SER~? 37.31 NA NA D1069 A 214 ASP C 35 ASP~? 34.97 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 51.10 65.11 20.73 52.62 63.74 19.42 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 48.59 58.89 25.78 50.13 59.74 24.61 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1sme_c04 PLASMEPSIN II user 14 3 # 14 A 34 ASP E 31 ASP~? 40.09 NA NA D1069 A 37 SER E 30 SER~? 42.45 NA NA D1069 A 214 ASP E 35 ASP~? 33.25 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 51.10 65.11 20.73 52.62 63.74 19.42 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 48.59 58.89 25.78 50.13 59.74 24.61 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1sme_c04 PLASMEPSIN II user 15 3 # 15 A 34 ASP E 35 ASP~? 33.25 NA NA D1069 A 37 SER E 34 SER~? 36.48 NA NA D1069 A 214 ASP E 31 ASP~? 40.09 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 51.10 65.11 20.73 52.62 63.74 19.42 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 48.59 58.89 25.78 50.13 59.74 24.61 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1sme_c04 PLASMEPSIN II user 16 3 # 16 A 34 ASP E 37 ASP~? 33.39 NA NA D1069 A 37 SER E 34 SER~? 36.48 NA NA D1069 A 214 ASP D 35 ASP~? 33.74 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 51.10 65.11 20.73 52.62 63.74 19.42 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 48.59 58.89 25.78 50.13 59.74 24.61 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1sme_c04 PLASMEPSIN II user 17 3 # 17 A 34 ASP E 37 ASP~? 33.39 NA NA D1069 A 37 SER E 38 SER~? 28.19 NA NA D1069 A 214 ASP E 35 ASP~? 33.25 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 51.10 65.11 20.73 52.62 63.74 19.42 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 48.59 58.89 25.78 50.13 59.74 24.61 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1sme_c04 PLASMEPSIN II user 18 3 # 18 A 34 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 37 SER F 30 SER~? 41.37 O ACT B1069 A 214 ASP F 35 ASP~? 38.96 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 51.10 65.11 20.73 52.62 63.74 19.42 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 48.59 58.89 25.78 50.13 59.74 24.61 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1sme_c04 PLASMEPSIN II user 19 3 # 19 A 34 ASP F 35 ASP~? 38.96 NA NA D1069 A 37 SER F 34 SER~? 40.55 NA NA D1069 A 214 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 51.10 65.11 20.73 52.62 63.74 19.42 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 48.59 58.89 25.78 50.13 59.74 24.61 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1sme_c04 PLASMEPSIN II user 20 3 # 20 A 34 ASP F 37 ASP~? 40.42 NA NA D1069 A 37 SER F 34 SER~? 40.55 NA NA D1069 A 214 ASP A 35 ASP~? 45.42 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 51.10 65.11 20.73 52.62 63.74 19.42 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 48.59 58.89 25.78 50.13 59.74 24.61 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1sme_c04 PLASMEPSIN II user 21 3 # 21 A 34 ASP F 37 ASP~? 40.42 NA NA D1069 A 37 SER F 38 SER~? 34.44 NA NA D1069 A 214 ASP F 35 ASP~? 38.96 NA NA D1069 coo 51.75 60.57 19.10 52.05 60.90 21.19 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 51.10 65.11 20.73 52.62 63.74 19.42 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 48.59 58.89 25.78 50.13 59.74 24.61 -15.17 14.97 -47.64 -14.21 13.34 -46.63 1sme_c04 source 1sme PLASMEPSIN II : 21 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 31 ASP~? 41.79 O ACT B1069 B 37 SER A 30 SER~? 40.12 CH3 ACT B1069 B 214 ASP A 35 ASP~? 45.42 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 20.67 100.44 55.84 20.21 98.51 54.45 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 12.41 98.71 58.47 14.37 98.17 58.05 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 37 ASP~? 48.68 NA NA D1069 B 37 SER A 34 SER~? 48.00 O ACT B1069 B 214 ASP B 35 ASP~? 46.31 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 20.67 100.44 55.84 20.21 98.51 54.45 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 12.41 98.71 58.47 14.37 98.17 58.05 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP B 31 ASP~? 42.18 CH3 ACT B1069 B 37 SER B 30 SER~? 40.67 CH3 ACT B1069 B 214 ASP B 35 ASP~? 46.31 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 20.67 100.44 55.84 20.21 98.51 54.45 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 12.41 98.71 58.47 14.37 98.17 58.05 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP B 37 ASP~? 39.88 NA NA D1069 B 37 SER B 34 SER~? 44.97 NA NA D1069 B 214 ASP F 35 ASP~? 38.96 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 20.67 100.44 55.84 20.21 98.51 54.45 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 12.41 98.71 58.47 14.37 98.17 58.05 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP C 31 ASP~? 40.83 NA NA D1069 B 37 SER C 30 SER~? 42.91 NA NA D1069 B 214 ASP C 35 ASP~? 34.97 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 20.67 100.44 55.84 20.21 98.51 54.45 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 12.41 98.71 58.47 14.37 98.17 58.05 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP C 37 ASP~? 33.08 NA NA D1069 B 37 SER C 34 SER~? 36.89 NA NA D1069 B 214 ASP E 35 ASP~? 33.25 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 20.67 100.44 55.84 20.21 98.51 54.45 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 12.41 98.71 58.47 14.37 98.17 58.05 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1sme_c05 PLASMEPSIN II user 7 3 # 7 B 34 ASP C 37 ASP~? 33.08 NA NA D1069 B 37 SER C 38 SER~? 28.14 NA NA D1069 B 214 ASP E 35 ASP~? 33.25 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 20.67 100.44 55.84 20.21 98.51 54.45 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 12.41 98.71 58.47 14.37 98.17 58.05 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1sme_c05 PLASMEPSIN II user 8 3 # 8 B 34 ASP D 31 ASP~? 40.40 NA NA D1069 B 37 SER D 30 SER~? 41.47 NA NA D1069 B 214 ASP D 35 ASP~? 33.74 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 20.67 100.44 55.84 20.21 98.51 54.45 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 12.41 98.71 58.47 14.37 98.17 58.05 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1sme_c05 PLASMEPSIN II user 9 3 # 9 B 34 ASP D 37 ASP~? 34.01 NA NA D1069 B 37 SER D 34 SER~? 37.31 NA NA D1069 B 214 ASP C 35 ASP~? 34.97 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 20.67 100.44 55.84 20.21 98.51 54.45 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 12.41 98.71 58.47 14.37 98.17 58.05 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1sme_c05 PLASMEPSIN II user 10 3 # 10 B 34 ASP E 31 ASP~? 40.09 NA NA D1069 B 37 SER E 30 SER~? 42.45 NA NA D1069 B 214 ASP E 35 ASP~? 33.25 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 20.67 100.44 55.84 20.21 98.51 54.45 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 12.41 98.71 58.47 14.37 98.17 58.05 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1sme_c05 PLASMEPSIN II user 11 3 # 11 B 34 ASP E 37 ASP~? 33.39 NA NA D1069 B 37 SER E 34 SER~? 36.48 NA NA D1069 B 214 ASP D 35 ASP~? 33.74 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 20.67 100.44 55.84 20.21 98.51 54.45 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 12.41 98.71 58.47 14.37 98.17 58.05 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 1sme_c05 PLASMEPSIN II user 12 3 # 12 B 34 ASP F 31 ASP~? 42.55 OXT ACT B1069 B 37 SER F 30 SER~? 41.37 O ACT B1069 B 214 ASP F 35 ASP~? 38.96 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 20.67 100.44 55.84 20.21 98.51 54.45 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 12.41 98.71 58.47 14.37 98.17 58.05 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1sme_c05 PLASMEPSIN II user 13 3 # 13 B 34 ASP F 37 ASP~? 40.42 NA NA D1069 B 37 SER F 34 SER~? 40.55 NA NA D1069 B 214 ASP A 35 ASP~? 45.42 NA NA D1069 coo 17.69 97.58 52.73 17.33 97.19 54.77 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 20.67 100.44 55.84 20.21 98.51 54.45 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 12.41 98.71 58.47 14.37 98.17 58.05 -19.74 24.00 -47.60 -18.54 25.65 -46.87 1sme_c05 source 1sme PLASMEPSIN II : 13 hits 1sme_c05 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY C 41 GLY~? 24.75 NA NA D1069 B 17 GLN C 47 GLN~? 17.45 NA NA D1069 B 140 GLU C 45 GLU~? 22.33 NA NA D1069 coo 61.49 19.86 5.96 61.52 19.46 5.16 8.36 0.13 -58.10 7.51 0.13 -58.17 coo 63.76 11.90 7.93 65.18 13.07 6.77 5.37 6.64 -65.74 3.79 7.76 -65.10 coo 66.44 19.00 7.38 67.69 17.67 8.37 9.55 -0.98 -62.99 10.23 -2.79 -62.14 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 1 hits 1t4c_c02 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 31 ASP~? 41.79 O ACT B1069 218 GLU E 45 GLU~? 20.97 NA NA D1069 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 31 ASP~? 41.79 O ACT B1069 218 GLU F 55 GLU~? 30.88 NA NA D1069 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 35 ASP~? 45.42 NA NA D1069 218 GLU A 55 GLU~? 31.92 NA NA D1069 329 ASP B 35 ASP~? 46.31 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 35 ASP~? 45.42 NA NA D1069 218 GLU B 55 GLU~? 15.33 NA NA D1069 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.58 8.63 -77.02 -13.81 8.49 -78.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 35 ASP~? 45.42 NA NA D1069 218 GLU B 55 GLU~? 15.33 NA NA D1069 329 ASP F 37 ASP~? 40.42 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.58 8.63 -77.02 -13.81 8.49 -78.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.97 21.18 -49.82 -12.35 22.97 -48.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 37 ASP~? 48.68 NA NA D1069 218 GLU E 45 GLU~? 20.97 NA NA D1069 329 ASP A 31 ASP~? 41.79 O ACT B1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 37 ASP~? 48.68 NA NA D1069 218 GLU E 45 GLU~? 20.97 NA NA D1069 329 ASP B 35 ASP~? 46.31 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 31 ASP~? 42.18 CH3 ACT B1069 218 GLU A 55 GLU~? 31.92 NA NA D1069 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 31 ASP~? 42.18 CH3 ACT B1069 218 GLU A 55 GLU~? 31.92 NA NA D1069 329 ASP B 37 ASP~? 39.88 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 31 ASP~? 42.18 CH3 ACT B1069 218 GLU E 45 GLU~? 20.97 NA NA D1069 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 35 ASP~? 46.31 NA NA D1069 218 GLU B 55 GLU~? 15.33 NA NA D1069 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.58 8.63 -77.02 -13.81 8.49 -78.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 35 ASP~? 46.31 NA NA D1069 218 GLU F 55 GLU~? 30.88 NA NA D1069 329 ASP A 35 ASP~? 45.42 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 35 ASP~? 46.31 NA NA D1069 218 GLU F 55 GLU~? 30.88 NA NA D1069 329 ASP A 37 ASP~? 48.68 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.69 24.58 -49.00 -27.86 23.75 -47.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 35 ASP~? 46.31 NA NA D1069 218 GLU F 55 GLU~? 30.88 NA NA D1069 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 37 ASP~? 39.88 NA NA D1069 218 GLU F 55 GLU~? 30.88 NA NA D1069 329 ASP F 35 ASP~? 38.96 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 70.09 11.71 8.46 70.56 12.89 6.77 -16.47 28.07 -74.52 -14.99 28.14 -72.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP C 35 ASP~? 34.97 NA NA D1069 218 GLU C 55 GLU~? 12.72 NA NA D1069 329 ASP E 35 ASP~? 33.25 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.93 8.59 -77.67 8.56 10.55 -76.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP C 35 ASP~? 34.97 NA NA D1069 218 GLU F 45 GLU~? 25.79 NA NA D1069 329 ASP D 37 ASP~? 34.01 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.64 -3.83 -48.60 3.65 -5.53 -47.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP C 37 ASP~? 33.08 NA NA D1069 218 GLU F 45 GLU~? 25.79 NA NA D1069 329 ASP E 31 ASP~? 40.09 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP D 31 ASP~? 40.40 NA NA D1069 218 GLU F 12 GLU~? 12.40 OXT ACT B1069 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP D 35 ASP~? 33.74 NA NA D1069 218 GLU C 55 GLU~? 12.72 NA NA D1069 329 ASP E 35 ASP~? 33.25 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.93 8.59 -77.67 8.56 10.55 -76.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP D 35 ASP~? 33.74 NA NA D1069 218 GLU D 55 GLU~? 12.40 NA NA D1069 329 ASP C 35 ASP~? 34.97 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 0.42 -8.60 -77.55 2.42 -8.94 -76.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP E 35 ASP~? 33.25 NA NA D1069 218 GLU D 55 GLU~? 12.40 NA NA D1069 329 ASP C 35 ASP~? 34.97 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 0.42 -8.60 -77.55 2.42 -8.94 -76.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP E 35 ASP~? 33.25 NA NA D1069 218 GLU D 55 GLU~? 12.40 NA NA D1069 329 ASP C 37 ASP~? 33.08 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 0.42 -8.60 -77.55 2.42 -8.94 -76.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 9.40 -0.47 -51.29 9.99 0.84 -49.79 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP F 31 ASP~? 42.55 OXT ACT B1069 218 GLU D 12 GLU~? 21.50 OXT ACT B1069 329 ASP D 31 ASP~? 40.40 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP F 35 ASP~? 38.96 NA NA D1069 218 GLU A 55 GLU~? 31.92 NA NA D1069 329 ASP B 35 ASP~? 46.31 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP F 35 ASP~? 38.96 NA NA D1069 218 GLU A 55 GLU~? 31.92 NA NA D1069 329 ASP B 37 ASP~? 39.88 NA NA D1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.83 14.81 -75.23 -29.77 12.78 -75.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.23 9.61 -49.11 -20.62 9.20 -47.75 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 26 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP D 31 ASP~? 40.40 NA NA D1069 242 GLU D 45 GLU~? 19.29 NA NA D1069 329 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.67 13.66 -41.84 -10.91 12.80 -40.94 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c05 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR B 48 TYR~? 25.63 NA NA D1069 A 317 GLU B 45 GLU~? 30.22 NA NA D1069 A 365 ARG B 40 ARG~? 36.76 NA NA D1069 coo 1.77 6.56 57.05 3.05 7.44 59.37 -21.01 7.50 -66.79 -21.78 5.40 -68.42 coo 3.06 2.85 52.79 4.83 3.89 53.24 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 3.82 17.09 49.56 4.09 14.32 50.84 -16.98 10.60 -53.04 -17.44 11.09 -50.03 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 48 TYR~? 25.63 NA NA D1069 A 317 GLU B 45 GLU~? 30.22 NA NA D1069 A 365 ARG B 56 ARG~? 24.39 NA NA D1069 coo 1.77 6.56 57.05 3.05 7.44 59.37 -21.01 7.50 -66.79 -21.78 5.40 -68.42 coo 3.06 2.85 52.79 4.83 3.89 53.24 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 3.82 17.09 49.56 4.09 14.32 50.84 -21.57 11.48 -78.51 -22.99 9.40 -76.67 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR D 48 TYR~? 17.05 NA NA D1069 A 317 GLU D 45 GLU~? 19.29 NA NA D1069 A 365 ARG D 40 ARG~? 31.12 NA NA D1069 coo 1.77 6.56 57.05 3.05 7.44 59.37 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 3.06 2.85 52.79 4.83 3.89 53.24 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 3.82 17.09 49.56 4.09 14.32 50.84 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR F 48 TYR~? 29.78 NA NA D1069 A 317 GLU F 45 GLU~? 25.79 NA NA D1069 A 365 ARG F 40 ARG~? 40.52 NA NA D1069 coo 1.77 6.56 57.05 3.05 7.44 59.37 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 3.06 2.85 52.79 4.83 3.89 53.24 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 3.82 17.09 49.56 4.09 14.32 50.84 -15.45 24.99 -53.23 -13.33 26.42 -51.43 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR F 48 TYR~? 29.78 NA NA D1069 A 317 GLU F 45 GLU~? 25.79 NA NA D1069 A 365 ARG F 56 ARG~? 22.05 NA NA D1069 coo 1.77 6.56 57.05 3.05 7.44 59.37 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 3.06 2.85 52.79 4.83 3.89 53.24 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 3.82 17.09 49.56 4.09 14.32 50.84 -13.14 21.58 -79.47 -10.11 21.88 -78.75 1vzx_c02 source 1vzx 2.04.01.0087 : 5 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR B 48 TYR~? 25.63 NA NA D1069 B1317 GLU B 45 GLU~? 30.22 NA NA D1069 B1365 ARG B 40 ARG~? 36.76 NA NA D1069 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -21.01 7.50 -66.79 -21.78 5.40 -68.42 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -16.98 10.60 -53.04 -17.44 11.09 -50.03 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 48 TYR~? 25.63 NA NA D1069 B1317 GLU B 45 GLU~? 30.22 NA NA D1069 B1365 ARG B 56 ARG~? 24.39 NA NA D1069 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -21.01 7.50 -66.79 -21.78 5.40 -68.42 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -25.09 10.14 -63.28 -24.58 8.57 -64.65 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -21.57 11.48 -78.51 -22.99 9.40 -76.67 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR D 48 TYR~? 17.05 NA NA D1069 B1317 GLU D 45 GLU~? 19.29 NA NA D1069 B1365 ARG D 40 ARG~? 31.12 NA NA D1069 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -7.88 -3.53 -64.36 -8.43 -5.21 -65.61 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -0.46 -7.22 -54.35 -0.29 -6.34 -51.39 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR F 48 TYR~? 29.78 NA NA D1069 B1317 GLU F 45 GLU~? 25.79 NA NA D1069 B1365 ARG F 56 ARG~? 22.05 NA NA D1069 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -13.14 21.58 -79.47 -10.11 21.88 -78.75 1vzx_c03 source 1vzx 2.04.01.0087 : 4 hits 1vzx_c03 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 35 ASP~? 45.42 NA NA D1069 231 ASP E 37 ASP~? 33.39 NA NA D1069 294 ASP B 35 ASP~? 46.31 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 35 ASP~? 46.31 NA NA D1069 231 ASP D 31 ASP~? 40.40 NA NA D1069 294 ASP A 35 ASP~? 45.42 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 37 ASP~? 39.88 NA NA D1069 231 ASP D 37 ASP~? 34.01 NA NA D1069 294 ASP F 35 ASP~? 38.96 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP D 31 ASP~? 40.40 NA NA D1069 231 ASP B 35 ASP~? 46.31 NA NA D1069 294 ASP E 37 ASP~? 33.39 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 33.16 106.80 7.72 33.34 104.87 6.92 -2.70 9.50 -50.33 -3.86 8.68 -48.67 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP D 37 ASP~? 34.01 NA NA D1069 231 ASP F 31 ASP~? 42.55 OXT ACT B1069 294 ASP C 35 ASP~? 34.97 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP E 37 ASP~? 33.39 NA NA D1069 231 ASP A 35 ASP~? 45.42 NA NA D1069 294 ASP D 31 ASP~? 40.40 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP E 37 ASP~? 33.39 NA NA D1069 231 ASP B 35 ASP~? 46.31 NA NA D1069 294 ASP D 31 ASP~? 40.40 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP E 37 ASP~? 33.39 NA NA D1069 231 ASP B 35 ASP~? 46.31 NA NA D1069 294 ASP D 35 ASP~? 33.74 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP F 35 ASP~? 38.96 NA NA D1069 231 ASP D 37 ASP~? 34.01 NA NA D1069 294 ASP B 37 ASP~? 39.88 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 33.16 106.80 7.72 33.34 104.87 6.92 -22.23 9.61 -49.11 -20.62 9.20 -47.75 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP F 35 ASP~? 38.96 NA NA D1069 231 ASP E 35 ASP~? 33.25 NA NA D1069 294 ASP B 37 ASP~? 39.88 NA NA D1069 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 -22.23 9.61 -49.11 -20.62 9.20 -47.75 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 10 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 31 ASP~? 41.79 O ACT B1069 38 SER A 30 SER~? 40.12 CH3 ACT B1069 218 ASP A 35 ASP~? 45.42 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo 46.04 57.35 103.96 44.97 58.52 105.78 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo 41.33 60.20 97.63 42.00 60.96 99.49 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP A 35 ASP~? 45.42 NA NA D1069 38 SER A 34 SER~? 48.00 O ACT B1069 218 ASP A 31 ASP~? 41.79 O ACT B1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -19.74 24.00 -47.60 -18.54 25.65 -46.87 coo 46.04 57.35 103.96 44.97 58.52 105.78 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 41.33 60.20 97.63 42.00 60.96 99.49 -19.20 25.92 -41.59 -18.99 27.58 -40.33 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP A 37 ASP~? 48.68 NA NA D1069 38 SER A 34 SER~? 48.00 O ACT B1069 218 ASP B 35 ASP~? 46.31 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 46.04 57.35 103.96 44.97 58.52 105.78 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo 41.33 60.20 97.63 42.00 60.96 99.49 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP A 37 ASP~? 48.68 NA NA D1069 38 SER A 38 SER~? 45.54 NA NA D1069 218 ASP A 35 ASP~? 45.42 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo 46.04 57.35 103.96 44.97 58.52 105.78 -23.87 25.64 -52.23 -22.97 27.39 -50.83 coo 41.33 60.20 97.63 42.00 60.96 99.49 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 3 # 5 35 ASP B 31 ASP~? 42.18 CH3 ACT B1069 38 SER B 30 SER~? 40.67 CH3 ACT B1069 218 ASP B 35 ASP~? 46.31 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo 46.04 57.35 103.96 44.97 58.52 105.78 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo 41.33 60.20 97.63 42.00 60.96 99.49 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 3 # 6 35 ASP B 35 ASP~? 46.31 NA NA D1069 38 SER B 34 SER~? 44.97 NA NA D1069 218 ASP B 31 ASP~? 42.18 CH3 ACT B1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -25.65 15.79 -47.19 -27.69 16.15 -46.71 coo 46.04 57.35 103.96 44.97 58.52 105.78 -25.07 11.19 -45.97 -27.35 10.45 -46.41 coo 41.33 60.20 97.63 42.00 60.96 99.49 -28.00 14.80 -41.54 -29.44 14.00 -40.22 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 3 # 7 35 ASP B 37 ASP~? 39.88 NA NA D1069 38 SER B 38 SER~? 40.72 NA NA D1069 218 ASP B 35 ASP~? 46.31 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -22.23 9.61 -49.11 -20.62 9.20 -47.75 coo 46.04 57.35 103.96 44.97 58.52 105.78 -25.06 11.70 -52.12 -27.29 12.47 -52.67 coo 41.33 60.20 97.63 42.00 60.96 99.49 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 8 3 # 8 35 ASP C 31 ASP~? 40.83 NA NA D1069 38 SER C 30 SER~? 42.91 NA NA D1069 218 ASP C 35 ASP~? 34.97 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo 46.04 57.35 103.96 44.97 58.52 105.78 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo 41.33 60.20 97.63 42.00 60.96 99.49 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 9 3 # 9 35 ASP C 37 ASP~? 33.08 NA NA D1069 38 SER C 34 SER~? 36.89 NA NA D1069 218 ASP E 35 ASP~? 33.25 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 46.04 57.35 103.96 44.97 58.52 105.78 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo 41.33 60.20 97.63 42.00 60.96 99.49 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 10 3 # 10 35 ASP C 37 ASP~? 33.08 NA NA D1069 38 SER C 38 SER~? 28.14 NA NA D1069 218 ASP C 35 ASP~? 34.97 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo 46.04 57.35 103.96 44.97 58.52 105.78 7.13 -2.99 -54.17 6.26 -5.07 -54.88 coo 41.33 60.20 97.63 42.00 60.96 99.49 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 11 3 # 11 35 ASP D 31 ASP~? 40.40 NA NA D1069 38 SER D 30 SER~? 41.47 NA NA D1069 218 ASP D 35 ASP~? 33.74 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo 46.04 57.35 103.96 44.97 58.52 105.78 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo 41.33 60.20 97.63 42.00 60.96 99.49 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 12 3 # 12 35 ASP D 35 ASP~? 33.74 NA NA D1069 38 SER D 34 SER~? 37.31 NA NA D1069 218 ASP D 31 ASP~? 40.40 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -4.99 1.62 -48.68 -6.67 2.69 -48.16 coo 46.04 57.35 103.96 44.97 58.52 105.78 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 41.33 60.20 97.63 42.00 60.96 99.49 -7.52 2.48 -42.94 -9.40 2.64 -41.94 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 13 3 # 13 35 ASP D 37 ASP~? 34.01 NA NA D1069 38 SER D 34 SER~? 37.31 NA NA D1069 218 ASP C 35 ASP~? 34.97 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo 46.04 57.35 103.96 44.97 58.52 105.78 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo 41.33 60.20 97.63 42.00 60.96 99.49 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 14 3 # 14 35 ASP E 31 ASP~? 40.09 NA NA D1069 38 SER E 30 SER~? 42.45 NA NA D1069 218 ASP E 35 ASP~? 33.25 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 5.80 7.64 -43.44 6.92 9.05 -42.34 coo 46.04 57.35 103.96 44.97 58.52 105.78 1.41 8.63 -41.51 1.21 9.99 -39.50 coo 41.33 60.20 97.63 42.00 60.96 99.49 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 15 3 # 15 35 ASP E 35 ASP~? 33.25 NA NA D1069 38 SER E 34 SER~? 36.48 NA NA D1069 218 ASP E 31 ASP~? 40.09 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 3.94 6.10 -49.30 5.84 6.97 -48.85 coo 46.04 57.35 103.96 44.97 58.52 105.78 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 41.33 60.20 97.63 42.00 60.96 99.49 5.80 7.64 -43.44 6.92 9.05 -42.34 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 16 3 # 16 35 ASP E 37 ASP~? 33.39 NA NA D1069 38 SER E 34 SER~? 36.48 NA NA D1069 218 ASP D 35 ASP~? 33.74 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 46.04 57.35 103.96 44.97 58.52 105.78 1.08 9.58 -47.46 1.38 11.36 -45.92 coo 41.33 60.20 97.63 42.00 60.96 99.49 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 17 3 # 17 35 ASP E 37 ASP~? 33.39 NA NA D1069 38 SER E 38 SER~? 28.19 NA NA D1069 218 ASP E 35 ASP~? 33.25 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo 46.04 57.35 103.96 44.97 58.52 105.78 0.51 9.62 -53.61 2.82 10.07 -54.28 coo 41.33 60.20 97.63 42.00 60.96 99.49 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 18 3 # 18 35 ASP F 31 ASP~? 42.55 OXT ACT B1069 38 SER F 30 SER~? 41.37 O ACT B1069 218 ASP F 35 ASP~? 38.96 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo 46.04 57.35 103.96 44.97 58.52 105.78 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo 41.33 60.20 97.63 42.00 60.96 99.49 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 19 3 # 19 35 ASP F 35 ASP~? 38.96 NA NA D1069 38 SER F 34 SER~? 40.55 NA NA D1069 218 ASP F 31 ASP~? 42.55 OXT ACT B1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -15.17 14.97 -47.64 -14.21 13.34 -46.63 coo 46.04 57.35 103.96 44.97 58.52 105.78 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 41.33 60.20 97.63 42.00 60.96 99.49 -12.67 13.66 -41.84 -10.91 12.80 -40.94 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 20 3 # 20 35 ASP F 37 ASP~? 40.42 NA NA D1069 38 SER F 34 SER~? 40.55 NA NA D1069 218 ASP A 35 ASP~? 45.42 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 46.04 57.35 103.96 44.97 58.52 105.78 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo 41.33 60.20 97.63 42.00 60.96 99.49 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 21 3 # 21 35 ASP F 37 ASP~? 40.42 NA NA D1069 38 SER F 38 SER~? 34.44 NA NA D1069 218 ASP F 35 ASP~? 38.96 NA NA D1069 coo 41.14 58.72 105.19 42.39 59.85 103.92 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo 46.04 57.35 103.96 44.97 58.52 105.78 -12.44 17.68 -52.77 -11.10 16.06 -51.61 coo 41.33 60.20 97.63 42.00 60.96 99.49 -15.17 14.97 -47.64 -14.21 13.34 -46.63 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 21 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 18 HIS~? 22.68 O ACT B1069 B 163 ALA F 17 ALA~? 23.53 OXT ACT B1069 B 182 SER F 15 SER~? 18.74 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -16.28 10.44 -21.93 -17.45 9.71 -21.44 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -16.65 14.44 -18.28 -15.27 16.35 -17.73 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 18 HIS~? 22.68 O ACT B1069 B 163 ALA F 17 ALA~? 23.53 OXT ACT B1069 B 182 SER F 19 SER~? 23.26 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -16.28 10.44 -21.93 -17.45 9.71 -21.44 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -13.87 14.96 -23.84 -12.87 16.04 -21.91 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 163 ALA A 17 ALA~? 23.19 O ACT B1069 B 182 SER A 15 SER~? 18.46 O ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -14.45 24.45 -21.92 -13.14 23.74 -21.61 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -17.50 21.98 -18.17 -19.80 22.08 -17.54 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 163 ALA A 17 ALA~? 23.19 O ACT B1069 B 182 SER A 19 SER~? 22.86 O ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -14.45 24.45 -21.92 -13.14 23.74 -21.61 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -19.63 24.38 -23.55 -20.78 24.69 -21.42 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 163 ALA D 17 ALA~? 28.82 OXT ACT B1069 B 182 SER D 15 SER~? 29.04 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -4.46 7.78 -23.16 -3.48 8.88 -22.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -2.29 4.33 -19.60 -2.69 2.08 -18.89 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 6 3 # 6 B 46 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 163 ALA D 17 ALA~? 28.82 OXT ACT B1069 B 182 SER D 19 SER~? 31.20 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -4.46 7.78 -23.16 -3.48 8.88 -22.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -5.05 2.59 -24.85 -5.23 1.18 -22.84 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 7 3 # 7 B 46 HIS D 18 HIS~? 32.59 OXT ACT B1069 B 163 ALA E 17 ALA~? 38.98 OXT ACT B1069 B 182 SER E 15 SER~? 31.11 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 9.15 4.32 -23.26 9.80 3.01 -22.93 coo 24.00 -0.17 2.07 24.51 1.00 0.04 5.12 4.34 -19.70 3.25 5.78 -19.17 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 8 3 # 8 B 46 HIS D 18 HIS~? 32.59 OXT ACT B1069 B 163 ALA E 17 ALA~? 38.98 OXT ACT B1069 B 182 SER E 19 SER~? 33.62 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 9.15 4.32 -23.26 9.80 3.01 -22.93 coo 24.00 -0.17 2.07 24.51 1.00 0.04 4.93 7.31 -25.24 4.19 8.25 -23.12 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 9 3 # 9 B 46 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 163 ALA C 17 ALA~? 36.82 OXT ACT B1069 B 182 SER C 15 SER~? 34.57 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -0.31 -5.91 -23.22 -1.83 -5.90 -23.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 1.50 -2.25 -19.56 3.70 -1.35 -19.01 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 10 3 # 10 B 46 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 163 ALA C 17 ALA~? 36.82 OXT ACT B1069 B 182 SER C 19 SER~? 38.98 OXT ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -0.31 -5.91 -23.22 -1.83 -5.90 -23.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 4.34 -3.67 -24.84 5.58 -3.18 -22.88 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 11 3 # 11 B 46 HIS F 18 HIS~? 22.80 CH3 ACT B1069 B 163 ALA B 17 ALA~? 22.86 CH3 ACT B1069 B 182 SER B 15 SER~? 18.52 CH3 ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -27.45 19.34 -21.22 -27.35 20.76 -20.76 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -23.57 17.59 -17.96 -22.72 15.36 -17.43 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 12 3 # 12 B 46 HIS F 18 HIS~? 22.80 CH3 ACT B1069 B 163 ALA B 17 ALA~? 22.86 CH3 ACT B1069 B 182 SER B 19 SER~? 22.94 CH3 ACT B1069 coo 30.42 1.98 4.36 29.07 0.41 4.68 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -27.45 19.34 -21.22 -27.35 20.76 -20.76 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -25.11 14.88 -23.41 -24.65 13.68 -21.35 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 12 hits 2bhg_c02 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 156 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 194 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 74.14 15.91 8.55 72.08 15.36 8.63 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 67.44 25.26 13.91 67.54 23.65 15.28 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 156 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 194 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 74.14 15.91 8.55 72.08 15.36 8.63 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 67.47 20.07 1.34 65.99 20.06 2.88 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU E 45 GLU~? 20.97 NA NA D1069 A 156 GLU F 45 GLU~? 25.79 NA NA D1069 A 194 ASN E 51 ASN~? 14.92 NA NA D1069 coo 74.14 15.91 8.55 72.08 15.36 8.63 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 67.47 20.07 1.34 65.99 20.06 2.88 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.35 5.89 -71.09 -8.92 4.59 -69.43 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU F 45 GLU~? 25.79 NA NA D1069 A 156 GLU E 45 GLU~? 20.97 NA NA D1069 A 194 ASN B 51 ASN~? 21.57 NA NA D1069 coo 74.14 15.91 8.55 72.08 15.36 8.63 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 67.47 20.07 1.34 65.99 20.06 2.88 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 67.44 25.26 13.91 67.54 23.65 15.28 -16.05 10.14 -69.47 -14.81 10.49 -67.72 2dbt_c00 source 2dbt CHITINASE C : 4 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU F 45 GLU~? 25.79 NA NA D1069 B 156 GLU E 45 GLU~? 20.97 NA NA D1069 B 194 ASN B 51 ASN~? 21.57 NA NA D1069 coo 45.64 63.11 17.20 47.48 62.43 16.45 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 54.43 67.89 19.82 55.62 67.90 18.07 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.05 10.14 -69.47 -14.81 10.49 -67.72 2dbt_c01 source 2dbt CHITINASE C : 1 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU D 12 GLU~? 21.50 OXT ACT B1069 C 156 GLU E 12 GLU~? 28.48 OXT ACT B1069 C 194 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 41.23 29.31 13.28 43.03 29.85 12.29 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 49.75 21.00 18.12 50.45 23.02 18.26 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU E 12 GLU~? 28.48 OXT ACT B1069 C 156 GLU C 12 GLU~? 32.57 OXT ACT B1069 C 194 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 41.23 29.31 13.28 43.03 29.85 12.29 5.80 6.61 -13.13 6.29 7.73 -11.36 coo 44.75 23.09 5.51 46.77 22.91 6.12 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU E 45 GLU~? 20.97 NA NA D1069 C 156 GLU F 45 GLU~? 25.79 NA NA D1069 C 194 ASN E 51 ASN~? 14.92 NA NA D1069 coo 41.23 29.31 13.28 43.03 29.85 12.29 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 44.75 23.09 5.51 46.77 22.91 6.12 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.35 5.89 -71.09 -8.92 4.59 -69.43 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU F 45 GLU~? 25.79 NA NA D1069 C 156 GLU E 45 GLU~? 20.97 NA NA D1069 C 194 ASN B 51 ASN~? 21.57 NA NA D1069 coo 41.23 29.31 13.28 43.03 29.85 12.29 -11.28 18.98 -63.57 -10.22 17.30 -62.81 coo 44.75 23.09 5.51 46.77 22.91 6.12 -2.74 11.36 -62.64 -2.77 13.30 -63.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 -16.05 10.14 -69.47 -14.81 10.49 -67.72 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 15 SER~? 18.46 O ACT B1069 B 158 HIS A 18 HIS~? 22.68 O ACT B1069 B 208 ASN A 16 ASN~? 20.18 O ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 48.67 45.40 71.68 47.67 46.90 70.60 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 48.91 49.12 65.17 47.29 49.14 66.54 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER A 15 SER~? 18.46 O ACT B1069 B 158 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 208 ASN A 16 ASN~? 20.18 O ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 48.67 45.40 71.68 47.67 46.90 70.60 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 48.91 49.12 65.17 47.29 49.14 66.54 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER A 19 SER~? 22.86 O ACT B1069 B 158 HIS A 18 HIS~? 22.68 O ACT B1069 B 208 ASN A 16 ASN~? 20.18 O ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo 48.67 45.40 71.68 47.67 46.90 70.60 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo 48.91 49.12 65.17 47.29 49.14 66.54 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 4 3 # 4 B 137 SER A 19 SER~? 22.86 O ACT B1069 B 158 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 208 ASN A 16 ASN~? 20.18 O ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo 48.67 45.40 71.68 47.67 46.90 70.60 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 48.91 49.12 65.17 47.29 49.14 66.54 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 5 3 # 5 B 137 SER B 15 SER~? 18.52 CH3 ACT B1069 B 158 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 208 ASN B 16 ASN~? 19.42 CH3 ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 48.67 45.40 71.68 47.67 46.90 70.60 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 48.91 49.12 65.17 47.29 49.14 66.54 -28.33 16.16 -18.08 -28.26 14.66 -16.54 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 6 3 # 6 B 137 SER B 19 SER~? 22.94 CH3 ACT B1069 B 158 HIS B 18 HIS~? 22.64 CH3 ACT B1069 B 208 ASN B 16 ASN~? 19.42 CH3 ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo 48.67 45.40 71.68 47.67 46.90 70.60 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo 48.91 49.12 65.17 47.29 49.14 66.54 -28.33 16.16 -18.08 -28.26 14.66 -16.54 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 7 3 # 7 B 137 SER C 15 SER~? 34.57 OXT ACT B1069 B 158 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 208 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo 48.67 45.40 71.68 47.67 46.90 70.60 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 48.91 49.12 65.17 47.29 49.14 66.54 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 8 3 # 8 B 137 SER C 19 SER~? 38.98 OXT ACT B1069 B 158 HIS C 18 HIS~? 33.75 OXT ACT B1069 B 208 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo 48.67 45.40 71.68 47.67 46.90 70.60 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 48.91 49.12 65.17 47.29 49.14 66.54 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 9 3 # 9 B 137 SER D 15 SER~? 29.04 OXT ACT B1069 B 158 HIS D 18 HIS~? 32.59 OXT ACT B1069 B 208 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 48.67 45.40 71.68 47.67 46.90 70.60 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 48.91 49.12 65.17 47.29 49.14 66.54 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 10 3 # 10 B 137 SER D 19 SER~? 31.20 OXT ACT B1069 B 158 HIS D 18 HIS~? 32.59 OXT ACT B1069 B 208 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo 48.67 45.40 71.68 47.67 46.90 70.60 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 48.91 49.12 65.17 47.29 49.14 66.54 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 11 3 # 11 B 137 SER E 15 SER~? 31.11 OXT ACT B1069 B 158 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 208 ASN E 16 ASN~? 36.35 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 48.67 45.40 71.68 47.67 46.90 70.60 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 48.91 49.12 65.17 47.29 49.14 66.54 8.81 7.50 -20.10 10.01 8.86 -21.26 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 12 3 # 12 B 137 SER E 19 SER~? 33.62 OXT ACT B1069 B 158 HIS E 18 HIS~? 36.76 OXT ACT B1069 B 208 ASN E 16 ASN~? 36.35 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 4.93 7.31 -25.24 4.19 8.25 -23.12 coo 48.67 45.40 71.68 47.67 46.90 70.60 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 48.91 49.12 65.17 47.29 49.14 66.54 8.81 7.50 -20.10 10.01 8.86 -21.26 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 13 3 # 13 B 137 SER F 15 SER~? 18.74 OXT ACT B1069 B 158 HIS F 18 HIS~? 22.80 CH3 ACT B1069 B 208 ASN F 16 ASN~? 19.66 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 48.67 45.40 71.68 47.67 46.90 70.60 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 48.91 49.12 65.17 47.29 49.14 66.54 -13.09 11.15 -18.82 -11.91 11.99 -17.22 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 14 3 # 14 B 137 SER F 19 SER~? 23.26 OXT ACT B1069 B 158 HIS F 18 HIS~? 22.80 CH3 ACT B1069 B 208 ASN F 16 ASN~? 19.66 OXT ACT B1069 coo 50.29 50.10 71.46 47.85 50.06 71.46 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 48.67 45.40 71.68 47.67 46.90 70.60 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 48.91 49.12 65.17 47.29 49.14 66.54 -13.09 11.15 -18.82 -11.91 11.99 -17.22 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 14 hits 2hdh_c02 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 31 ASP~? 41.79 O ACT B1069 A 35 SER A 30 SER~? 40.12 CH3 ACT B1069 A 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -19.20 25.92 -41.59 -18.99 27.58 -40.33 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -23.61 24.44 -39.99 -25.35 25.14 -38.41 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -19.74 24.00 -47.60 -18.54 25.65 -46.87 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP A 37 ASP~? 48.68 NA NA D1069 A 35 SER A 34 SER~? 48.00 O ACT B1069 A 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -26.69 24.58 -49.00 -27.86 23.75 -47.45 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -23.97 25.66 -45.97 -23.29 28.01 -46.28 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP B 31 ASP~? 42.18 CH3 ACT B1069 A 35 SER B 30 SER~? 40.67 CH3 ACT B1069 A 215 ASP B 35 ASP~? 46.31 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -28.00 14.80 -41.54 -29.44 14.00 -40.22 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -25.65 15.79 -47.19 -27.69 16.15 -46.71 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP C 31 ASP~? 40.83 NA NA D1069 A 35 SER C 30 SER~? 42.91 NA NA D1069 A 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 5.67 -5.91 -43.09 6.81 -7.53 -42.25 coo -13.21 66.21 45.84 -15.49 65.90 45.84 7.89 -1.91 -41.38 8.76 -3.42 -39.67 coo -10.72 64.19 37.77 -12.20 64.43 39.15 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 2jxr_c04 LIGAND CP-081282 user 5 3 # 5 A 32 ASP C 37 ASP~? 33.08 NA NA D1069 A 35 SER C 34 SER~? 36.89 NA NA D1069 A 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 9.40 -0.47 -51.29 9.99 0.84 -49.79 coo -13.21 66.21 45.84 -15.49 65.90 45.84 8.32 -2.72 -47.74 10.00 -3.61 -46.28 coo -10.72 64.19 37.77 -12.20 64.43 39.15 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 2jxr_c04 LIGAND CP-081282 user 6 3 # 6 A 32 ASP D 31 ASP~? 40.40 NA NA D1069 A 35 SER D 30 SER~? 41.47 NA NA D1069 A 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -7.52 2.48 -42.94 -9.40 2.64 -41.94 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 2jxr_c04 LIGAND CP-081282 user 7 3 # 7 A 32 ASP D 37 ASP~? 34.01 NA NA D1069 A 35 SER D 34 SER~? 37.31 NA NA D1069 A 215 ASP C 35 ASP~? 34.97 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -5.26 -5.51 -50.22 -4.30 -6.69 -48.75 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -6.51 -2.55 -46.92 -8.16 -2.74 -45.19 coo -10.72 64.19 37.77 -12.20 64.43 39.15 3.64 -3.83 -48.60 3.65 -5.53 -47.40 ULMN 3 2jxr_c04 LIGAND CP-081282 user 8 3 # 8 A 32 ASP E 31 ASP~? 40.09 NA NA D1069 A 35 SER E 30 SER~? 42.45 NA NA D1069 A 215 ASP E 35 ASP~? 33.25 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 5.80 7.64 -43.44 6.92 9.05 -42.34 coo -13.21 66.21 45.84 -15.49 65.90 45.84 1.41 8.63 -41.51 1.21 9.99 -39.50 coo -10.72 64.19 37.77 -12.20 64.43 39.15 3.94 6.10 -49.30 5.84 6.97 -48.85 ULMN 3 2jxr_c04 LIGAND CP-081282 user 9 3 # 9 A 32 ASP E 37 ASP~? 33.39 NA NA D1069 A 35 SER E 34 SER~? 36.48 NA NA D1069 A 215 ASP D 35 ASP~? 33.74 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -2.70 9.50 -50.33 -3.86 8.68 -48.67 coo -13.21 66.21 45.84 -15.49 65.90 45.84 1.08 9.58 -47.46 1.38 11.36 -45.92 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -4.99 1.62 -48.68 -6.67 2.69 -48.16 ULMN 3 2jxr_c04 LIGAND CP-081282 user 10 3 # 10 A 32 ASP F 31 ASP~? 42.55 OXT ACT B1069 A 35 SER F 30 SER~? 41.37 O ACT B1069 A 215 ASP F 35 ASP~? 38.96 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -12.67 13.66 -41.84 -10.91 12.80 -40.94 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -12.37 18.11 -40.06 -10.05 18.58 -39.94 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -15.17 14.97 -47.64 -14.21 13.34 -46.63 ULMN 3 2jxr_c04 LIGAND CP-081282 user 11 3 # 11 A 32 ASP F 37 ASP~? 40.42 NA NA D1069 A 35 SER F 34 SER~? 40.55 NA NA D1069 A 215 ASP A 35 ASP~? 45.42 NA NA D1069 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -11.97 21.18 -49.82 -12.35 22.97 -48.70 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -11.64 18.01 -46.50 -9.86 17.52 -44.92 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -19.74 24.00 -47.60 -18.54 25.65 -46.87 2jxr_c04 source 2jxr LIGAND CP-081282 : 11 hits 2jxr_c04 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 20 GLN~? 26.25 O ACT B1069 94 HIS F 18 HIS~? 22.80 CH3 ACT B1069 96 HIS A 18 HIS~? 22.68 O ACT B1069 coo 12.06 13.83 19.61 9.96 13.82 20.00 -16.13 28.22 -24.10 -14.26 29.12 -23.45 coo 15.69 26.32 19.80 17.39 27.17 20.68 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 14.38 20.59 22.16 12.49 20.21 21.35 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN C 20 GLN~? 44.05 OXT ACT B1069 94 HIS D 18 HIS~? 32.59 OXT ACT B1069 96 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo 12.06 13.83 19.61 9.96 13.82 20.00 3.21 -8.72 -25.28 5.19 -9.22 -25.96 coo 15.69 26.32 19.80 17.39 27.17 20.68 0.09 5.21 -23.56 1.84 6.25 -23.07 coo 14.38 20.59 22.16 12.49 20.21 21.35 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 3 3 # 3 83 GLN D 20 GLN~? 27.84 OXT ACT B1069 94 HIS C 18 HIS~? 33.75 OXT ACT B1069 96 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 12.06 13.83 19.61 9.96 13.82 20.00 -8.87 6.33 -25.59 -9.25 7.64 -23.90 coo 15.69 26.32 19.80 17.39 27.17 20.68 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 14.38 20.59 22.16 12.49 20.21 21.35 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 4 3 # 4 83 GLN D 20 GLN~? 27.84 OXT ACT B1069 94 HIS E 18 HIS~? 36.76 OXT ACT B1069 96 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo 12.06 13.83 19.61 9.96 13.82 20.00 -8.87 6.33 -25.59 -9.25 7.64 -23.90 coo 15.69 26.32 19.80 17.39 27.17 20.68 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo 14.38 20.59 22.16 12.49 20.21 21.35 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 5 3 # 5 83 GLN E 20 GLN~? 40.55 OXT ACT B1069 94 HIS C 18 HIS~? 33.75 OXT ACT B1069 96 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo 12.06 13.83 19.61 9.96 13.82 20.00 9.94 8.19 -25.75 12.00 8.12 -25.32 coo 15.69 26.32 19.80 17.39 27.17 20.68 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo 14.38 20.59 22.16 12.49 20.21 21.35 4.68 1.62 -23.48 4.77 -0.36 -22.80 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 5 hits 5fit_c00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 16 ASN~? 20.18 O ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.11 26.84 -18.75 -15.28 27.06 -17.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 32 ASN~? 43.02 O ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.92 20.96 -42.86 -17.84 20.80 -42.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 46 ASN~? 36.06 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 51 ASN~? 34.27 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.79 17.13 -69.58 -28.71 15.77 -67.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 16 ASN~? 19.42 CH3 ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.33 16.16 -18.08 -28.26 14.66 -16.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 32 ASN~? 44.46 CH3 ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.06 16.63 -42.50 -22.29 18.12 -43.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 46 ASN~? 32.72 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.42 15.21 -63.35 -23.25 15.93 -62.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 51 ASN~? 21.57 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.05 10.14 -69.47 -14.81 10.49 -67.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN C 16 ASN~? 39.67 OXT ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.45 -6.99 -19.73 3.49 -8.62 -20.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN C 32 ASN~? 38.18 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.88 -1.65 -44.11 1.31 -2.92 -43.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN C 46 ASN~? 17.71 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 3.13 0.40 -64.92 2.77 -1.60 -64.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 51 ASN~? 14.73 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.22 6.66 -71.10 6.71 7.78 -69.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN D 16 ASN~? 26.04 OXT ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.94 5.71 -19.85 -8.66 6.26 -20.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN D 32 ASN~? 35.97 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.45 1.96 -43.96 -0.91 2.51 -45.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN D 46 ASN~? 15.85 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN D 51 ASN~? 15.51 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -0.08 -6.89 -71.02 1.09 -7.36 -69.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN E 16 ASN~? 36.35 OXT ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.81 7.50 -20.10 10.01 8.86 -21.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN E 32 ASN~? 37.73 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.49 3.56 -44.42 4.29 2.46 -43.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN E 46 ASN~? 17.39 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN E 51 ASN~? 14.92 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.35 5.89 -71.09 -8.92 4.59 -69.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN F 16 ASN~? 19.66 OXT ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.09 11.15 -18.82 -11.91 11.99 -17.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN F 32 ASN~? 43.23 CH3 ACT B1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.15 16.45 -42.97 -18.10 14.62 -42.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN F 46 ASN~? 28.25 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.12 18.46 -63.92 -16.59 16.49 -63.17 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN F 51 ASN~? 32.81 NA NA D1069 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.64 25.99 -69.86 -17.87 26.72 -68.26 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 24 hits 1kbk_p00 naa= 1 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 48 TYR~? 40.75 NA NA D1069 A 108 ASN B 46 ASN~? 32.72 NA NA D1069 A 135 ASN A 46 ASN~? 36.06 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 12.36 16.24 15.27 12.06 14.29 16.05 -21.42 15.21 -63.35 -23.25 15.93 -62.53 coo 18.05 11.56 12.71 17.57 10.75 14.60 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 48 TYR~? 40.75 NA NA D1069 A 108 ASN F 46 ASN~? 28.25 NA NA D1069 A 135 ASN A 46 ASN~? 36.06 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 12.36 16.24 15.27 12.06 14.29 16.05 -17.12 18.46 -63.92 -16.59 16.49 -63.17 coo 18.05 11.56 12.71 17.57 10.75 14.60 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR C 48 TYR~? 19.10 NA NA D1069 A 108 ASN D 46 ASN~? 15.85 NA NA D1069 A 135 ASN C 46 ASN~? 17.71 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 10.00 3.76 -66.60 11.23 5.15 -64.53 coo 12.36 16.24 15.27 12.06 14.29 16.05 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 18.05 11.56 12.71 17.57 10.75 14.60 3.13 0.40 -64.92 2.77 -1.60 -64.24 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR D 48 TYR~? 17.05 NA NA D1069 A 108 ASN C 46 ASN~? 17.71 NA NA D1069 A 135 ASN D 46 ASN~? 15.85 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 12.36 16.24 15.27 12.06 14.29 16.05 3.13 0.40 -64.92 2.77 -1.60 -64.24 coo 18.05 11.56 12.71 17.57 10.75 14.60 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR D 48 TYR~? 17.05 NA NA D1069 A 108 ASN E 46 ASN~? 17.39 NA NA D1069 A 135 ASN D 46 ASN~? 15.85 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 12.36 16.24 15.27 12.06 14.29 16.05 -0.49 5.22 -65.06 1.32 6.08 -64.31 coo 18.05 11.56 12.71 17.57 10.75 14.60 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR E 48 TYR~? 17.09 NA NA D1069 A 108 ASN C 46 ASN~? 17.71 NA NA D1069 A 135 ASN E 46 ASN~? 17.39 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 12.36 16.24 15.27 12.06 14.29 16.05 3.13 0.40 -64.92 2.77 -1.60 -64.24 coo 18.05 11.56 12.71 17.57 10.75 14.60 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR E 48 TYR~? 17.09 NA NA D1069 A 108 ASN D 46 ASN~? 15.85 NA NA D1069 A 135 ASN E 46 ASN~? 17.39 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 12.36 16.24 15.27 12.06 14.29 16.05 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 18.05 11.56 12.71 17.57 10.75 14.60 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR F 48 TYR~? 29.78 NA NA D1069 A 108 ASN A 46 ASN~? 36.06 NA NA D1069 A 135 ASN F 46 ASN~? 28.25 NA NA D1069 coo 17.59 4.66 17.88 15.38 5.96 18.97 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 12.36 16.24 15.27 12.06 14.29 16.05 -23.19 22.33 -63.43 -22.08 24.02 -62.58 coo 18.05 11.56 12.71 17.57 10.75 14.60 -17.12 18.46 -63.92 -16.59 16.49 -63.17 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 8 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 48 TYR~? 40.75 NA NA D1069 A 108 ASN B 46 ASN~? 32.72 NA NA D1069 A 135 ASN A 46 ASN~? 36.06 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 12.22 15.98 15.24 11.94 14.05 16.09 -21.42 15.21 -63.35 -23.25 15.93 -62.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 48 TYR~? 40.75 NA NA D1069 A 108 ASN F 46 ASN~? 28.25 NA NA D1069 A 135 ASN A 46 ASN~? 36.06 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 12.22 15.98 15.24 11.94 14.05 16.09 -17.12 18.46 -63.92 -16.59 16.49 -63.17 coo 17.94 11.43 12.65 17.42 10.61 14.53 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR C 48 TYR~? 19.10 NA NA D1069 A 108 ASN D 46 ASN~? 15.85 NA NA D1069 A 135 ASN C 46 ASN~? 17.71 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 10.00 3.76 -66.60 11.23 5.15 -64.53 coo 12.22 15.98 15.24 11.94 14.05 16.09 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 3.13 0.40 -64.92 2.77 -1.60 -64.24 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR D 48 TYR~? 17.05 NA NA D1069 A 108 ASN C 46 ASN~? 17.71 NA NA D1069 A 135 ASN D 46 ASN~? 15.85 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 12.22 15.98 15.24 11.94 14.05 16.09 3.13 0.40 -64.92 2.77 -1.60 -64.24 coo 17.94 11.43 12.65 17.42 10.61 14.53 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR D 48 TYR~? 17.05 NA NA D1069 A 108 ASN E 46 ASN~? 17.39 NA NA D1069 A 135 ASN D 46 ASN~? 15.85 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 12.22 15.98 15.24 11.94 14.05 16.09 -0.49 5.22 -65.06 1.32 6.08 -64.31 coo 17.94 11.43 12.65 17.42 10.61 14.53 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR E 48 TYR~? 17.09 NA NA D1069 A 108 ASN C 46 ASN~? 17.71 NA NA D1069 A 135 ASN E 46 ASN~? 17.39 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 12.22 15.98 15.24 11.94 14.05 16.09 3.13 0.40 -64.92 2.77 -1.60 -64.24 coo 17.94 11.43 12.65 17.42 10.61 14.53 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR E 48 TYR~? 17.09 NA NA D1069 A 108 ASN D 46 ASN~? 15.85 NA NA D1069 A 135 ASN E 46 ASN~? 17.39 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 12.22 15.98 15.24 11.94 14.05 16.09 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 17.94 11.43 12.65 17.42 10.61 14.53 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR F 48 TYR~? 29.78 NA NA D1069 A 108 ASN A 46 ASN~? 36.06 NA NA D1069 A 135 ASN F 46 ASN~? 28.25 NA NA D1069 coo 17.50 4.57 17.85 15.28 5.88 18.97 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 12.22 15.98 15.24 11.94 14.05 16.09 -23.19 22.33 -63.43 -22.08 24.02 -62.58 coo 17.94 11.43 12.65 17.42 10.61 14.53 -17.12 18.46 -63.92 -16.59 16.49 -63.17 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 8 hits 1uy4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN B 46 ASN~? 32.72 NA NA D1069 A 384 ASN E 46 ASN~? 17.39 NA NA D1069 A 385 GLU E 45 GLU~? 20.97 NA NA D1069 coo 22.28 63.17 110.61 22.47 65.06 111.53 -21.42 15.21 -63.35 -23.25 15.93 -62.53 coo 7.06 50.07 96.17 8.50 48.54 96.31 -0.49 5.22 -65.06 1.32 6.08 -64.31 coo 11.59 49.83 99.41 10.92 47.97 100.16 -2.74 11.36 -62.64 -2.77 13.30 -63.54 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN D 46 ASN~? 15.85 NA NA D1069 A 384 ASN F 46 ASN~? 28.25 NA NA D1069 A 385 GLU F 45 GLU~? 25.79 NA NA D1069 coo 22.28 63.17 110.61 22.47 65.06 111.53 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 coo 7.06 50.07 96.17 8.50 48.54 96.31 -17.12 18.46 -63.92 -16.59 16.49 -63.17 coo 11.59 49.83 99.41 10.92 47.97 100.16 -11.28 18.98 -63.57 -10.22 17.30 -62.81 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 2 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 18 HIS~? 22.68 O ACT B1069 A 166 SER A 15 SER~? 18.46 O ACT B1069 A 168 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 18 HIS~? 22.68 O ACT B1069 A 166 SER A 19 SER~? 22.86 O ACT B1069 A 168 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS A 18 HIS~? 22.68 O ACT B1069 A 166 SER B 15 SER~? 18.52 CH3 ACT B1069 A 168 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS A 18 HIS~? 22.68 O ACT B1069 A 166 SER B 15 SER~? 18.52 CH3 ACT B1069 A 168 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 5 3 # 5 A 82 HIS A 18 HIS~? 22.68 O ACT B1069 A 166 SER F 15 SER~? 18.74 OXT ACT B1069 A 168 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 6 3 # 6 A 82 HIS A 18 HIS~? 22.68 O ACT B1069 A 166 SER F 19 SER~? 23.26 OXT ACT B1069 A 168 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 7 3 # 7 A 82 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 166 SER A 15 SER~? 18.46 O ACT B1069 A 168 HIS A 18 HIS~? 22.68 O ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 8 3 # 8 A 82 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 166 SER A 19 SER~? 22.86 O ACT B1069 A 168 HIS A 18 HIS~? 22.68 O ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 9 3 # 9 A 82 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 166 SER B 15 SER~? 18.52 CH3 ACT B1069 A 168 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 10 3 # 10 A 82 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 166 SER B 19 SER~? 22.94 CH3 ACT B1069 A 168 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 11 3 # 11 A 82 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 166 SER F 15 SER~? 18.74 OXT ACT B1069 A 168 HIS A 18 HIS~? 22.68 O ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 12 3 # 12 A 82 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 166 SER F 15 SER~? 18.74 OXT ACT B1069 A 168 HIS F 18 HIS~? 22.80 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -19.58 14.64 -22.09 -21.60 14.41 -21.58 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 13 3 # 13 A 82 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 166 SER C 15 SER~? 34.57 OXT ACT B1069 A 168 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 14 3 # 14 A 82 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 166 SER C 19 SER~? 38.98 OXT ACT B1069 A 168 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 15 3 # 15 A 82 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 166 SER D 15 SER~? 29.04 OXT ACT B1069 A 168 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 16 3 # 16 A 82 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 166 SER D 19 SER~? 31.20 OXT ACT B1069 A 168 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 17 3 # 17 A 82 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 166 SER E 15 SER~? 31.11 OXT ACT B1069 A 168 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 18 3 # 18 A 82 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 166 SER E 15 SER~? 31.11 OXT ACT B1069 A 168 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 19 3 # 19 A 82 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 166 SER C 15 SER~? 34.57 OXT ACT B1069 A 168 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 20 3 # 20 A 82 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 166 SER C 15 SER~? 34.57 OXT ACT B1069 A 168 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 21 3 # 21 A 82 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 166 SER D 15 SER~? 29.04 OXT ACT B1069 A 168 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 22 3 # 22 A 82 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 166 SER D 19 SER~? 31.20 OXT ACT B1069 A 168 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 23 3 # 23 A 82 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 166 SER E 15 SER~? 31.11 OXT ACT B1069 A 168 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 5.12 4.34 -19.70 3.25 5.78 -19.17 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 24 3 # 24 A 82 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 166 SER E 19 SER~? 33.62 OXT ACT B1069 A 168 HIS E 18 HIS~? 36.76 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 4.93 7.31 -25.24 4.19 8.25 -23.12 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.68 1.62 -23.48 4.77 -0.36 -22.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 25 3 # 25 A 82 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 166 SER C 15 SER~? 34.57 OXT ACT B1069 A 168 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 26 3 # 26 A 82 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 166 SER C 19 SER~? 38.98 OXT ACT B1069 A 168 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 27 3 # 27 A 82 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 166 SER D 15 SER~? 29.04 OXT ACT B1069 A 168 HIS C 18 HIS~? 33.75 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 28 3 # 28 A 82 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 166 SER D 15 SER~? 29.04 OXT ACT B1069 A 168 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 29 3 # 29 A 82 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 166 SER E 19 SER~? 33.62 OXT ACT B1069 A 168 HIS D 18 HIS~? 32.59 OXT ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 4.93 7.31 -25.24 4.19 8.25 -23.12 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 0.09 5.21 -23.56 1.84 6.25 -23.07 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 30 3 # 30 A 82 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 166 SER A 15 SER~? 18.46 O ACT B1069 A 168 HIS A 18 HIS~? 22.68 O ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 31 3 # 31 A 82 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 166 SER A 15 SER~? 18.46 O ACT B1069 A 168 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 32 3 # 32 A 82 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 166 SER B 15 SER~? 18.52 CH3 ACT B1069 A 168 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 33 3 # 33 A 82 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 166 SER B 19 SER~? 22.94 CH3 ACT B1069 A 168 HIS B 18 HIS~? 22.64 CH3 ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.21 19.92 -21.93 -21.36 21.77 -21.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 34 3 # 34 A 82 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 166 SER F 15 SER~? 18.74 OXT ACT B1069 A 168 HIS A 18 HIS~? 22.68 O ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 35 3 # 35 A 82 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 166 SER F 19 SER~? 23.26 OXT ACT B1069 A 168 HIS A 18 HIS~? 22.68 O ACT B1069 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.48 19.55 -22.12 -15.26 17.88 -21.72 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 35 hits 2vmg_p00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN B 20 GLN~? 28.17 CH3 ACT B1069 A 11 ASN B 16 ASN~? 19.42 CH3 ACT B1069 A 13 ARG B 13 ARG~? 20.17 CH3 ACT B1069 coo 33.45 2.10 7.21 34.51 1.09 5.67 -30.66 16.91 -25.47 -32.45 17.63 -24.54 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -28.33 16.16 -18.08 -28.26 14.66 -16.54 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -29.58 23.13 -14.77 -28.38 25.80 -15.87 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN C 20 GLN~? 44.05 OXT ACT B1069 A 11 ASN C 16 ASN~? 39.67 OXT ACT B1069 A 13 ARG C 13 ARG~? 33.47 OXT ACT B1069 coo 33.45 2.10 7.21 34.51 1.09 5.67 3.21 -8.72 -25.28 5.19 -9.22 -25.96 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 2.45 -6.99 -19.73 3.49 -8.62 -20.55 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -3.15 -8.11 -14.39 -4.15 -10.29 -12.50 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN D 20 GLN~? 27.84 OXT ACT B1069 A 11 ASN D 16 ASN~? 26.04 OXT ACT B1069 A 13 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 33.45 2.10 7.21 34.51 1.09 5.67 -8.87 6.33 -25.59 -9.25 7.64 -23.90 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -6.94 5.71 -19.85 -8.66 6.26 -20.99 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN D 20 GLN~? 27.84 OXT ACT B1069 A 11 ASN F 16 ASN~? 19.66 OXT ACT B1069 A 13 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 33.45 2.10 7.21 34.51 1.09 5.67 -8.87 6.33 -25.59 -9.25 7.64 -23.90 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -13.09 11.15 -18.82 -11.91 11.99 -17.22 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -18.65 6.83 -15.20 -21.43 5.64 -15.99 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 5 3 # 5 A 9 GLN F 20 GLN~? 29.50 OXT ACT B1069 A 11 ASN D 16 ASN~? 26.04 OXT ACT B1069 A 13 ARG D 13 ARG~? 25.10 OXT ACT B1069 coo 33.45 2.10 7.21 34.51 1.09 5.67 -11.88 9.77 -25.24 -10.47 10.17 -26.89 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -6.94 5.71 -19.85 -8.66 6.26 -20.99 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -4.31 12.49 -16.74 -2.75 13.80 -19.09 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 6 3 # 6 A 9 GLN F 20 GLN~? 29.50 OXT ACT B1069 A 11 ASN F 16 ASN~? 19.66 OXT ACT B1069 A 13 ARG F 13 ARG~? 20.80 CH3 ACT B1069 coo 33.45 2.10 7.21 34.51 1.09 5.67 -11.88 9.77 -25.24 -10.47 10.17 -26.89 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -13.09 11.15 -18.82 -11.91 11.99 -17.22 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -18.65 6.83 -15.20 -21.43 5.64 -15.99 1bdv_d00 source 1bdv GENE REGULATION/DNA : 6 hits 1bdv_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 3 SER~? 8.16 O ACT B1069 E 5 VAL A 8 VAL~? 8.70 O ACT B1069 E 7 ARG B 7 ARG~? 8.67 O ACT B1069 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -10.33 17.80 -2.05 -10.39 20.20 -2.10 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -15.53 20.44 -8.42 -17.35 20.79 -7.24 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -19.45 25.45 -6.07 -16.42 24.98 -5.80 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 3 SER~? 8.11 CH3 ACT B1069 E 5 VAL B 8 VAL~? 8.61 CH3 ACT B1069 E 7 ARG F 7 ARG~? 8.59 CH3 ACT B1069 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -22.25 25.44 -1.76 -24.43 24.37 -1.48 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -22.59 19.57 -8.13 -21.89 17.84 -7.03 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -24.79 13.40 -5.76 -25.67 16.36 -5.50 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER C 3 SER~? 20.83 OXT ACT B1069 E 5 VAL C 8 VAL~? 27.41 OXT ACT B1069 E 7 ARG E 7 ARG~? 30.80 OXT ACT B1069 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -6.40 -1.33 -3.63 -8.43 -0.54 -4.77 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -0.58 -1.11 -9.69 1.28 -0.57 -8.64 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 4.93 -4.34 -8.45 2.17 -4.93 -7.13 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER D 3 SER~? 18.95 OXT ACT B1069 E 5 VAL D 8 VAL~? 22.94 OXT ACT B1069 E 7 ARG C 7 ARG~? 19.09 OXT ACT B1069 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 2.14 10.59 -3.07 -0.19 11.09 -3.36 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -0.72 5.81 -9.90 -1.25 4.25 -8.40 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -6.20 1.88 -7.39 -5.63 4.84 -7.28 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER E 3 SER~? 32.62 OXT ACT B1069 E 5 VAL E 8 VAL~? 28.36 OXT ACT B1069 E 7 ARG D 7 ARG~? 28.00 OXT ACT B1069 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 7.87 -2.43 -3.07 9.41 -0.57 -3.09 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 5.50 2.39 -9.69 4.12 3.78 -8.63 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 4.77 8.93 -7.43 7.03 6.86 -7.43 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER F 3 SER~? 9.64 CH3 ACT B1069 E 5 VAL F 8 VAL~? 8.76 OXT ACT B1069 E 7 ARG A 7 ARG~? 9.33 OXT ACT B1069 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -22.61 10.54 -1.90 -24.99 10.44 -2.58 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -18.28 13.96 -8.32 -17.40 14.89 -6.55 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -11.74 15.04 -6.24 -13.56 12.56 -6.11 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN E 57 GLN~? -4.15 NA NA D1069s C 44 LYS E 58 LYS~? 12.90 NA NA D1069 C 75 ARG D 56 ARG~? 10.15 NA NA D1069 coo 34.33 34.01 1.06 32.24 34.35 1.22 -3.15 2.11 -79.93 -2.73 0.31 -78.84 coo 36.27 30.15 5.40 32.93 24.83 5.96 -8.17 3.03 -82.99 -12.72 1.37 -78.84 coo 30.88 29.31 6.12 29.39 29.02 3.47 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 1 hits 2er8_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG B 56 ARG~? 24.39 NA NA D1069 A 32 LYS A 58 LYS~? 28.69 NA NA D1069 A 46 ARG F 56 ARG~? 22.05 NA NA D1069 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -21.57 11.48 -78.51 -22.99 9.40 -76.67 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -25.52 13.14 -80.97 -27.21 10.04 -75.84 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -13.14 21.58 -79.47 -10.11 21.88 -78.75 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG E 56 ARG~? 8.81 NA NA D1069 A 32 LYS C 58 LYS~? 11.96 NA NA D1069 A 46 ARG D 56 ARG~? 10.15 NA NA D1069 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -1.98 8.80 -79.85 -2.24 9.73 -76.86 coo -5.15 8.65 26.69 -4.26 5.48 32.02 4.28 9.49 -82.02 3.93 12.91 -77.18 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 2 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 19 SER~? 22.86 O ACT B1069 B 37 ASN A 16 ASN~? 20.18 O ACT B1069 B 45 THR B 9 THR~? 11.95 CH3 ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -17.11 26.84 -18.75 -15.28 27.06 -17.82 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -26.28 19.68 -8.80 -28.15 19.96 -7.76 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 19 SER~? 22.94 CH3 ACT B1069 B 37 ASN B 16 ASN~? 19.42 CH3 ACT B1069 B 45 THR F 9 THR~? 12.54 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -28.33 16.16 -18.08 -28.26 14.66 -16.54 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.74 10.62 -9.25 -15.99 8.78 -8.22 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 30 SER~? 40.67 CH3 ACT B1069 B 37 ASN B 32 ASN~? 44.46 CH3 ACT B1069 B 45 THR A 23 THR~? 30.70 O ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -24.44 11.77 -39.85 -26.42 10.90 -38.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -23.06 16.63 -42.50 -22.29 18.12 -43.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -20.76 25.94 -29.57 -21.24 27.84 -28.70 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER C 19 SER~? 38.98 OXT ACT B1069 B 37 ASN C 16 ASN~? 39.67 OXT ACT B1069 B 45 THR E 9 THR~? 32.59 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo -23.05 39.62 69.74 -22.86 39.59 67.61 2.45 -6.99 -19.73 3.49 -8.62 -20.55 coo -30.87 34.84 80.57 -28.94 34.51 81.49 8.89 3.83 -10.60 10.62 4.71 -9.53 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER D 15 SER~? 29.04 OXT ACT B1069 B 37 ASN D 16 ASN~? 26.04 OXT ACT B1069 B 45 THR F 23 THR~? 30.88 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -6.94 5.71 -19.85 -8.66 6.26 -20.99 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -12.26 15.05 -29.85 -10.32 14.58 -29.05 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER D 19 SER~? 31.20 OXT ACT B1069 B 37 ASN D 16 ASN~? 26.04 OXT ACT B1069 B 45 THR C 9 THR~? 30.78 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -6.94 5.71 -19.85 -8.66 6.26 -20.99 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -1.17 -4.82 -10.56 -1.46 -6.75 -9.59 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER D 19 SER~? 31.20 OXT ACT B1069 B 37 ASN D 16 ASN~? 26.04 OXT ACT B1069 B 45 THR F 23 THR~? 30.88 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -6.94 5.71 -19.85 -8.66 6.26 -20.99 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -12.26 15.05 -29.85 -10.32 14.58 -29.05 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER D 30 SER~? 41.47 NA NA D1069 B 37 ASN D 32 ASN~? 35.97 NA NA D1069 B 45 THR E 23 THR~? 39.33 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -6.00 -1.74 -40.88 -8.07 -2.95 -40.91 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -2.45 1.96 -43.96 -0.91 2.51 -45.29 coo -30.87 34.84 80.57 -28.94 34.51 81.49 4.91 8.80 -31.33 5.27 10.74 -30.48 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 B 34 SER E 19 SER~? 33.62 OXT ACT B1069 B 37 ASN E 16 ASN~? 36.35 OXT ACT B1069 B 45 THR D 9 THR~? 18.30 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 4.93 7.31 -25.24 4.19 8.25 -23.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 8.81 7.50 -20.10 10.01 8.86 -21.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -3.48 8.28 -10.68 -4.69 9.73 -9.70 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 B 34 SER E 30 SER~? 42.45 NA NA D1069 B 37 ASN E 32 ASN~? 37.73 NA NA D1069 B 45 THR C 23 THR~? 46.23 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 1.41 8.63 -41.51 1.21 9.99 -39.50 coo -23.05 39.62 69.74 -22.86 39.59 67.61 2.49 3.56 -44.42 4.29 2.46 -43.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 6.15 -4.56 -30.92 6.89 -6.53 -30.30 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 B 34 SER F 15 SER~? 18.74 OXT ACT B1069 B 37 ASN F 16 ASN~? 19.66 OXT ACT B1069 B 45 THR D 9 THR~? 18.30 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.09 11.15 -18.82 -11.91 11.99 -17.22 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -3.48 8.28 -10.68 -4.69 9.73 -9.70 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 B 34 SER F 19 SER~? 23.26 OXT ACT B1069 B 37 ASN F 16 ASN~? 19.66 OXT ACT B1069 B 45 THR A 9 THR~? 12.00 O ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.09 11.15 -18.82 -11.91 11.99 -17.22 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -13.51 23.50 -9.41 -12.46 25.07 -8.35 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 B 34 SER F 19 SER~? 23.26 OXT ACT B1069 B 37 ASN F 16 ASN~? 19.66 OXT ACT B1069 B 45 THR D 9 THR~? 18.30 OXT ACT B1069 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.09 11.15 -18.82 -11.91 11.99 -17.22 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -3.48 8.28 -10.68 -4.69 9.73 -9.70 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 13 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 15 SER~? 18.46 O ACT B1069 A 20 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 22 LEU B 22 LEU~? 27.60 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -22.86 15.09 -27.04 -20.89 15.79 -26.41 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 15 SER~? 18.46 O ACT B1069 A 20 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 22 LEU B 22 LEU~? 27.60 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -22.86 15.09 -27.04 -20.89 15.79 -26.41 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 15 SER~? 18.46 O ACT B1069 A 20 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 22 LEU F 21 LEU~? 29.14 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -17.50 21.98 -18.17 -19.80 22.08 -17.54 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -17.85 12.24 -27.26 -19.71 11.62 -28.31 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER A 19 SER~? 22.86 O ACT B1069 A 20 HIS A 18 HIS~? 22.68 O ACT B1069 A 22 LEU A 11 LEU~? 13.29 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -16.03 19.11 -12.51 -16.40 16.95 -12.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER A 19 SER~? 22.86 O ACT B1069 A 20 HIS A 18 HIS~? 22.68 O ACT B1069 A 22 LEU F 21 LEU~? 29.14 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -19.63 24.38 -23.55 -20.78 24.69 -21.42 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -17.85 12.24 -27.26 -19.71 11.62 -28.31 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 15 SER~? 18.52 CH3 ACT B1069 A 20 HIS A 18 HIS~? 22.68 O ACT B1069 A 22 LEU A 21 LEU~? 29.02 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -15.37 22.37 -27.38 -14.08 21.16 -28.80 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 18 SER B 15 SER~? 18.52 CH3 ACT B1069 A 20 HIS A 18 HIS~? 22.68 O ACT B1069 A 22 LEU F 22 LEU~? 27.80 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -15.56 17.03 -27.42 -17.12 18.31 -26.69 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 18 SER B 15 SER~? 18.52 CH3 ACT B1069 A 20 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 22 LEU F 22 LEU~? 27.80 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -23.57 17.59 -17.96 -22.72 15.36 -17.43 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -15.56 17.03 -27.42 -17.12 18.31 -26.69 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 18 SER B 19 SER~? 22.94 CH3 ACT B1069 A 20 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 22 LEU A 21 LEU~? 29.02 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -15.37 22.37 -27.38 -14.08 21.16 -28.80 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 18 SER B 19 SER~? 22.94 CH3 ACT B1069 A 20 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 22 LEU B 11 LEU~? 13.05 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -21.40 19.96 -12.28 -19.41 20.78 -12.03 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 18 SER B 19 SER~? 22.94 CH3 ACT B1069 A 20 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 22 LEU F 11 LEU~? 13.17 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.11 14.88 -23.41 -24.65 13.68 -21.35 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -19.37 14.85 -12.38 -21.12 16.06 -12.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 18 SER C 15 SER~? 34.57 OXT ACT B1069 A 20 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 22 LEU D 21 LEU~? 35.40 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -2.75 6.66 -28.66 -1.31 7.78 -29.96 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 18 SER C 15 SER~? 34.57 OXT ACT B1069 A 20 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 22 LEU E 22 LEU~? 37.21 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -14.55 2.62 13.63 -14.94 2.66 11.50 2.88 5.97 -28.74 1.20 4.77 -28.13 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 18 SER C 15 SER~? 34.57 OXT ACT B1069 A 20 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 22 LEU E 22 LEU~? 37.21 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 1.50 -2.25 -19.56 3.70 -1.35 -19.01 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 2.88 5.97 -28.74 1.20 4.77 -28.13 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 A 18 SER C 19 SER~? 38.98 OXT ACT B1069 A 20 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 22 LEU C 11 LEU~? 27.29 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.71 -0.02 -13.93 -1.97 1.52 -13.12 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 16 3 # 16 A 18 SER C 19 SER~? 38.98 OXT ACT B1069 A 20 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 22 LEU D 21 LEU~? 35.40 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 4.34 -3.67 -24.84 5.58 -3.18 -22.88 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -2.75 6.66 -28.66 -1.31 7.78 -29.96 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 17 3 # 17 A 18 SER D 15 SER~? 29.04 OXT ACT B1069 A 20 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 22 LEU C 21 LEU~? 40.36 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.28 -4.02 -28.71 -1.92 -3.46 -30.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 18 3 # 18 A 18 SER D 15 SER~? 29.04 OXT ACT B1069 A 20 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 22 LEU C 22 LEU~? 40.32 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -14.55 2.62 13.63 -14.94 2.66 11.50 4.29 -1.09 -28.75 3.77 0.83 -28.02 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 19 3 # 19 A 18 SER D 15 SER~? 29.04 OXT ACT B1069 A 20 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 22 LEU C 21 LEU~? 40.36 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.28 -4.02 -28.71 -1.92 -3.46 -30.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 20 3 # 20 A 18 SER D 15 SER~? 29.04 OXT ACT B1069 A 20 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 22 LEU C 22 LEU~? 40.32 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 4.29 -1.09 -28.75 3.77 0.83 -28.02 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 21 3 # 21 A 18 SER D 15 SER~? 29.04 OXT ACT B1069 A 20 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 22 LEU E 21 LEU~? 42.34 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.29 4.33 -19.60 -2.69 2.08 -18.89 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 7.50 2.99 -28.81 8.06 1.40 -30.18 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 22 3 # 22 A 18 SER D 19 SER~? 31.20 OXT ACT B1069 A 20 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 22 LEU D 11 LEU~? 27.11 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -14.55 2.62 13.63 -14.94 2.66 11.50 0.65 5.39 -13.84 2.80 4.91 -13.76 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 23 3 # 23 A 18 SER D 19 SER~? 31.20 OXT ACT B1069 A 20 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 22 LEU E 21 LEU~? 42.34 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -5.05 2.59 -24.85 -5.23 1.18 -22.84 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -14.55 2.62 13.63 -14.94 2.66 11.50 7.50 2.99 -28.81 8.06 1.40 -30.18 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 24 3 # 24 A 18 SER E 15 SER~? 31.11 OXT ACT B1069 A 20 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 22 LEU C 21 LEU~? 40.36 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 5.12 4.34 -19.70 3.25 5.78 -19.17 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.28 -4.02 -28.71 -1.92 -3.46 -30.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 25 3 # 25 A 18 SER E 15 SER~? 31.11 OXT ACT B1069 A 20 HIS C 18 HIS~? 33.75 OXT ACT B1069 A 22 LEU D 22 LEU~? 36.80 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 5.12 4.34 -19.70 3.25 5.78 -19.17 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -0.60 -0.60 -23.43 -2.39 0.38 -22.94 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -3.05 1.31 -28.60 -1.05 0.72 -27.95 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 26 3 # 26 A 18 SER E 15 SER~? 31.11 OXT ACT B1069 A 20 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 22 LEU D 22 LEU~? 36.80 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 5.12 4.34 -19.70 3.25 5.78 -19.17 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -3.05 1.31 -28.60 -1.05 0.72 -27.95 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 27 3 # 27 A 18 SER E 19 SER~? 33.62 OXT ACT B1069 A 20 HIS D 18 HIS~? 32.59 OXT ACT B1069 A 22 LEU D 11 LEU~? 27.11 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 4.93 7.31 -25.24 4.19 8.25 -23.12 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 0.09 5.21 -23.56 1.84 6.25 -23.07 coo -14.55 2.62 13.63 -14.94 2.66 11.50 0.65 5.39 -13.84 2.80 4.91 -13.76 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 28 3 # 28 A 18 SER E 19 SER~? 33.62 OXT ACT B1069 A 20 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 22 LEU C 21 LEU~? 40.36 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 4.93 7.31 -25.24 4.19 8.25 -23.12 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.28 -4.02 -28.71 -1.92 -3.46 -30.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 29 3 # 29 A 18 SER E 19 SER~? 33.62 OXT ACT B1069 A 20 HIS E 18 HIS~? 36.76 OXT ACT B1069 A 22 LEU E 11 LEU~? 30.72 OXT ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 4.93 7.31 -25.24 4.19 8.25 -23.12 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.68 1.62 -23.48 4.77 -0.36 -22.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 4.47 1.49 -13.86 2.96 -0.11 -13.71 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 30 3 # 30 A 18 SER F 15 SER~? 18.74 OXT ACT B1069 A 20 HIS A 18 HIS~? 22.68 O ACT B1069 A 22 LEU A 22 LEU~? 27.69 O ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -16.48 19.55 -22.12 -15.26 17.88 -21.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -20.93 22.17 -27.18 -21.35 20.21 -26.45 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 31 3 # 31 A 18 SER F 15 SER~? 18.74 OXT ACT B1069 A 20 HIS B 18 HIS~? 22.64 CH3 ACT B1069 A 22 LEU B 21 LEU~? 28.08 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -16.65 14.44 -18.28 -15.27 16.35 -17.73 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -22.21 19.92 -21.93 -21.36 21.77 -21.46 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -25.55 19.67 -26.82 -26.43 21.64 -26.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 32 3 # 32 A 18 SER F 19 SER~? 23.26 OXT ACT B1069 A 20 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 22 LEU B 21 LEU~? 28.08 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -25.55 19.67 -26.82 -26.43 21.64 -26.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 33 3 # 33 A 18 SER F 19 SER~? 23.26 OXT ACT B1069 A 20 HIS F 18 HIS~? 22.80 CH3 ACT B1069 A 22 LEU F 11 LEU~? 13.17 CH3 ACT B1069 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -13.87 14.96 -23.84 -12.87 16.04 -21.91 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -19.37 14.85 -12.38 -21.12 16.06 -12.09 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 33 hits 3gxq_d00 naa= 3 ULMN 3 3kmp_d00 TRANSCRIPTION REGULATOR/DNA user 1 3 # 1 A 74 ARG B 56 ARG~? 24.39 NA NA D1069 A 76 GLN A 59 GLN~? 34.47 NA NA D1069 A 81 LYS A 58 LYS~? 28.69 NA NA D1069 coo -17.53 -1.82 -11.90 -18.53 0.50 -13.59 -21.57 11.48 -78.51 -22.99 9.40 -76.67 coo -11.64 3.92 -10.28 -12.34 5.87 -10.62 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo -12.79 -0.17 -12.32 -15.96 3.61 -9.93 -25.52 13.14 -80.97 -27.21 10.04 -75.84 3kmp_d00 source 3kmp TRANSCRIPTION REGULATOR/DNA : 1 hits 3kmp_d00 naa= 3 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG F 13 ARG~? 20.80 CH3 ACT B1069 G 387 HIS F 18 HIS~? 22.80 CH3 ACT B1069 G 390 SER F 15 SER~? 18.74 OXT ACT B1069 coo 93.17 52.97 31.81 95.66 54.71 32.14 -18.65 6.83 -15.20 -21.43 5.64 -15.99 coo 95.60 53.07 40.31 97.10 52.52 41.67 -19.58 14.64 -22.09 -21.60 14.41 -21.58 coo 93.25 46.91 38.79 94.12 47.43 36.62 -16.65 14.44 -18.28 -15.27 16.35 -17.73 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 1 hits 3qrf_d00 naa= 3 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 81 ARG B 56 ARG~? 24.39 NA NA D1069 A 83 GLN A 59 GLN~? 34.47 NA NA D1069 A 88 LYS A 58 LYS~? 28.69 NA NA D1069 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -21.57 11.48 -78.51 -22.99 9.40 -76.67 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -29.47 16.46 -82.19 -30.70 18.21 -82.20 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -25.52 13.14 -80.97 -27.21 10.04 -75.84 3qsv_d00 source 3qsv TRANSCRIPTION/DNA : 1 hits 3qsv_d00 naa= 3 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 44 GLN~? 43.08 NA NA D1069 A 41 TYR A 48 TYR~? 40.75 NA NA D1069 A 43 ASN A 46 ASN~? 36.06 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -29.17 20.14 -58.33 -30.48 20.48 -56.65 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 14.90 7.30 8.78 14.25 8.14 6.97 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN A 47 GLN~? 34.25 NA NA D1069 A 41 TYR A 48 TYR~? 40.75 NA NA D1069 A 43 ASN A 46 ASN~? 36.06 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -27.90 17.70 -64.48 -26.57 16.10 -64.39 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 14.90 7.30 8.78 14.25 8.14 6.97 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 21 GLN A 49 GLN~? 33.84 NA NA D1069 A 41 TYR A 48 TYR~? 40.75 NA NA D1069 A 43 ASN A 46 ASN~? 36.06 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -23.88 23.73 -70.51 -22.44 25.27 -70.20 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 14.90 7.30 8.78 14.25 8.14 6.97 -23.19 22.33 -63.43 -22.08 24.02 -62.58 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 21 GLN A 49 GLN~? 33.84 NA NA D1069 A 41 TYR A 48 TYR~? 40.75 NA NA D1069 A 43 ASN A 51 ASN~? 34.27 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -23.88 23.73 -70.51 -22.44 25.27 -70.20 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -30.58 22.77 -66.16 -32.81 22.42 -64.52 coo 14.90 7.30 8.78 14.25 8.14 6.97 -28.79 17.13 -69.58 -28.71 15.77 -67.97 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 21 GLN B 44 GLN~? 31.01 NA NA D1069 A 41 TYR B 48 TYR~? 25.63 NA NA D1069 A 43 ASN B 46 ASN~? 32.72 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -18.25 9.40 -58.44 -18.17 8.09 -56.71 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -21.01 7.50 -66.79 -21.78 5.40 -68.42 coo 14.90 7.30 8.78 14.25 8.14 6.97 -21.42 15.21 -63.35 -23.25 15.93 -62.53 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 21 GLN B 47 GLN~? 24.93 NA NA D1069 A 41 TYR B 48 TYR~? 25.63 NA NA D1069 A 43 ASN B 46 ASN~? 32.72 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -15.74 11.77 -64.15 -14.74 13.64 -64.51 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -21.01 7.50 -66.79 -21.78 5.40 -68.42 coo 14.90 7.30 8.78 14.25 8.14 6.97 -21.42 15.21 -63.35 -23.25 15.93 -62.53 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 21 GLN C 49 GLN~? 11.67 NA NA D1069 A 41 TYR C 48 TYR~? 19.10 NA NA D1069 A 43 ASN C 46 ASN~? 17.71 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 18.67 0.21 9.03 16.70 -1.66 8.55 10.00 3.76 -66.60 11.23 5.15 -64.53 coo 14.90 7.30 8.78 14.25 8.14 6.97 3.13 0.40 -64.92 2.77 -1.60 -64.24 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 21 GLN C 49 GLN~? 11.67 NA NA D1069 A 41 TYR C 48 TYR~? 19.10 NA NA D1069 A 43 ASN C 51 ASN~? 14.73 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 6.75 -1.36 -70.51 6.64 -1.84 -72.70 coo 18.67 0.21 9.03 16.70 -1.66 8.55 10.00 3.76 -66.60 11.23 5.15 -64.53 coo 14.90 7.30 8.78 14.25 8.14 6.97 7.22 6.66 -71.10 6.71 7.78 -69.35 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 21 GLN C 52 GLN~? 11.89 NA NA D1069 A 41 TYR C 48 TYR~? 19.10 NA NA D1069 A 43 ASN C 51 ASN~? 14.73 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 8.98 1.89 -75.30 9.69 -0.13 -74.98 coo 18.67 0.21 9.03 16.70 -1.66 8.55 10.00 3.76 -66.60 11.23 5.15 -64.53 coo 14.90 7.30 8.78 14.25 8.14 6.97 7.22 6.66 -71.10 6.71 7.78 -69.35 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 21 GLN D 44 GLN~? 25.45 NA NA D1069 A 41 TYR D 48 TYR~? 17.05 NA NA D1069 A 43 ASN D 46 ASN~? 15.85 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -1.76 -7.13 -59.95 -2.19 -8.44 -58.33 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 14.90 7.30 8.78 14.25 8.14 6.97 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 21 GLN D 47 GLN~? 19.58 NA NA D1069 A 41 TYR D 48 TYR~? 17.05 NA NA D1069 A 43 ASN D 46 ASN~? 15.85 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 1.62 -4.84 -65.29 2.54 -5.50 -63.53 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -4.80 -7.68 -68.21 -6.26 -9.02 -70.16 coo 14.90 7.30 8.78 14.25 8.14 6.97 -2.97 -0.36 -64.37 -2.04 1.11 -65.57 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 21 GLN E 44 GLN~? 24.76 NA NA D1069 A 41 TYR E 48 TYR~? 17.09 NA NA D1069 A 43 ASN E 46 ASN~? 17.39 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -6.48 7.16 -59.68 -7.74 8.35 -58.46 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 14.90 7.30 8.78 14.25 8.14 6.97 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 21 GLN E 47 GLN~? 16.16 NA NA D1069 A 41 TYR E 48 TYR~? 17.09 NA NA D1069 A 43 ASN E 46 ASN~? 17.39 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -7.19 3.95 -65.74 -6.97 2.03 -66.63 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 14.90 7.30 8.78 14.25 8.14 6.97 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 21 GLN E 49 GLN~? 13.17 NA NA D1069 A 41 TYR E 48 TYR~? 17.09 NA NA D1069 A 43 ASN E 46 ASN~? 17.39 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 14.90 7.30 8.78 14.25 8.14 6.97 -0.49 5.22 -65.06 1.32 6.08 -64.31 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 A 21 GLN E 49 GLN~? 13.17 NA NA D1069 A 41 TYR E 48 TYR~? 17.09 NA NA D1069 A 43 ASN E 51 ASN~? 14.92 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -0.90 9.03 -70.89 1.09 9.62 -70.31 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -6.32 10.66 -67.74 -6.74 12.95 -69.31 coo 14.90 7.30 8.78 14.25 8.14 6.97 -8.35 5.89 -71.09 -8.92 4.59 -69.43 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 16 3 # 16 A 21 GLN F 44 GLN~? 36.24 NA NA D1069 A 41 TYR F 48 TYR~? 29.78 NA NA D1069 A 43 ASN F 46 ASN~? 28.25 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -15.05 24.73 -58.95 -14.10 25.53 -57.13 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 14.90 7.30 8.78 14.25 8.14 6.97 -17.12 18.46 -63.92 -16.59 16.49 -63.17 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 17 3 # 17 A 21 GLN F 47 GLN~? 33.35 NA NA D1069 A 41 TYR F 48 TYR~? 29.78 NA NA D1069 A 43 ASN F 46 ASN~? 28.25 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -18.85 24.82 -64.98 -20.45 24.10 -66.19 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 14.90 7.30 8.78 14.25 8.14 6.97 -17.12 18.46 -63.92 -16.59 16.49 -63.17 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 18 3 # 18 A 21 GLN F 49 GLN~? 22.45 NA NA D1069 A 41 TYR F 48 TYR~? 29.78 NA NA D1069 A 43 ASN F 46 ASN~? 28.25 NA NA D1069 coo 22.03 6.35 12.16 20.71 6.08 10.54 -13.98 18.28 -69.92 -12.44 18.33 -71.36 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -11.92 24.93 -66.40 -10.22 27.05 -67.15 coo 14.90 7.30 8.78 14.25 8.14 6.97 -17.12 18.46 -63.92 -16.59 16.49 -63.17 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 18 hits 3ssc_d00 naa= 3 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG C 56 ARG~? 9.44 NA NA D1069 A 82 LYS D 58 LYS~? 12.68 NA NA D1069 A 97 ARG E 56 ARG~? 8.81 NA NA D1069 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 7.82 2.72 -82.08 8.63 1.22 -84.68 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 3.16 -4.62 -82.15 7.67 -7.34 -78.86 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG D 56 ARG~? 10.15 NA NA D1069 A 82 LYS D 58 LYS~? 12.68 NA NA D1069 A 97 ARG E 56 ARG~? 8.81 NA NA D1069 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 3.16 -4.62 -82.15 7.67 -7.34 -78.86 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -1.98 8.80 -79.85 -2.24 9.73 -76.86 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG E 56 ARG~? 8.81 NA NA D1069 A 82 LYS C 58 LYS~? 11.96 NA NA D1069 A 97 ARG D 56 ARG~? 10.15 NA NA D1069 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -1.98 8.80 -79.85 -2.24 9.73 -76.86 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 4.28 9.49 -82.02 3.93 12.91 -77.18 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -4.73 -3.44 -81.62 -7.23 -4.76 -80.39 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 3 hits 4er8_d00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 12 GLU~? 11.83 O ACT B1069 A 44 ASP B 6 ASP~? 10.84 CH3 ACT B1069 A 50 THR B 9 THR~? 11.95 CH3 ACT B1069 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -25.70 24.60 -4.72 -27.42 24.68 -3.40 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -26.28 19.68 -8.80 -28.15 19.96 -7.76 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 12 GLU~? 11.90 CH3 ACT B1069 A 44 ASP F 6 ASP~? 11.75 OXT ACT B1069 A 50 THR F 9 THR~? 12.54 OXT ACT B1069 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -20.77 8.67 -5.03 -20.07 6.91 -4.07 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -16.74 10.62 -9.25 -15.99 8.78 -8.22 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU C 12 GLU~? 32.57 OXT ACT B1069 A 44 ASP E 6 ASP~? 34.65 OXT ACT B1069 A 50 THR E 9 THR~? 32.59 OXT ACT B1069 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 10.60 -0.59 -6.55 11.81 -0.09 -4.91 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.89 3.83 -10.60 10.62 4.71 -9.53 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU D 12 GLU~? 21.50 OXT ACT B1069 A 44 ASP C 6 ASP~? 26.20 OXT ACT B1069 A 50 THR C 9 THR~? 30.78 OXT ACT B1069 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -6.00 -4.16 -6.70 -6.49 -5.63 -5.27 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -1.17 -4.82 -10.56 -1.46 -6.75 -9.59 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU E 12 GLU~? 28.48 OXT ACT B1069 A 44 ASP D 6 ASP~? 18.23 OXT ACT B1069 A 50 THR D 9 THR~? 18.30 OXT ACT B1069 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -0.05 12.02 -6.83 -0.93 13.40 -5.45 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -3.48 8.28 -10.68 -4.69 9.73 -9.70 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU F 12 GLU~? 12.40 OXT ACT B1069 A 44 ASP A 6 ASP~? 11.36 O ACT B1069 A 50 THR A 9 THR~? 12.00 O ACT B1069 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -9.40 20.26 -5.39 -7.91 21.27 -4.18 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -13.51 23.50 -9.41 -12.46 25.07 -8.35 3hde_o00 source 3HDE LYSOZYME : 6 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 12 GLU~? 11.83 O ACT B1069 B 44 ASP B 6 ASP~? 10.84 CH3 ACT B1069 B 50 THR B 9 THR~? 11.95 CH3 ACT B1069 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -25.70 24.60 -4.72 -27.42 24.68 -3.40 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -26.28 19.68 -8.80 -28.15 19.96 -7.76 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 12 GLU~? 11.90 CH3 ACT B1069 B 44 ASP F 6 ASP~? 11.75 OXT ACT B1069 B 50 THR F 9 THR~? 12.54 OXT ACT B1069 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -20.77 8.67 -5.03 -20.07 6.91 -4.07 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -16.74 10.62 -9.25 -15.99 8.78 -8.22 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU C 12 GLU~? 32.57 OXT ACT B1069 B 44 ASP E 6 ASP~? 34.65 OXT ACT B1069 B 50 THR E 9 THR~? 32.59 OXT ACT B1069 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 10.60 -0.59 -6.55 11.81 -0.09 -4.91 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 8.89 3.83 -10.60 10.62 4.71 -9.53 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU D 12 GLU~? 21.50 OXT ACT B1069 B 44 ASP C 6 ASP~? 26.20 OXT ACT B1069 B 50 THR C 9 THR~? 30.78 OXT ACT B1069 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -6.00 -4.16 -6.70 -6.49 -5.63 -5.27 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -1.17 -4.82 -10.56 -1.46 -6.75 -9.59 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU E 12 GLU~? 28.48 OXT ACT B1069 B 44 ASP D 6 ASP~? 18.23 OXT ACT B1069 B 50 THR D 9 THR~? 18.30 OXT ACT B1069 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 5.80 6.61 -13.13 6.29 7.73 -11.36 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -0.05 12.02 -6.83 -0.93 13.40 -5.45 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -3.48 8.28 -10.68 -4.69 9.73 -9.70 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU F 12 GLU~? 12.40 OXT ACT B1069 B 44 ASP A 6 ASP~? 11.36 O ACT B1069 B 50 THR A 9 THR~? 12.00 O ACT B1069 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -9.40 20.26 -5.39 -7.91 21.27 -4.18 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -13.51 23.50 -9.41 -12.46 25.07 -8.35 3hde_o01 source 3HDE LYSOZYME : 6 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 12 GLU~? 11.83 O ACT B1069 C 44 ASP B 6 ASP~? 10.84 CH3 ACT B1069 C 50 THR B 9 THR~? 11.95 CH3 ACT B1069 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -17.70 24.35 -11.61 -17.46 25.17 -9.66 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -25.70 24.60 -4.72 -27.42 24.68 -3.40 coo 25.48 4.87 1.60 23.90 4.95 0.15 -26.28 19.68 -8.80 -28.15 19.96 -7.76 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 12 GLU~? 11.90 CH3 ACT B1069 C 44 ASP F 6 ASP~? 11.75 OXT ACT B1069 C 50 THR F 9 THR~? 12.54 OXT ACT B1069 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -24.87 16.12 -11.22 -25.79 15.51 -9.37 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -20.77 8.67 -5.03 -20.07 6.91 -4.07 coo 25.48 4.87 1.60 23.90 4.95 0.15 -16.74 10.62 -9.25 -15.99 8.78 -8.22 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU C 12 GLU~? 32.57 OXT ACT B1069 C 44 ASP E 6 ASP~? 34.65 OXT ACT B1069 C 50 THR E 9 THR~? 32.59 OXT ACT B1069 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 2.79 -3.74 -12.78 3.22 -4.81 -10.95 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 10.60 -0.59 -6.55 11.81 -0.09 -4.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 8.89 3.83 -10.60 10.62 4.71 -9.53 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU D 12 GLU~? 21.50 OXT ACT B1069 C 44 ASP C 6 ASP~? 26.20 OXT ACT B1069 C 50 THR C 9 THR~? 30.78 OXT ACT B1069 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -4.87 3.90 -13.16 -5.51 4.18 -11.17 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -6.00 -4.16 -6.70 -6.49 -5.63 -5.27 coo 25.48 4.87 1.60 23.90 4.95 0.15 -1.17 -4.82 -10.56 -1.46 -6.75 -9.59 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU F 12 GLU~? 12.40 OXT ACT B1069 C 44 ASP A 6 ASP~? 11.36 O ACT B1069 C 50 THR A 9 THR~? 12.00 O ACT B1069 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -14.17 13.80 -11.75 -13.10 13.24 -9.99 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -9.40 20.26 -5.39 -7.91 21.27 -4.18 coo 25.48 4.87 1.60 23.90 4.95 0.15 -13.51 23.50 -9.41 -12.46 25.07 -8.35 3hde_o02 source 3HDE LYSOZYME : 5 hits 3hde_o02 naa= 3